,Tweet content,date,symbol,increase
0,"$ALXN received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 479Want the latest upgrades &amp; downgrades for $ALXN $PLX $RIGL $PCL $RYN? Checkout MarketBeat Daily https://t.co/nSJuDsYidj$ALXN:US Alexion: Kanuma Approved In Japan For Treatment Of LAL-D #ALEXION PHARMACEUTICALS INC  https://t.co/RGqatDyBT6 #NASDAQRT @ChinaInvest: RT SeekingAlpha: Biotechnology Poised To Move Higher https://t.co/IwULX56BKJ $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EG…RT SeekingAlpha: Biotechnology Poised To Move Higher https://t.co/IwULX56BKJ $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EGRX $GILD $IBB $I…Biotechnology Poised To Move Higher https://t.co/oFuep5f2Zi $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EGRX $GILD $IBB $ILMN $INCY $IONSRT @moderna_tx: Saqib Islam - formerly of $ALXN - will join @moderna_tx as CBO, bringing key expertise to advance our pipeline https://t.co…$ALXN Kanuma approved in Japan https://t.co/fhd2XACCgPRT @moderna_tx: Saqib Islam - formerly of $ALXN - will join @moderna_tx as CBO, bringing key expertise to advance our pipeline https://t.co…Alexion's enzyme replacement therapy for LAL-D cleared in Japan https://t.co/wO90FTXX62 $ALXN
#biotechRT @OptionAlert: Unusually heavy option volume on today's open include $XLNX, $PAYX, $PVH, $GME, and $ALXN.$ALXN:US Alexion: Kanuma Approved In Japan For Treatment Of LAL-D #ALEXION PHARMACEUTICALS INC  https://t.co/WmRAg9yYoP #NASDAQRT @OptionAlert: Unusually heavy option volume on today's open include $XLNX, $PAYX, $PVH, $GME, and $ALXN.Unusually heavy option volume on today's open include $XLNX, $PAYX, $PVH, $GME, and $ALXN.$ALXN:US Alexion: Kanuma Approved In Japan For Treatment Of LAL-D #ALEXION PHARMACEUTICALS INC  https://t.co/0PcxOCU5ai #SP500Alexion's enzyme replacement therapy for LAL-D cleared in Japan https://t.co/ON4PUM0kF2 $ALXNAlexion's enzyme replacement therapy for LAL-D cleared in Japan https://t.co/XnSa61iuMb $ALXNAlexion's enzyme replacement therapy for LAL-D cleared in Japan https://t.co/7Yo8LoWbSB $ALXNRT @moderna_tx: Saqib Islam - formerly of $ALXN - will join @moderna_tx as CBO, bringing key expertise to advance our pipeline https://t.co…RT @moderna_tx: Saqib Islam - formerly of $ALXN - will join @moderna_tx as CBO, bringing key expertise to advance our pipeline https://t.co…Saqib Islam - formerly of $ALXN - will join @moderna_tx as CBO, bringing key expertise to advance our pipeline https://t.co/c5n828vmu0BRIEF-#Alexion Pharmaceuticals Kanuma receives marketing approval in Japan. Read more: https://t.co/BVa5NlRqNZ $ALXNBRIEF-#Alexion Pharmaceuticals Kanuma receives marketing approval in Japan. Read more: https://t.co/tu22LwUYLC $ALXNRT @techwhitepapers: Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016 $AGN $AKRX $ALXN  https://t.co/33Shz5yCF…$ALXN Kanuma(R) (sebelipase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Lysosom
From our Stock News Alerts App#Alexion Pharmaceuticals : Kanuma® (sebelipase alfa) Receives Marketing Approv... https://t.co/dWeXg5qpOS $ALXNWeekly Nasdaq100 #Stocks Performance $INCY $SPLS $ILMN $WYNN $NVDA $WDC $BMRN $AMZN $ALXN $CELG $MYL $ISRG  more@ https://t.co/YdSIjFJqHfPiper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016 $AGN $AKRX $ALXN  https://t.co/33Shz5yCF0 via @benzinga good",2016-03-28,ALXN,1
1,"Our Picks Are Seeing Incredible Gains! Get Exclusive Early Access To Our New Alerts: https://t.co/dWbN7JMySK $ALXN $PCAR $REGN#Alexion Pharmaceuticals' Kanuma Gains Approval in Japan. Read more: https://t.co/klelCaFOgP $ALXN#Alexion Pharmaceuticals' Kanuma Gains Approval in Japan. Read more: https://t.co/5byw4kaoRs $ALXNConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $ALXN $PCAR $REGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $ALXN $PCAR $REGN#Alexion Japanese approval for Kanuma in LAL-D. Read more: https://t.co/YpQvYUMV3l $ALXN$ALXN Apr 140 Call buyer +750 for $1.30#Alexion Japanese approval for Kanuma in LAL-D. Read more: https://t.co/cg1Flt4wyi $ALXN$ALXN $TSL:

Active Stocks to Watch: Chevron Corporation (NYSE:CVX), Alexion …:

https://t.co/6fMqSeZZ0H$CVX $ALXN:

Active Stocks to Watch: Chevron Corporation (NYSE:CVX), Alexion …:

https://t.co/sJxNs9eyELAlexion Pharmaceuticals, Inc. $ALXN Shares Bought by RidgeWorth Capital Management LLC https://t.co/k2bhujQsbwAlexion Pharmaceuticals, Inc. $ALXN Shares Bought by RidgeWorth Capital Management LLC https://t.co/MiVzR6RflRAlexion Pharmaceuticals, Inc. $ALXN Shares Bought by RidgeWorth Capital Management LLC https://t.co/R30JC0YNrb$ALXN:

The Daily Startup: Slice Labs Seeded to Provide Insurance for On …:

https://t.co/LernU4I4T2Sawtooth Asset Management Inc. Has $1,389,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/kQunPmlZMWSawtooth Asset Management Inc. Has $1,389,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/kYMNGFxZazWeekly Nasdaq100 #Stocks Performance $SPLS $AMZN $NVDA $FB $ORLY $CTSH $ALXN $SRCL $EA $BMRN $HSIC $AMGN  more@ https://t.co/YdSIjFJqHfhttps://t.co/5ebuP2U6fG Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBS$ALXN:

Shares of Alexion Pharmaceuticals (NASDAQ:ALXN) Sees Large …:

https://t.co/5RROghkjxTJapanese approvals for #Alexion, Eisai, Biocon. Read more: https://t.co/S3shaHCCfA $ALXNJapanese approvals for #Alexion, Eisai, Biocon. Read more: https://t.co/onne0OBFtk $ALXNBiotech Trade Alerts Archive -2016-03-24- $ACAD $AERI $ALDR $ALXN $ARLZ $CASI $EGRX $ONTX $OXGN $XNPT https://t.co/iVBMSFykmC$ALXN:

The Daily Startup: Slice Labs Seeded to Provide Insurance for On …:

https://t.co/xH7nGX7IcmRT @moderna_tx: Saqib Islam - formerly of $ALXN - will join @moderna_tx as CBO, bringing key expertise to advance our pipeline https://t.co…$ALXN | Alexion Pharmaceuticals, Inc. is down 28% since we reported $11,534,985 of insider selling on ... - https://t.co/jCfiaVVN8Z",2016-03-29,ALXN,1
2,"Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $ALXN $PCAR $REGNParabolic SAR Buy https://t.co/PDR0nsKeZg $ADS $MSG $ILMN $FDS $IHE $KMB $ALXN $JAZZ $LFUS $ALV $LH $CEO $BTI $ANAT $CMI $DEO $SPBMutual of America Capital Management LLC Acquires 118 Shares of #Alexion Pharmaceuticals, I... Read more: https://t.co/xGxYL7zhW4 $ALXNMutual of America Capital Management LLC Acquires 118 Shares of #Alexion Pharmaceuticals, I... Read more: https://t.co/Bj5JTKdikl $ALXNBp Plc Has $3,815,000 Stake in #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/oaoFRZY2BE $ALXNBp Plc Has $3,815,000 Stake in #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/cBWXfHxtEm $ALXNRT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR…RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR…RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR…RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR…Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR $ALNY $BIIBThornburg Investment Management Inc. Has $21,911,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/HFNtvrScSUMutual of America Capital Management LLC Acquires 118 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/gyKfaFIqKIBp Plc Has $3,815,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/V73detRjIdBp Plc Has $3,815,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/RZuVyVzhZqBp Plc Has $3,815,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/Rdccje03xlmRNA Co Moderna hires new CBO from partner $ALXN: https://t.co/38gykNCPK2 Does that mean partnership has fallen apart?Three Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $ALXN $PCAR $REGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $ALXN $PCAR $REGN",2016-03-30,ALXN,1
3,"Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $ALXN $PCAR $REGNS&amp;P500 #Stocks Performance $MRO $SWN $DVN $HOG $SIG $HES $ALXN $MUR $XRX $MLM $VIAB $OKE $RIG $BBY $CHK  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $VIP $INCY $BMRN $ALXN $ILMN $VIAB $BIIB $WDC $NTAP $DISCA $VRSK $VRTX $PAYX  more@ https://t.co/YdSIjFJqHf$ALXN New SEC Document(s) for Alexion Pharmaceuticals, Inc.
From our Stock News Alerts App$ALXN:

New SEC Filing for ALXN: Form DEFA14A (No. 0000899866-16-000284):

https://t.co/7eg4TX1dRI https://t.co/uGXm2QRuNBAlexion Pharmaceuticals releases salary data. CEO sees compensation rise 21%25 https://t.co/VH6HPP7AZW $ALXNhttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSS&amp;P500 #Stocks Performance $MRO $SWN $DVN $HOG $ALXN $HES $SIG $MUR $BBY $VRTX $MLM $OKE $XRX $RIG $BIIB  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $INCY $VIP $BMRN $ALXN $ILMN $VRTX $TSLA $BIIB $VIAB $WDC $NTAP $CELG $DISCA  more@ https://t.co/YdSIjFJqHf#stocks some bear flags https://t.co/vRmWELX9X9 $ALXN $RIGL $BAMNBConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNR$ALXN: 1mRunaway+:4 [+3%,.8%offHi], tf:0111001; TLM:1.3; ILM:1.3, 1WkHi+, DyVol:1.06M:0.8x:0.6x, DyRng:4.4%:1.4x:1.3x (PotLONG)$IBB $.SPX $VRTX $REGN $ALXN $BIIB $CELG $GILD $AMGN:

Can biotech recover from big slide?:

https://t.co/uP5kvz4wVF$ALXN | Alexion Pharmaceuticals, Inc. is down 28% since we reported $5,871,623 of insider selling on ... - https://t.co/8ItBr2mwHUS&amp;P500 #Stocks Performance $SWN $MRO $XRX $BBY $CHK $ALXN $DVN $MUR $HES $IBM $MLM $SNI $RCL $HAR $VRTX  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $INCY $BMRN $VIP $ILMN $ALXN $VRTX $PAYX $TSLA $CELG $BIIB $BIDU $NTAP $VRSK  more@ https://t.co/YdSIjFJqHfNorinchukin Bank The Has $2,008,000 Position in #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/XsCA0rSxjl $ALXNNorinchukin Bank The Has $2,008,000 Position in #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/wkTwDWuMhe $ALXN$ALXN: 1mRunaway+:3 [+3%,.1%offHi], 0NearHi, tf:0111111; TLM:1.1; ILM:1.1, 1WkHi+, DyVol:432T:0.3x:0.3x, DyRng:3.4%:1.1x:1x (PotLONG)Yesterday We Made $94,000 In Just One Trade More Info Here https://t.co/ZMvOsK1CVa .. $ALXN $PCAR $REGNNotable gainers among liquid option names this morning include $SWN (+4.3%), $MRO (+4.0%), $XRX (+3.7%), $BBY (+3.3%), and $ALXN (+2.9%),Unusually heavy option volume on today's open include $CCE, $ALXN, $GT, $CCL, and $XRX.Norinchukin Bank The Has $2,008,000 Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/tTFGKBCzwyNorinchukin Bank The Has $2,008,000 Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/ukjPwnRHAd$BKD $ALXN:

Healthcor Management Lp Increased Brookdale Sr Living Inc (NYSE …:

https://t.co/XRyX4aeCNNToronto Dominion Bank Sells 294 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/51L2DJFUOmThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sgRRp $ALXN $PCAR $REGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8QMnm $ALXN $PCAR $REGNPremium Alerts Ranked #1 For Gains 2834% Last Week At https://t.co/ewcYkLb72h .. $ALXN $GIII $PTNRAny #BioTech investors out there?

Check out this fund:  https://t.co/8v5qUgfoS5

$GILD $BIIB $JAZZ $INSY $ALXN $AMRI $ANIK $BMRN #StocksThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $ALXN $PCAR $REGN",2016-03-31,ALXN,1
4,"https://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBSEnter Ichimoku https://t.co/ICgK38O3FT $NKE $WFT $EXEL $MTG $HZNP $ALXN $KBE $EGN $SVU $DVAX $WRK $MPLX $HMC $TDC $STMP $GIG $AGIO $CEMPS&amp;P500 #Stocks Trend $EW $ABBV $ALXN $BSX $ISRG $PFE $CCE $CAH $BCR $VAR $AAPL $TMO $BDX $TWX $GIS $AMGN $MSI  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $EW $SWN $VRTX $AGN $ABBV $CI $ALXN $BSX $ISRG $PFE $RRC $CNX $CCE $MDT $CAH  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $TSLA $ALXN $ISRG $AAPL $ILMN $AMGN $INTU $LBTYA $GILD $BMRN $CTXS $YHOO $FOXA $CHTR  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $VRTX $TSLA $ALXN $ISRG $CHTR $SYMC $AAPL $CERN $ADSK $ILMN $AMGN $INCY $INTU more@ https://t.co/YdSIjFJqHfFor 8ema cross 21ema stocks 
$GRPN
$SKYS
$MDT
$EXEL
$SC
$SNY
$RTN
$HOLX
$HZNP
$BIIB
$ALXN
$REGN
$KITE
Nice crossToday was the 5th consecutive winning day for $ALXN. Can it end up again? https://t.co/k3tOdGfSIX #stocks https://t.co/nOkoMSFE6tI always watch out for these crappy insider sales, nearly almost a deep impact for a stock. Yuk! No pos $ALXN ;) https://t.co/FQX86MmmxP$IBB has 190 holdings; top 10 = 57.83% weight; basically you are saying $AMGN $GILD $REGN $BIIB $CELG $ILMN $MYL $ALXN $VRTX $INCYAlexion Pharmaceuticals, Inc. $ALXN Trading Up 3.8% https://t.co/dvDW11M8f8RT @InsiderWire: $ALXN | Alexion Pharmaceuticals, Inc. is down 24% since we reported $5,871,623 of insider selling on ... - https://t.co/G0…$ALXN | Alexion Pharmaceuticals, Inc. is down 24% since we reported $5,871,623 of insider selling on ... - https://t.co/G0GdHG3LcDS&amp;P500 #Stocks Trend $EW $ALXN $ABBV $ISRG $BSX $PFE $MDT $ADSK $VAR $AAPL $CCE $BDX $TMO $TWX $BCR $CAH $HCN  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $EW $SWN $VRTX $ALXN $CNX $AGN $ABBV $ISRG $CI $BSX $RRC $PFE $TSO $MDT $CMA  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $TSLA $ALXN $ISRG $CHTR $ADSK $AAPL $BMRN $ILMN $AMGN $CELG $GILD $LBTYA $INTU $CTXS  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $VRTX $TSLA $ALXN $ISRG $CHTR $ADSK $AAPL $BMRN $SYMC $CERN $INCY $REGN $ILMN more@ https://t.co/YdSIjFJqHfIt's Official: The Good Times Are Over https://t.co/SMnhHtdjUQ $IBB, $XBI, $BIB, $BBH, $FBT, $JNJ, $GSK, $VRX, $REGN, $ALXN, $VRTX, $TEVA$ALXN,List:Coming out of Bear Trend,Quote:148.23,Change:5.29,Target:166.0$ALXN 20160415 83 trade. ~$1.2 MM notional value.$ALXN #Alexion 148.20
For Mon Apr 4
VZVOBO:
Get Long  BSTP 146.61
Today's O=143.48
So far H=148.45
CAM R4=146.97, R5=148.81, R6=150.65all the action is mostly in Healthcare, Drugs, and Biotech
$SPX $SPY $XBI $IBB $NBIX $ALXN $VRTX $AGN $ABBV $PFE https://t.co/RGPiSZF1r0$IBB doing well today even into this weakness.. #biotech stocks pushed up well since last week 
$JAZZ $AMGN $BIIB $CELG $REGN $ALXN etc.S&amp;P500 #Stocks Performance $EW $SWN $RRC $CNX $VRTX $CMA $ALXN $AGN $ABBV $COG $CI $PFE $TSO $MCK $ENDP  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $VRTX $TSLA $ALXN $BMRN $ISRG $MYL $AAPL $ADSK $SYMC $CHTR $CELG $CERN $AMGN  more@ https://t.co/YdSIjFJqHfRT @OptionAlert: Unusually heavy option volume on today's open include $DLPH, $SJM, $EW, $ALXN, and $MDT.RT @newbieHH: $ALXN @TradeIdeas1 https://t.co/70Bifkw1EoRT @OptionAlert: Unusually heavy option volume on today's open include $DLPH, $SJM, $EW, $ALXN, and $MDT.Unusually heavy option volume on today's open include $DLPH, $SJM, $EW, $ALXN, and $MDT.$FATE with breakout +7%...biotech rally $IBB $JAZZ $ALXN $SGEN $JUNO$ALXN @TradeIdeas1 https://t.co/70Bifkw1Eo$ALXN: Alexion Pharma presents new data showing children with perinatal- and infantile-onset HPP treated with... https://t.co/FeN5Sfv2Bl$AZN $ALXN:

Two Movers inside Analysts Radar: Astrazeneca PLC (NYSE:AZN …:

https://t.co/8kpAMOM7EH$ALXN:

Two Movers inside Analysts Radar: Astrazeneca PLC (NYSE:AZN …:

https://t.co/BPuq9a3kf9https://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSMitsubishi UFJ Kokusai Asset Management CO. LTD. Acquires 1,933 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/V7TnhhqkJPMitsubishi UFJ Kokusai Asset Management CO. LTD. Acquires 1,933 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/dRDvJO77XCMitsubishi UFJ Kokusai Asset Management CO. LTD. Acquires 1,933 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/UlDy62qdbd#Alexion Pharmaceuticals : Data Presented at ENDO 2016 Show Sustained Improvem... https://t.co/7RI4FN0lmR $ALXN$ALXN Data Presented at ENDO 2016 Show Sustained Improvements in Survival Rates, Bone Healing, Respiratory Su
From our Stock News Alerts AppWeekly S&amp;P500 #Stocks Performance $RCL $REGN $TRIP $CCL $ATVI $HOG $ALXN $MNK $CSC $RHI $DLTR $UHS $AMAT  more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Performance $REGN $TRIP $ATVI $ILMN $ALXN $DLTR $AMAT $LBTYA $CERN $INCY $VIP  more@ https://t.co/YdSIjFJqHfConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRDeere &amp; Co. Sells 215 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/7CvMcd4mfgDeere &amp; Co. Sells 215 Shares of #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/d9V2mtAD9A $ALXNDeere &amp; Co. Sells 215 Shares of #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/mRiGiKjEn6 $ALXN$ALXN - BUY Signal at 142.96 on Apr 01, 16 By https://t.co/6PpjiKmc9G, Trading Robot#Stockstowatch #Stockmarket #trading #trade #investingDeere &amp; Co. Sells 215 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/3moiLRXijgViral Video on the Biggest Bubble in the entire U.S. Economy! https://t.co/CY8xcPtqvO 
$AFL $AMG $A $GAS $APD $ARG $AKAM $AA $AGN $ALXN $ADSAmalgamated Bank Sells 1,666 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/V7vEaodEpxBrokerages Set #Alexion Pharmaceuticals, Inc. Target Price at $206.73. Read more: https://t.co/ozAogbQXeV $ALXNBrokerages Set #Alexion Pharmaceuticals, Inc. Target Price at $206.73. Read more: https://t.co/u2lSfqI06c $ALXN$ALXN:

Brokerages Set Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN …:

https://t.co/XY8LxVUY0tRT @lancejepsen: Analyst Actions and Breaking News $WILN $WFM $MT $NVGN $ATVI $ASYS $ABBV $ALXN https://t.co/TtbrYQAVM9 https://t.co/RSdmVz…$ALXN:

Company Shares of Alexion Pharmaceuticals (NASDAQ:ALXN …:

https://t.co/FQGCIvSxFsConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNR",2016-04-04,ALXN,1
5,"S&amp;P500 #Stocks Trend $PFE $GILD $CELG $LMT $ALXN $NOC $PM $CCE $MRK $BMY $ABBV $EW $ZTS $EBAY $NFLX $ISRG $BSX @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $TSLA $GILD $CELG $ALXN $EBAY $NFLX $ISRG $FOXA $BMRN $INCY $AMGN $ILMN $GRMN $ADP $TXN @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $TSLA $VRTX $EBAY $GILD $CELG $BIIB $ALXN $NFLX $GRMN $LLTC $CHRW $ADP $NTAP  more@ https://t.co/YdSIjFJqHfNice and might run more 
$RJDG
$CVM
$GRPN
$RTN
$BIIB
$ALXN$ALXN New SEC Document(s) for Alexion Pharmaceuticals, Inc.
From our Stock News Alerts App$ALXN:

New Insider Transaction on ALXN by CEO:

https://t.co/RwR7Q3b8lx https://t.co/TajQ3iwCurS&amp;P500 #Stocks Trend $PFE $GILD $CELG $ALXN $LMT $NOC $MRK $BMY $CCE $PM $EW $ABBV $ADP $BSX $ISRG $ZTS $LLL  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $TSLA $GILD $CELG $ALXN $ADP $ISRG $BMRN $EBAY $NFLX $TXN $FOXA $INCY $CHTR $AAPL $AMGN @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $TSLA $VRTX $GILD $EBAY $CELG $ALXN $NFLX $BIIB $NTAP $LLTC $FAST $REGN $ADP  more@ https://t.co/YdSIjFJqHfRT @RareDR: #ENDO2016 Long Term Effects of Asfotase Alfa in Hypophosphatasia Patients https://t.co/byYdYOTbcI $ALXN https://t.co/La4KqWLzIt#ENDO2016 Long Term Effects of Asfotase Alfa in Hypophosphatasia Patients https://t.co/byYdYOTbcI $ALXN https://t.co/La4KqWLzItRT @SullyCNBC: If Pfizer/Allergan deal falls through, Cowen &amp; Co says ""potential targets"" for $AGN could be: $BIIB $ALXN $BMRN or $VRTX to…clayton: ALXN 146.60 Alexion Pharm Inc $ALXN added to my https://t.co/2yQ7qpNhULclayton: ALXN 146.60 Alexion Pharm Inc $ALXN added to my https://t.co/CZB5IKiZhKRT @SullyCNBC: If Pfizer/Allergan deal falls through, Cowen &amp; Co says ""potential targets"" for $AGN could be: $BIIB $ALXN $BMRN or $VRTX to…ALXN 146.60 Alexion Pharm Inc $ALXN added to my watch list. Right now with ALXN I am watching the last price 1 https://t.co/7qQDls7XZZRT @SullyCNBC: If Pfizer/Allergan deal falls through, Cowen &amp; Co says ""potential targets"" for $AGN could be: $BIIB $ALXN $BMRN or $VRTX to…If Pfizer/Allergan deal falls through, Cowen &amp; Co says ""potential targets"" for $AGN could be: $BIIB $ALXN $BMRN or $VRTX to lesser extentResearch Analysts’ Updated EPS Estimates for April, 5th $ALXN, ASB, ATUSF, BKU, BPFH, CLVS, FNFG, FRC, GWB, ICPT https://t.co/boB3FJdA76#FastMoneyEspresso
FINAL CALLS:
Stephanie Link —&gt; buy $ALXN
Sarat Sethi—&gt; buy retailers
Pete Najarian —&gt; buy $AGN call spreads$ALXN 20160415 97 trade. ~$1.4 MM notional value.Vetr users have downgraded Alexion Pharmaceutic... to a BUY Rating (4 stars), giving $ALXN a target price of $161.67 https://t.co/9E59wxz4mNS&amp;P500 #Stocks Trend $GILD $PFE $NOC $LMT $ALXN $CCE $MRK $BSX $BMY $PM $BDX $MNK $EW $ABBV $JNJ $KMB $EL $PEP @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $GILD $ALXN $ISRG $TSLA $BMRN $FOXA $INCY $EBAY $NFLX $SPLS $AMGN $ILMN $ADP $TXN $SBAC @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $VRTX $GILD $INCY $REGN $BIIB $TXN $LLTC $ALXN $EBAY $CELG $MNST $NFLX $FB  more@ https://t.co/YdSIjFJqHf$ALXN,List:Coming out of Bear Trend,Quote:147.74,Change:0.64,Target:166.0Alexion Pharmaceuticals’ $ALXN Buy Rating Reiterated at Piper Jaffray https://t.co/BaEJq2XFHpAlexion Pharmaceuticals's buy rating reiterated at Piper Jaffray. $212.00 PT. https://t.co/JNLXDlF7cS $ALXN #ALXNAlexion Pharmaceuticals Reiterated Rating by Piper Jaffray (Ranked 60th) to Buy with 212 PT $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals's buy rating reiterated at Piper Jaffray. $212.00 PT. https://t.co/x5yoV1fpjs $ALXN #ALXNPiper Jaffray Assigned a Buy Rating to Alexion Pharmaceuticals $ALXN https://t.co/tlD3CQdbm5$ALXN PiperJaffray hosted a call to preview the upcoming Myasthenia Gravis data---reiterate Overweight &amp; $212 PTCYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $ALNEV.PA $ALNOV.PA $ALNY $ALONC.PA $ALSE $ALSED $ALXN $AMARAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Morgan Stanley https://t.co/jpkDTnyvZXAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Morgan Stanley https://t.co/wqPKPRDaZT#Alexion Pharmaceuticals, Inc. Rating Reiterated by Morgan Stanley. Read more: https://t.co/p61MP2LD5f $ALXNAlexion Pharmaceuticals, Inc. $ALXN Position Boosted by Principal Financial Group Inc. https://t.co/w14UesRhfHAlexion Pharmaceuticals, Inc. $ALXN Position Boosted by Principal Financial Group Inc. https://t.co/DeNrvCQXR8Alexion Pharmaceuticals, Inc. $ALXN Stock Price Up 3.8% https://t.co/yX9rUEmtQPRT @hybridfund: Watch List: $TSLA $VRX $AGN $NUGT $REGN $ALXN $BLUEWatch List: $TSLA $VRX $AGN $NUGT $REGN $ALXN $BLUEStocks on the Move – 4/4
https://t.co/ixSQFJRzfw
$BAC $PFE $FB $GE $F $FCX $AAPL $SWN $CHK $PHM $EW $VRTX $ANTM $AGN $ABBV $CI $ALXN $BSX$ALXN $MRK:

Shining Stocks in News Recap- Alexion Pharmaceuticals (NASDAQ …:

https://t.co/A638qBrQlzHealthcare Sector Trader’s Buzzers: $GBSN $ALXN https://t.co/Xftk8VDERaWeekly S&amp;P500 #Stocks Trend $EW $ALXN $ZTS $MNK $BSX $ISRG $GIS $AAPL $ABBV $VAR $CRM $BMY $YHOO $AMT $AMGN  @ https://t.co/RPeaHBHYi0Weekly S&amp;P500 #Stocks Performance $EW $SWN $REGN $ALXN $RCL $ZTS $CCL $MNK $BSX $ATVI $ISRG $HOG $TSS  more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $ALXN $ILMN $TSLA $BMRN $ISRG $LBTYA $AAPL $YHOO $AMGN $CTXS $INTU $FOXA $GILD  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $REGN $ALXN $ILMN $INCY $TSLA $BMRN $ATVI $ISRG $CERN $LBTYA $AAPL  more@ https://t.co/YdSIjFJqHf$ALXN Data Presented at ENDO 2016 Show Sustained Improvements … https://t.co/ZrFjblBrVUCYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $ALX $ALXA $ALXN $AM $AMAG $AMAT $AMBA $AMBCHealthcare Stocks Lead On A Lackluster Day $BMY $EW $RHHBY $ACAD $ALNY $ALXN $ANAC $IBB $GILD $NBIX $VRTX $ZIOP ... https://t.co/RfC2zV4csiAlexion Pharmaceuticals, Inc. $ALXN Downgraded by Vetr Inc. to Buy https://t.co/RJRzGrVLQ2$ALXN  https://t.co/nt8XiwrWrk via https://t.co/11Wpw9PIRBHealthcare Stocks Lead On A Lackluster Day $BMY $EW $RHHBY $ACAD $ALNY $ALXN $ANAC $IBB $GILD $NBIX $VRTX $ZIOP ... https://t.co/TeucuTOu6h$FSC 2
$GRA 2
$HRTX 2
$IAC 2
$IBB 2
$IHE 2
$INCY 2
$INSM 2
$BIIB 2
$AMRI 2
$LHCG 2
$LPLA 2
$ALXN 2
$MDSO 2
$MGNX 2
$MRTX 2
$OTIC 2
$PBE 2$ALXN:

Ruling stocks in today’s market: Alexion Pharmaceuticals, Inc …:

https://t.co/WDvrfhNgYE",2016-04-05,ALXN,1
6,"keep it simple. lower channel breakout. stop 150.. let it riiiddeee long https://t.co/pBlpQNpfEq  $ALXNRT @tgtxdough: BMO Initiating Coverage $ALXN $NBIX $INCY $ICPT and $BMRN  Competition Picking Up &amp; ALXN-1210 May Not Be the Best AnswerS&amp;P500 #Stocks Trend $ALXN $CELG $STZ $REGN $OI $MCK $BIIB $PFE $AMGN $MNK $EBAY $KMX $EW $CAH $ZTS $SEE $MLM  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $BHI $ENDP $VRTX $ALXN $CELG $HAL $STZ $REGN $OI $MCK $HES $MYL $BIIB $APA $PFE more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $INCY $BMRN $ILMN $ALXN $CELG $REGN $BIIB $AMGN $EBAY $TSLA $ISRG $GILD $FOXA $ADP  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $VRTX $BMRN $ILMN $ALXN $CELG $REGN $MYL $BIIB $AMGN $EBAY $TSLA $AKAM  more@ https://t.co/YdSIjFJqHfExpansion Breakout https://t.co/YJO7WO1zrz $STZ $IBB $IRWD $LABU $XBI $XLV $KMX $ZTS $GNC $SEE $MRK $HALO $ALXN $NKTR $DNKN $WU $ALB $ABTRT @tgtxdough: BMO Initiating Coverage $ALXN $NBIX $INCY $ICPT and $BMRN  Competition Picking Up &amp; ALXN-1210 May Not Be the Best AnswerRT @tgtxdough: BMO Initiating Coverage $ALXN $NBIX $INCY $ICPT and $BMRN  Competition Picking Up &amp; ALXN-1210 May Not Be the Best AnswerRT @tgtxdough: BMO Initiating Coverage $ALXN $NBIX $INCY $ICPT and $BMRN  Competition Picking Up &amp; ALXN-1210 May Not Be the Best AnswerBMO Initiating Coverage $ALXN $NBIX $INCY $ICPT and $BMRN  Competition Picking Up &amp; ALXN-1210 May Not Be the Best AnswerAlexion Pharmaceuticals, Inc. $ALXN Receives New Coverage from Analysts at BMO Capital Markets https://t.co/TJRw7DpktcAlexion Pharmaceuticals initiated by BMO Capital Markets at market perform. https://t.co/JJuYrjTTbp $ALXN #ALXNAlexion Pharmaceuticals, Inc. $ALXN Receives New Coverage from Analysts at BMO Capital Markets https://t.co/1fxrj4EVHHAlexion Pharmaceuticals Initiated Coverage by BMO Capital Markets (Ranked 12th) to Market Perform $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals initiated by BMO Capital Markets at market perform. https://t.co/Mrd1m6AxFi $ALXN #ALXNBig day for #biotechs , 5% pop for the sector , help #nasdaq gain 76 points for the day. $BBH $AMGN $ALXN $REGN $VRTX $JAZZS&amp;P500 #Stocks Trend $VRTX $CELG $REGN $BIIB $OI $ALXN $STZ $PFE $MCK $EBAY $AMGN $EW $KMX $ZTS $CAH $UA $MLM  @ https://t.co/RPeaHBHYi0Today, I increased my investment in $ALXN $CERN $TMO.  I think all three have the potential for higher prices.S&amp;P500 #Stocks Performance $VRTX $BHI $ENDP $HAL $CELG $REGN $BIIB $OI $ALXN $MYL $STZ $PFE $MCK $HES $APA more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $INCY $VRTX $BMRN $CELG $ILMN $REGN $BIIB $ALXN $EBAY $AMGN $TSLA $ISRG $FOXA $GILD  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $VRTX $BMRN $CELG $ILMN $REGN $BIIB $ALXN $MYL $EBAY $AMGN $TSLA $AKAM  more@ https://t.co/YdSIjG11yNExcellent watchlist for this week.
$GD $CNO $ACN $HIMX $ALXN $SWKS $DHR $SWHC $CS $CBG https://t.co/jXBSnBhTW4Alexion Pharmaceuticals  Inc. (ALXN) 4 Days to Cover Short Sellers https://t.co/wSYesL0wnd  $ALXN  #investor  #stocks  #investingVetr Inc. Downgrades Alexion Pharmaceuticals, Inc. $ALXN to Buy https://t.co/61T3UM53Tc$ANAC $INCY $ALXN $JAZZ $VRTX $CELG $BLUE $VRX $BMRN $GWPH несколько активных стаков из растущих биотеховAlexion Pharmaceuticals Takes Over #59 Spot From Delphi Automotive  $ALXN $DLPH #etfs https://t.co/iwsZvq8iMJAlexion Pharmaceuticals Takes Over #59 Spot From Delphi Automotive  $ALXN $DLPH #etfs: In a study of analyst r... https://t.co/cwiDXA0qczAlexion Pharmaceuticals, Inc., $ALXN, is up 5.2% - https://t.co/sJv4mQlP9YS&amp;P500 #Stocks Trend $CELG $STZ $KMX $ALXN $PFE $EBAY $EW $AMGN $ISRG $MDT $BMY $ABBV $MRK $GILD $FOXA $CCE  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $BHI $VRTX $HAL $OI $DVN $HES $CELG $MRO $STZ $NFX $MUR $AGN $KMX $ALXN $PFE  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $CELG $ILMN $ALXN $EBAY $AMGN $ISRG $TSLA $GILD $FOXA $BMRN $INCY $NFLX $LMCA $AAPL  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $VRTX $CELG $ILMN $BMRN $ALXN $MYL $EBAY $BIIB $AMGN $AKAM $ISRG $TSLA  more@ https://t.co/YdSIjFJqHf$IBB $CELG $GILD $BIIB $AMGN $REGN MY TOP 10 POSITIONS BIOTECHNOLOGY, $VRTX $ALXN 
(Giant company) , https://t.co/borQWNNOrx$ALXN ripper

no position sadlyTop gainers: $ANAC $GPN $CELG $PRI $ALXN $MOMO $VRTX $BHI $BLUE $BMRN@CGrantWSJ well hello $BMRN $ALXNRT @ConsumerFeed: Alexion Pharmaceuticals CEO David Hallal Sells $192,134.32 in $ALXN https://t.co/Romd9yh2s5Alexion Pharmaceuticals CEO David Hallal Sells $192,134.32 in $ALXN https://t.co/wKKYe5XgxKAlexion Pharmaceuticals CEO David Hallal Sells $192,134.32 in $ALXN https://t.co/Romd9yh2s5Alexion Pharmaceuticals, Inc. $ALXN CEO David Hallal Sells 1,414 Shares https://t.co/JpjwHhKSNmAdvantus Capital Management Inc Raises Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/VeCwwTPPFAWeekly S&amp;P500 #Stocks Trend $EW $ALXN $PFE $GILD $CCE $NOC $ABBV $BMY $LMT $CELG $MRK $PM $ZTS $BSX $ISRG  @ https://t.co/RPeaHBHYi0Weekly S&amp;P500 #Stocks Performance $SHW $PX $EW $ALXN $REGN $ZTS $VRTX $RCL $PFE $BIIB $CCL $GILD $CCE $BSX more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $TSLA $ALXN $GILD $CELG $ISRG $EBAY $NFLX $BMRN $FOXA $INCY $ILMN $AMGN $GRMN  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $TSLA $ALXN $REGN $VRTX $INCY $BMRN $BIIB $ILMN $GILD $CERN $MDLZ  more@ https://t.co/YdSIjFJqHf$ALXN Statement of Changes in Beneficial Ownership (4)… https://t.co/n1SW5QnXvWZweig DiMenna Associates LLC Has $21,032,000 Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/EBtsW0ec7zBrokerages Set #Alexion Pharmaceuticals, Inc. Target Price at $206.73. Read more: https://t.co/ohUX2HRTdi $ALXNBrokerages Set #Alexion Pharmaceuticals, Inc. Target Price at $206.73. Read more: https://t.co/HMl7wZbciG $ALXNDavid Hallal Sells 1,414 Shares of #Alexion Pharmaceuticals, Inc. Stock. Read more: https://t.co/4Iagu46FI5 $ALXNDavid Hallal Sells 1,414 Shares of #Alexion Pharmaceuticals, Inc. Stock. Read more: https://t.co/yIEf3pHDQP $ALXN$ALXN:

Analysts give average Rating of “Buy” to Alexion Pharmaceuticals …:

https://t.co/BxfN2IiXIlAlexion Pharmaceuticals, Inc. $ALXN Receives Average Rating of “Buy” from Analysts https://t.co/ME14yasDSC$ALXN:

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Receives Average …:

https://t.co/sMrdt4y7Jv$ALXN has had a nice run. watch your positions as it tests channel resistance https://t.co/P8OAsPpSjqBAML Large-Cap Biotech: Buy $ALXN &amp; $BMRN with the pullback$ALXN Alexion Pharmac closed up 0.63% after making our Long Top Picks yesterday. See our most recent #stockpicks at https://t.co/oXwrHoydcM",2016-04-06,ALXN,0
7,"$ALXN: Analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/dK99yP8k7f https://t.co/f2H1LbiS1jSlingshot Bullish https://t.co/qUksP8MPmj $IONS $TRXC $EBAY $ALXN $FOXA $SGEN $HAIN $BMY $QLD $INTU $NFLX $ULTA $RLGY $DRWI $CEVA $TILE$ALXN:

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Stock Rating in Focus:

https://t.co/ek8RA15zTR30pts lower at lows--&gt; Not exactly fans of rally to $SPX 2066 
$SPY $GILD $CELG $ALXN $BIIB 
https://t.co/xZhjbNutNg https://t.co/0PNeSQWJHv$ALXN:

Alexion Pharma (ALXN) Stock Receives ‘Market Perform’ Rating at …:

https://t.co/ycifm4iQLshttps://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBSAlexion Pharma $ALXN Stock Receives 'Market Perform' Rating at BMO Capital https://t.co/chCpIQqsVnAlexion Pharma $ALXN Stock Receives 'Market Perform' Rating at BMO Capital https://t.co/imBLomQ4IX #StockActionRT @TalkMarkets: Healthcare Stocks Lead On A Lackluster Day $BMY $EW $RHHBY $ACAD $ALNY $ALXN $ANAC $IBB $GILD $NBIX $VRTX $ZIOP ... https:…$ALXN:

BMO Capital Says Its Time To Market Perform Alexion …:

https://t.co/K4adXjvuPVbarronsonline: RT barronsstckblog: Is Biotech Back? https://t.co/e75eDmb81W via barronsonline $REGN $VRTX $GILD $ALXN $CELGRT @barronsstckblog: Is Biotech Back? https://t.co/r5L11Nchog via @barronsonline $REGN $VRTX $GILD $ALXN $CELGAlexion Pharmaceuticals, Inc., $ALXN, is down 5.1% - https://t.co/sJv4mQlP9YIs Biotech Back? https://t.co/r5L11Nchog via @barronsonline $REGN $VRTX $GILD $ALXN $CELGALXN 155.00 Alexion Pharm Inc $ALXN added to my watch list. Right now with ALXN I am watching the last price 1 https://t.co/AiLBi2OQfV$ALXN biggest % drop of blue chip bios.RT SeekingAlpha: Why Are Quality Biotech's Soaring? https://t.co/rXauMlrt4n $AGN $ALXN $BIIB $BMY $CELG $GILD $IBB $MDVN $PFE $REGN$ALXN:

Valuation Of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN):

https://t.co/Vay5ZdDddVRT @agrudadvisors: Alexion Pharmaceuticals gains 6.07% to $157.02 on Wednesday : Among top 10 gainers on S&amp;P500.  $ALXN #pharma #healthcareWhy Are Quality Biotech's Soaring? https://t.co/rUgLvq0W80 $AGN $ALXN $BIIB $BMY $CELG $GILD $IBB $MDVN $PFE $REGNNasdaq100 #Stocks Trend $BBBY $CHKP $CELG $REGN $BMRN $TSLA $INCY $WYNN $AMGN $ALXN $SBUX $SPLS $GILD $ILMN  @ https://t.co/YdSIjFJqHfVetr users have downgraded Alexion Pharmaceuti... to a HOLD Rating (3 stars), giving $ALXN a target price of $161.67 https://t.co/9E59wxz4mNCall/Put Highest % volume changes:  Calls: $EOG, $BBRY, $PYPL, $ALXN, $P.  Puts: $CMCSA, $HUM, $MMM, $KRE, $FFIV.Alexion Pharmaceuticals $ALXN Is Today's Perilous Reversal Stock $ALXN https://t.co/0AjhlSAWja$ALXN 20160415 92 trade. ~$1.4 MM notional value.BMO analyst Ian Somaiya initiated coverage of Alexion $ALXN with a “market perform” rating and $165 price target.Alexion Pharmaceuticals gains 6.07% to $157.02 on Wednesday : Among top 10 gainers on S&amp;P500.  $ALXN #pharma #healthcareCentury Capital Management LLC Decreases Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/gXm4OBlFeyRT @iviewmarkets: $SPY names recently crossing their 50 Day $LLY $MYL $VRTX $ALXN $MU $REGN $MDLZ https://t.co/tJMqFPSfqt$SPY names recently crossing their 50 Day $LLY $MYL $VRTX $ALXN $MU $REGN $MDLZ https://t.co/tJMqFPSfqt$ANTM $ALXN:

Overview of Price Moves: Anthem, Inc. (NYSE:ANTM) , Alexion …:

https://t.co/bSs0nhF2EcWeekly S&amp;P500 #Stocks Trend $EW $REGN $ALXN $BIIB $CELG $PFE $MNK $ZTS $AMGN $GILD $MLM $EBAY $STZ $ABBV $BMY  @ https://t.co/RPeaHBHYi0Weekly S&amp;P500 #Stocks Performance $EW $REGN $ALXN $VRTX $BIIB $CELG $PFE $MNK $ZTS $AMGN $GILD $HES $MLM  more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $INCY $REGN $TSLA $ALXN $BMRN $ILMN $BIIB $CELG $AMGN $GILD $EBAY $ISRG $FOXA  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $INCY $REGN $TSLA $ALXN $VRTX $BMRN $ILMN $BIIB $CELG $AMGN $GILD  more@ https://t.co/YdSIjFJqHfDavid Hallal Sells 1,414 Shares of Alexion Pharmaceuticals, Inc. $ALXN Stock https://t.co/Muf02Djv6TAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Reaffirmed by Piper Jaffray https://t.co/ICOTRvySo1Alexion Pharmaceuticals, Inc. $ALXN Shares Bought by Pitcairn Co. https://t.co/o9yVCxwMMtRT @BioBounce: $IBB has 190 holdings; top 10 = 57.83% weight; basically you are saying $AMGN $GILD $REGN $BIIB $CELG $ILMN $MYL $ALXN $VRTX…This weeks watch list was a little different, I chose possible long term breakout stocks. So Far $ALXN has been the… https://t.co/vYV163i7ld#biotechmania $ANIP $BLUE $ALXN ON &amp; on $CELG $IBB $BIB $BSTC $NBIX $CURE $AKRX $CLDX $SRPT $ANIK $ICLR $GWPH $XON all clear or eye on $BIS?RT @tgtxdough: BMO Initiating Coverage $ALXN $NBIX $INCY $ICPT and $BMRN  Competition Picking Up &amp; ALXN-1210 May Not Be the Best AnswerBiggest gainers today large caps:
$VRX 18.93%
$AYI 13.27%
$INCY 11.62%
$BHI 8.82%
$VRTX 8.50%
$BMRN 7.61%
$ILMN 6.37%
$ALXN 6.07%$ALXN:

Key Stocks of the Day: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN):

https://t.co/YAGVwMD7Oc",2016-04-07,ALXN,1
8,"$ALXN: Analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/dK99yP8k7f https://t.co/YlLqwesxMlNR7 Stocks https://t.co/ijcEJIUz9w $ACAD $VIAB $FOSL $XEC $MOS $ALXN $HALO $SWHC $SBUX $PNC $FHN $SDLP $MMM $MEOH $OAS $FCX $MTDR $NTRShttps://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBShttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSLots of bear flags setting up on the 15 minute charts. #shorts #stocks $AMZN $GOOGL $ALXN $PCLN $NFLX are a few.Sloppy action usually leads to lower prices and we saw sloppy action begin last Thursday. #stocks $FB $TSLA $PCLN $ALXN $AMZN #short #stocksAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Reaffirmed by Piper Jaffray https://t.co/KqdBCXd2JRRT @AndysCycles: $IBB components sorted by RS (23d 130d 260d weighted): 
$AMGN $CELG $ILMN $GILD $BIIB $MYL $ALXN $BMRN $REGN $VRTX https:/…RT @SheffStation: Biotech Catalysts the next 3-6 Months..$ADRO $ALDR $ALNY $ALXN $BLUE $BMRN $BMY $CERU $DERM $EXEL $FOLD $GWPH $ITCI https…Investment Analysts’ Upgrades for April, 11th $ALXN, AU, BECN, BLMN, BOFI, BURL, COH, CTRP, CVS, DFS https://t.co/9C8XAPhkD7$ALXN:

Alexion Pharmaceuticals, Inc. (ALXN) Given New $210.00 Price …:

https://t.co/WRd6hOw9pxAlexion Pharmaceuticals, Inc. $ALXN Given New $210.00 Price Target at Morgan Stanley https://t.co/UPu9QYTVqeFort Washington Investment Advisors Inc. OH Lowers Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/CHdDRyo9O4$CELG und $ALXN #BBBiotech Beteiligungen in Top 3 der #Biotech Unternehmen mit größtem EBITDA Wachstum #Buy /SC https://t.co/Kd9RYgxPdgEaton Vance Management Has $41,442,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/iGAW6nZl85Alexion Pharmaceuticals, Inc. $ALXN Upgraded to Buy by Vetr Inc. https://t.co/zq2PXvm6gS$ALXN: Analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/dK99yP8k7f https://t.co/eocTFy5JwpRT @SheffStation: Biotech Catalysts the next 3-6 Months..$ADRO $ALDR $ALNY $ALXN $BLUE $BMRN $BMY $CERU $DERM $EXEL $FOLD $GWPH $ITCI https…",2016-04-11,ALXN,1
9,"GSA Capital Partners LLP Sells 46,636 Shares of #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/AVXvtRmMG1 $ALXNGSA Capital Partners LLP Sells 46,636 Shares of #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/5up25CnzMo $ALXNdo you see the cup and handle BO ? $ALXN https://t.co/V3MkREMrC2$ALXN chart: do you see the cup and handle BO ?. https://t.co/UCT5QVopEGGSA Capital Partners LLP Sells 46,636 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/tvW1WzoqOiGSA Capital Partners LLP Sells 46,636 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/MLoNfH9olE$ALXN Alexion Pharmaceuticals to Report First Quarter 2016 Res… https://t.co/vbO78jcbsV$ALXN: Analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/dK99yP8k7f https://t.co/Mvr8oSY12U@TradeTexasBig If $ALXN gets a pos readout on Soliris data in MG this stock will hit $170 easily----as it would add another $500 mil-$1 bil$ALXN Institutional ownership up 5.25% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0K#Alexion Pharmaceuticals to Report First Quarter 2016 Results on Thursday April 28 2016. Read more: https://t.co/Ty1mwk2QCf $ALXN#Alexion Pharmaceuticals to Report First Quarter 2016 Results on Thursday April 28 2016. Read more: https://t.co/IpLyBm1DKY $ALXN$ALXN 20160415 =&gt; 20160520 75 spreads trade. ~$1.2 MM notional value.$ALXN &gt; 150 is a 170+ stock$ALXN 20160415 =&gt; 20160520 75 spreads trade. ~$1.1 MM notional value.#Alexion Pharmaceuticals : to Report First Quarter 2016 Results on Thursday, A... https://t.co/UKBlIt2BVI $ALXN$ALXN Alexion Pharmaceuticals to Report First Quarter 2016 Results on Thursday, April 28, 2016
From our Stock News Alerts AppLeerink out today saying $ALXN's Kanuma is gaining traction ahead of consensus &amp; points to a stronger upside---adds further upside $216 PTRT @ConsumerFeed: Alexion Pharmaceuticals initiated by BMO Capital Markets at market perform. https://t.co/JJuYrjTTbp $ALXN #ALXNRT @AmericanBanking: $ALXN - Alexion Pharmaceuticals, Inc. #ALXN PT Raised to $210.00 at Morgan Stanley https://t.co/C5iL1SQ55uRT @ConsumerFeed: Alexion Pharmaceuticals's outperform rating reiterated at Leerink Swann. https://t.co/0uWVaQvdLQ $ALXN #ALXNWeekly Nasdaq100 #Stocks Trend $ULTA $STX $LBTYA $CTRP $NXPI $QCOM $AMAT $CTXS $ILMN $MAR $ALXN $VOD $NVDA  @ https://t.co/YdSIjG11yNAlexion Pharmaceuticals, Inc. $ALXN Shares Bought by Alliancebernstein L.P. https://t.co/39aOf9UR26Ranks #1 with over 80% in alert gains today. Click here https://t.co/ewcYkLb72h .. $ALXN $GIII $PTNR",2016-04-12,ALXN,0
10,"JBEM pick FLKS data release on 4/19. Read here: https://t.co/RJhHbIwnlX $ALX $ALXA $ALXN $AM $AMAG $AMAT $AMBA $AMBCBiotech Stock Roundup: FDA Advisory Panels Say Yes to Intercept, No to Clovis. $ALXN $VRTX $ABBV $CLVS https://t.co/9VI7L7in1I$ALXN Alexion Pharmaceuticals, Inc. (ALXN) Stake Lowered by US Bancorp DE .More at https://t.co/pttz5MBVarXLV Remains Stable as Big Healthcare Stocks Try to Turn the Tide $ALXN $CI $REGN $SPY https://t.co/D6k7ukVlJnRT @DozenStocks: Weekly Nasdaq100 #Stocks Trend $ALXN $ISRG $MAT $LBTYA $STX $ILMN $GILD $TXN $CTXS $AAPL $ULTA $QCOM $TSLA  @ https://t.co…Weekly Nasdaq100 #Stocks Trend $ALXN $ISRG $MAT $LBTYA $STX $ILMN $GILD $TXN $CTXS $AAPL $ULTA $QCOM $TSLA  @ https://t.co/YdSIjG11yNWeekly Nasdaq100 #Stocks Performance $VOD $STX $INCY $ULTA $ILMN $ALXN $AMGN $MDLZ $LBTYA $CERN $MAR $AMZN  more@ https://t.co/YdSIjG11yNNasdaq100 #Stocks Trend $ALXN $MAT $ISRG $LBTYA $ILMN $GILD $STX $TXN $CTXS $AAPL $ULTA $QCOM $TSLA $AMGN $AMZN @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $ALXN $ENDP $SBAC $REGN $TSCO $INCY $BMRN $MAT $CSX $EBAY $FB $BBBY $NFLX  more@ https://t.co/YdSIjFJqHfLots of stock rolling over now like $FB $PCLN $NFLX $GOOGL $ALXN $AMZN &amp; $SPY. Let's see if we can get some power to the downside.Suntrust Banks Inc. Increases Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/6fV85zRbEUMorgan Stanley Boosts #Alexion Pharmaceuticals, Inc. Price Target to $210.00. Read more: https://t.co/MYOTmxc7U8 $ALXNMorgan Stanley Boosts #Alexion Pharmaceuticals, Inc. Price Target to $210.00. Read more: https://t.co/2W5JSiZevo $ALXN$ALXN:

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) topped earnings-per …:

https://t.co/08RMDEdEPmMorgan Stanley Boosts Alexion Pharmaceuticals, Inc. $ALXN Price Target to $210.00 https://t.co/P9PqtIlPUfAlexion Pharmaceuticals, Inc. $ALXN Rating Increased to Buy at Vetr Inc. https://t.co/V4aATmHaHGRT @CowenResearch: Eric Schmidt publishes takeaways from Cowen's conference call with myasthenia gravis specialists to review prospects for…Healthcare Stocks Traders Alert: $ALXN $VRTX https://t.co/ouGyd77IH1Eric Schmidt publishes takeaways from Cowen's conference call with myasthenia gravis specialists to review prospects for $ALXN #eculizumabHartford Investment Management Co. Sells 5,011 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/JcR8U2dhqj@chartseer @Scelliott81 there are a few looking like but $alxn clearly looking to test 200 sma@TradeTexasBig @Scelliott81 that $ALXN is a wild one for sure@Scelliott81 @chartseer lot of recent pump biotechs have that look .. Look at $alxn , 20 points",2016-04-13,ALXN,1
11,"Nasdaq100 #Stocks Trend $PCLN $CTXS $BIDU $NFLX $EBAY $NXPI $CHKP $NVDA $FOXA $LBTYA $AAPL $CTRP $LMCA $ALXN  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $AAL $VRTX $EXPE $TSCO $PCLN $CTXS $WFM $ALXN $GILD $AMZN $CERN $BIDU $AMAT  more@ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Trend $CTXS $PCLN $NFLX $BIDU $CHKP $EBAY $NVDA $FOXA $LBTYA $AAPL $CTRP $NXPI $LMCA $ALXN  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $AAL $VRTX $TSCO $EXPE $CTXS $WFM $PCLN $NFLX $AMZN $ALXN $GILD $CERN $MYL  more@ https://t.co/YdSIjFJqHfPrice Target Alert: Trading the Zacks price target change for ALEXION PHARMACEUTICALS $ALXN https://t.co/K3Z0eKxlGd https://t.co/uUZ4mzbFLSIf you rode this wave higher, I didn't, I'd be looking to lock in some gains. $AMZN $TSLA $SPY $PCLN $ALXN $FB look set to roll over.RT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyIndustry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOeyAlexion Pharmaceuticals, Inc. $ALXN Stock Price Down 0.4% https://t.co/rn4f5eB3c2Alexion Pharmaceuticals, Inc. $ALXN Lifted to Buy at Vetr Inc. https://t.co/X1IOxb11zWJBEM pick CYDY runng hard, FLKS is nxt: https://t.co/RJhHbIwnlX $ALNEV.PA $ALNOV.PA $ALNY $ALONC.PA $ALSE $ALSED $ALXN $AMAR$ALXN:

Movers inside Traders Limelight: Alexion Pharmaceuticals, Inc …:

https://t.co/1poHU68mMw19,105 Shares in Alexion Pharmaceuticals, Inc. $ALXN Acquired by Ashburton Jersey Ltd https://t.co/mCE5ePBj1a$ALXN:

Analyst Review: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN):

https://t.co/LVeNSpOSiBRoosevelt Investment Group Inc. Has $1,454,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/XAYTYtI6J0Alexion Pharmaceuticals, Inc. $ALXN PT Raised to $210.00 at Morgan Stanley https://t.co/0VXCnQZoWIAlexion Pharmaceuticals, Inc. $ALXN PT Raised to $210.00 at Morgan Stanley https://t.co/2hqbtE6jv3Employees Retirement System of Texas Reduces Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/zOU1fh0sQnConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5t0Bl  $DIS $ALXN $NOAH $GILD $QUNR$ALXN: Analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/dK99yP8k7f https://t.co/7TzpQvSA2G",2016-04-14,ALXN,0
12,"RT @John_StockCoach: Day Trading Stocks $TSLA $BIDU $ALXN $CPXX $NFLX $VRX $ETE 12 Trades, 7 Wins, 5 even - Overall: $19,500 https://t.co/C…RT @nobullshytrader: $TSLA $BIDU $ALXN $CPXX $NFLX $VRX $ETE only $20K 2day coach? ouch https://t.co/df3wqPTseF$TSLA $BIDU $ALXN $CPXX $NFLX $VRX $ETE only $20K 2day coach? ouch https://t.co/df3wqPTseFDay Trading Stocks $TSLA $BIDU $ALXN $CPXX $NFLX $VRX $ETE 12 Trades, 7 Wins, 5 even - Overall: $19,500 https://t.co/CwxYWIcKPkMarshall Wace LLP Acquires Shares of 51,729 Alexion Pharmaceuticals, Inc. $ALXN https://t.co/JSh1G4luZq$ALXN Jennison Associates LLC Has $1401254000 Stake in Alexion Pharmaceuticals, Inc ... .More at https://t.co/pttz5MBVarJennison Associates LLC Has $1,401,254,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/2mbu2XMYMZ$ALXN Out, break even - price stall$ALXN Short - 2KJBEM releases new pick 'MBVX'.Full DD here:  https://t.co/BXfT4dyvo5 $ALX $ALXA $ALXN $AM $AMAG $AMAT $AMBA $AMBCSome weakness, some strength today. $SPY $PCLN $AMZN $TXMD $SCTY &amp; $ALXN a few strong names while $TSLA &amp; $NFLX are weak.$ALXN Out .59 X 2K shares = $1,180$ALXN Short - 2K SharesAlexion Pharmaceuticals, Inc. $ALXN Position Reduced by BlackRock Investment Management LLC https://t.co/BeXwzvwa4JNR7-2 https://t.co/nJVObASJEY         $ACWI $DWTI $SMH $UVXY $PACB $IWN $TVIX $AGN $IEFA $VOO $GPN $ALXN $XLI $DBEF $TWM $VIXY $VGK $NSC#FusionIQ NEW Positive Timing Signal on $ALXN Today https://t.co/9ImlXz4YNa Please Retweet #SignalsNR7-2 https://t.co/nJVObASJEY        $ACWI $DWTI $SMH $UVXY $PACB $IWN $TVIX $AGN $IEFA $VOO $GPN $ALXN $XLI $DBEF $TWM $VIXY $VGK $NSCPrice T Rowe Associates Inc. MD Has $5,397,353,000 Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/llEWTgAzI6Alexion Pharmaceuticals Reiterated Rating by Cowen &amp; Co (Ranked 53rd) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2SRT @AndyBiotech: Benzinga's excellent track record on bio M&amp;A rumor

$SNY -&gt; $PTCT before RTF
https://t.co/lFXCUE6I7t

$ALXN -&gt; $RTRX
https…https://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBS$ALXN:

Top Gainers Today: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN):

https://t.co/LF4JksG7SlNR7-2 https://t.co/nJVObASJEY       $ACWI $DWTI $SMH $UVXY $PACB $IWN $TVIX $AGN $IEFA $VOO $GPN $ALXN $XLI $DBEF $TWM $VIXY $VGK $NSC",2016-04-18,ALXN,0
13,"$ALXN:

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Check on Analyst …:

https://t.co/mUFby10ssLRT @BMTEdny: Industry satellite events at #ILC2016 $GILD $ICPT $ALXN $MRK $NVS $UNVR $GNFT:EN #cava #tapas ??? https://t.co/cGAGPIjOey$ALXN #uptrend continuation detected around 3:00 PM, Apr 19 EDT; use 155.62, 153.72 as stop #bullish$ALXN Alexion Pharmaceuticals, Inc. (ALXN) Stake Held by Utah Retirement Systems .More at https://t.co/pttz5MBVarhttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSAlexion Pharmaceuticals, Inc. $ALXN Stake Held by Utah Retirement Systems https://t.co/2gjOV4J1V7BlackRock Advisors LLC Has $251,946,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/UxiLqEMMnyFavor Healthcare stocks like the traditionally strong $UNH, $JNJ, $BCR, $BDX, $SYK, while better risk rewards in $MDT, $GILD, $ALXN,  $XRAYVetr users have downgraded Alexion Pharmaceuti... to a HOLD Rating (3 stars), giving $ALXN a target price of $161.67 https://t.co/9E59wxz4mNThe Manufacturers Life Insurance Company  Has $62,068,000 Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/ZLu7YpiJEu#Alexion Pharmaceuticals, Inc. Stock Rating Lowered by Vetr Inc. Read more: https://t.co/VO1BaY09wh $ALXNMorgan Stanley Has $52,486,000 Position in #Alexion Pharmaceuticals, Inc. (). Read more: https://t.co/a7AQtDpmIc $ALXNMillennium Management LLC Cuts Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/zPb1H5HRHYAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Lowered by Vetr Inc. https://t.co/XIiIXSy3RCAlexion Pharmaceuticals downgraded by Vetr Inc. to hold. $161.67 PT. https://t.co/qHWA8sT8pq $ALXN #ALXNAlexion Pharmaceuticals downgraded by Vetr Inc. to hold. $161.67 PT. https://t.co/BxctNbXw1m $ALXN #ALXN",2016-04-19,ALXN,1
14,"$SPY #stocks in #downtrend at w/ 1/5 Risk Reward $ABC $ALXN $ESRX $FLS $GS $HUM $JWN $LLY $LUK $M $NBL $RIG https://t.co/WTDZAADhaM8 days for $ALXN to add another 11 points.$ALXN on its way$ALXN Take a look at Price Moves: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) , XOMA ... .More at https://t.co/pttz5MBVar$ALXN - Investment Analysts' Recent Ratings Updates for Alexion Pharmaceuticals #ALXN https://t.co/GsD1CXPRYZ$ALXN Institutional ownership up 5.25% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0KInvestment Analysts’ Recent Ratings Updates for Alexion Pharmaceuticals $ALXN https://t.co/rXVWOpC0LB$ALXN:

Take a look at Price Moves: Alexion Pharmaceuticals, Inc. (NASDAQ …:

https://t.co/cFUH5pVyvZThe majority of users on Vetr are bullish on Alexion Pharmaceutica..., indicating a BUY Rating (3.5 stars) for $ALXN https://t.co/9E59wxz4mN",2016-04-20,ALXN,1
15,"Schroder Investment Management Group Decreases Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/qxYcB9yflOOver Keltner https://t.co/sZqRLaRFgj $ABBV $PLCM $MON $CNQ $DEPO $PAH $TXMD $PSLV $BWP $ALXN $AMAG $JNUG $CALD $FPRX $FBP $PEN $NMR32 #breakout 2 #breakdown $AGIO $ALXN $AMGN $BMY $CELG $JCI $NEM $SWK $TYC $UNP $DF https://t.co/Rt46yZWIaD https://t.co/lwQBaBYQuH@bradloncar Don't miss $BIIB &amp; $ALXN !@FortuneMagazine $ALXN maybe :)$ALXN Investment Analysts&amp;#39; Recent Ratings Updates for Alexion Pharmaceuticals (ALXN) .More at https://t.co/pttz5MBVar$ALXN 20160520 95 trade. ~$1.5 MM notional value.@TradeTexasBig $ALXN should look pretty---it has the best top &amp; bottom line picture in large cap biotech with 2 new product launches$ALXN is looking prettier every day.$ALXN Institutional ownership up 5.25% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0K$ALXN  6 days to price target. looking good.$alxn to 162 @smartertrader @swat_premiumAlexion Pharmaceuticals, Inc. $ALXN Downgraded by Vetr Inc. https://t.co/3wsXaVXD6YVetr users have downgraded Alexion Pharmaceuti... to a HOLD Rating (3 stars), giving $ALXN a target price of $161.67 https://t.co/9E59wxz4mNhttps://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBS",2016-04-21,ALXN,0
16,"Over Ichimoku https://t.co/p62K9W5ova $ASHR $CXP $MKC $ALXN $NNN $CAKE $SJM $ANET $EDR $AKR $QGEN $EQY $FAF $PLAB $ATHN $LOGM $BAHRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…$ALXN ER on 4/28 Before Open. SP were UP 16 times out of last 24 qtrs (66%) in ER. https://t.co/nx6sPfzvANRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…$ALXN Traders Observable Healthcare Stocks: Alexion Pharmaceuticals, Inc. (NASDAQ ... .More at https://t.co/pttz5MBVarRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @DozenStocks: Nasdaq100 #Stocks Trend $TMUS $MXIM $BIIB $CELG $TSCO $FOXA $GILD $ALXN $CSX $TSLA $CTXS $AMGN $QCOM $LLTC  @ https://t.co…Nasdaq100 #Stocks Trend $TMUS $MXIM $BIIB $CELG $TSCO $FOXA $GILD $ALXN $CSX $TSLA $CTXS $AMGN $QCOM $LLTC  @ https://t.co/YdSIjFJqHfRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…MON $SRPT adcom #SCOTUS IPR WED $VRX senate hearing $VRTX earnings THU $ABBV $ALXN $BMY $CELG $AMGN $BMRN $GILD FRI CHMPRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…https://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBSAlexion Pharmaceuticals, Inc. $ALXN Shares Sold by Ameriprise Financial Inc. https://t.co/rNKTD6NRnVRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BMRN $GILD

FRI
CHMPWeekly Nasdaq100 #Stocks Trend $BMRN $ESRX $FOXA $NXPI $TSCO $LLTC $CTXS $SBAC $ADSK $VOD $BIIB $ALXN $GILD  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $ENDP $VIAB $DISH $BMRN $WDC $VRTX $CSX $TSCO $BIIB $ALXN $GILD $ESRX  more@ https://t.co/YdSIjFJqHfchartguy89: ALXN 159.10 Stock Charts $ALXN Alexion https://t.co/bJGKmd1DyXchartguy89: ALXN 159.10 Stock Charts $ALXN Alexion https://t.co/8d6OlmYhrOchartguy89: 2016 Trending Stocks: ALXN 159.10 Stock Charts $ALXN Alexion https://t.co/18TZfZR2zn",2016-04-25,ALXN,0
17,"Parabolic SAR Sell https://t.co/NU8SgYcG2a $IBB $AMGN $ALXN $TMO $IHE $TARO $WAT $LGND $TNH $LQD $BBH $CRED $CIU $FICO $FBT $TECH $VCITBNP Paribas Arbitrage SA Has $21,698,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/KLqVb9HoutConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5t0Bl  $DIS $ALXN $NOAH $GILD $QUNRTuesday Sector Laggards: Healthcare, Utilities $ALXN $WAT $XLV $SCG $AEE #stocks https://t.co/cLdMPByHfo$ALXN #uptrend continuation detected around 2:30 PM, Apr 26 EDT; use 153.22, 151.96 as stop #bullish$ALXN Traders Observable Healthcare Stocks: Alexion Pharmaceuticals, Inc. (NASDAQ ... .More at https://t.co/pttz5MBVar@NSkiF1j1 @matthewherper @adamfeuerstein @jonnajarian I like $SRPT buyout. $GSK has #DMD experience, I like $ALXN, $AGN has $$$. 15-20/per?Alexion mulls producing pipeline drugs in Ireland https://t.co/eFv26h2s6h $ALXNRT @USAIC: Speakers for #USAIC16 (June 2, Boston) announced. $ALXN R&amp;D head Martin Mackay will join the program https://t.co/fyyQKpahOy$IBB big week - 5 large cap biotechs reporting $VRTX 27th, $ALXN 28th, CELG 28th $AMGN 28th, GILD 28th watch $IBB 285 level for a breakoutAlexion Pharmaceuticals Reiterated Rating by CIBC Oppenheimer (Ranked 52nd) to Buy with 228 PT $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals, Inc. $ALXN Position Reduced by Connor Clark &amp; Lunn Investment Management Ltd. https://t.co/PM9LO2MeEdAlexion Pharmaceuticals's buy rating reiterated at Oppenheimer. $228.00 PT. https://t.co/hRXig4qRJh $ALXN #ALXN$ALXN Institutional ownership up 5.25% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0K$ALXN:US 4 Biotechs That Will Escape Weak Seasonal Trends for theSector #ALEXION PHARMACEUTICALS INC  https://t.co/cvUUC2bJLr #NASDAQSpeakers for #USAIC16 (June 2, Boston) announced. $ALXN R&amp;D head Martin Mackay will join the program https://t.co/fyyQKpahOyGet the latest news and updates for $IRF $BCSI $GT $ALXN $PLX automatically with MarketBeat Daily https://t.co/nSJuDsYidjNew Buy Recommendation for This Healthcare Giant $ALXN https://t.co/06Z4WiKIV8Transports, Biotechs, And Small-Caps Spring Back To Life https://t.co/UzT4KtWxlk $ADM $ALK $ALXN $AMGN $BHP $BIIB $CDE $CELG $CHRW $CLFThe majority of users on Vetr are bullish on Alexion Pharmaceutica..., indicating a BUY Rating (3.5 stars) for $ALXN https://t.co/9E59wxQFelRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…#Biotech #options trend 4 companies Rptg #earnings this Wk. Trade timely #options Hi VOL in $GILD;Hi OI in $ALXN https://t.co/0kgRXUIcjuAlexion Pharmaceuticals, Inc. $ALXN Raised to “Buy” at Vetr Inc. https://t.co/UTd3QuucSIAlexion Pharmaceuticals, Inc. $ALXN Raised to “Buy” at Vetr Inc. https://t.co/a5NISJuDFK$CELG, $AMGN, $ALXN, $GILD reporting #earnings this week. Trade #Biotech #options to realize high profits. #stocks https://t.co/oQEwZcVBc8Alexion Pharmaceuticals upgraded by Vetr Inc. to buy. $170.00 PT. https://t.co/4le5BrFAvJ $ALXN #ALXNRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…chartguy89: 2016 Trending Stocks: ALXN 158.02 Stock Charts $ALXN Alexion https://t.co/g5jL8oBh2l",2016-04-26,ALXN,0
18,"1234 Bullish https://t.co/dezFYTL5UM $DNKN $BHI $RKUS $LUV $AGNC $QQQ $FHN $PX $BHP $ALXN $AZN $SABR $BABA $AMZN $EWJ $YHOO $TQQQScan results - 1,2,3 Pullback Bullish today: $AOS $PENN $EDU $LGND $WAT $RKUS $PTC $ALXN $X $UGP ... https://t.co/nd4nD8ecNxRT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…RT @WrigleyTom: pm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://…Earnings Before Open 4-28-2016 https://t.co/q8aWUd1Qjy $AUO $ABBV $ACOR $AET $AGEN $APD $ALXN $ALKS $ALLE $AB $ASPS $MO $AEP $AME $AIT $AVTpm
$FB $SNDK $FSLR
$PYPL $SFLY $ORLY $VRTX

Cramer guests $CMG $BWLD

am
$UPS $DPZ $DNKN $CAB
$CELG $ALXN $BMY $MA https://t.co/PxIjZ9k8Rh$IBB components were easy to setup 4 max profit by MMs to hedge 2morrow big ER day. $CELG $AMGN $GILD $ALXN. Going upNicholas Co. Inc. WI Has $6,205,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/0kXXxdlqbVNicholas Co. Inc. WI Has $6,205,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/htncx8jL6HRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…$ALXN 4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG .More at https://t.co/pttz5MBVarList of Potential Trades for Today's ER  https://t.co/yEr7CUV7i2 $VRX $ALXN $DNKN $TXN $ORLY $FB $FSLREarnings Next Week – https://t.co/2v13NpiTnN reporting tomorrow AM - $ABBV $AET
$ALXN $MO $BMY $CELG $CLF $CME $COP $DOW $EPD $F $LINE $MPChttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSRT @tgtxdough: CS $VRTX preview for tonight  $ALXN https://t.co/zR4naBmXwKAlexion Pharmaceuticals (ALXN:NASDAQ) loses 2.54% to $154.01 on Tuesday : Among top 10 losers on S&amp;P500 $ALXN #NASDAQ #StockMarket #pharmaAlexion Pharmaceuticals (ALXN:NASDAQ) loses 2.54% to $154.01 on Tuesday : Among top 10 losers on S&amp;P500 $ALXN #NASDAQ #StockMarket #pharmaCS $VRTX preview for tonight  $ALXN https://t.co/zR4naBmXwKSFTW Investor long-term stock recommendation: $ALXN Alexion Pharmaceuticals Inc. (SS: 66) https://t.co/ajLDr7suctTop Earnings Thur 4/28 Pre: $ABBV $ACOR $$ADP $AEP $AET $ALKS $ALXN $APD $BC $BG $BLL $BMY $BWA $BXLT $CAB $CAH $CCE $CELG $CHTR $CIT (1/3)RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM…Alexion Pharmaceuticals, Inc. $ALXN Position Maintained by Bellevue Asset Management AG https://t.co/4x91OrN7c3Alexion Pharmaceuticals, Inc. $ALXN Set to Announce Quarterly Earnings on Thursday https://t.co/kYG1UuTqyVAlexion Pharmaceuticals, Inc. $ALXN Set to Announce Quarterly Earnings on Thursday https://t.co/A7fH7yGdRSThe majority of users on Vetr are bullish on Alexion Pharma..., indicating a STRONG BUY Rating (4.5 stars) for $ALXN https://t.co/9E59wxz4mN$ALXN Institutional ownership up 5.25% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0K",2016-04-27,ALXN,0
19,"Alexion Pharmaceuticals, Inc. $ALXN Trading Down 4% on Disappointing Earnings https://t.co/s7BZf1PthSRT @DailyStockPlays: Bullish Doji https://t.co/BjUwkf8lV4 $OCN $ALXN $CHRW $ALLY $UPS $IEFA $VLY $SCHF $HEDJ $ORCL $PGR $FOLD $HEZU $DBEU $…Bullish Doji https://t.co/BjUwkf8lV4 $OCN $ALXN $CHRW $ALLY $UPS $IEFA $VLY $SCHF $HEDJ $ORCL $PGR $FOLD $HEZU $DBEU $CERN $UIS $SXLRT @361Capital: EPS Movers:
$FB +7%
$NOV $MJN $CCE+4%
$CL $F $BMY $WM $MNST+3%
$EQT $VAR $ORLY -3%
$ALXN -5%
$SYMC -7%
$SEE $AME -8%
$CAH $…RT @361Capital: EPS Movers:
$FB +7%
$NOV $MJN $CCE+4%
$CL $F $BMY $WM $MNST+3%
$EQT $VAR $ORLY -3%
$ALXN -5%
$SYMC -7%
$SEE $AME -8%
$CAH $…EPS Movers:
$FB +7%
$NOV $MJN $CCE+4%
$CL $F $BMY $WM $MNST+3%
$EQT $VAR $ORLY -3%
$ALXN -5%
$SYMC -7%
$SEE $AME -8%
$CAH $XL $XLNX -9%$ALXN:

New SEC Filing for ALXN: Form 8-K (No. 0000899866-16-000288):

https://t.co/LK0dLz3nD3 https://t.co/es4U0YdA52$ALXN - SELL Signal at 145.1 on Apr 28, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investing$ALXN Institutional ownership up 5.25% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0K$ALXN after morning earnings ends day with a doji on bottom of BBs after gapping down. https://t.co/mMR7cmgF6RAlexion Pharmaceuticals, Inc. $ALXN Trading Down 4% Following Weak Earnings https://t.co/Zc8wyVXPReAlexion Pharmaceuticals, Inc. $ALXN Trading Down 4% Following Weak Earnings https://t.co/5IqIJVjJElAlexion Pharmaceuticals, Inc., $ALXN, is down 5.1% - https://t.co/sJv4mQlP9YCall/Put Highest % volume changes:  Calls: $KCG, $EXC, $ALXN, $FNV, $PCAR.  Puts: $PCAR, $AMBA, $YNDX, $DVAX, $BHP.Alexion Pharmaceuticals, Inc. $ALXN Lifted to Buy at Vetr Inc. https://t.co/RRjQkETvi0Member Sheet https://t.co/bbybKLvsSV $ADMS $ADXS $AEZS $CLF $FB $MDVN $MEMP $SRPT $STJ $TXTR $VXX $XIV $ALXN $DPZ $FE $GNC $TPX $SYMC $RCII$ALXN Alexion (ALXN) Misses on Q1 Earnings and Revenues .More at https://t.co/pttz5MBVarWhy ALXN Is DOWN Thursday https://t.co/RDvQDi01u1 $ALXNAlexion Pharmaceuticals, Inc. $ALXN Releases Quarterly  Earnings Results, Misses Estimates By $0.02 EPS https://t.co/PcVfqGz7tMRT @adamfeuerstein: Bio earnings reax:

$VRTX flat
$CELG flat
$ALXN -4%
$ACOR -1%
$BMY flatThe *largest decliners in the premarket* for you to watch at the open: $INFN $STMP $SYMC $EVEP and $ALXN.Alexion reports Q1 results, updates guidance https://t.co/FkY5TGdzyA $ALXNAlexion reports Q1 results, updates guidance https://t.co/lRJfIyuXZb $ALXNAlexion reports Q1 results, updates guidance https://t.co/30H4SrCAaR $ALXNBio earnings reax:

$VRTX flat
$CELG flat
$ALXN -4%
$ACOR -1%
$BMY flat$UTHR, $ALXN, $ACOR, $INSY, $ALKS, $BMY Q1 earnings https://t.co/mBIOSd32veRT SeekingAlpha: Alexion Pharmaceuticals (ALXN) Q1 2016 Results - Earnings Call Webcast https://t.co/UsULCzJEWw $ALXNAlexion Pharmaceuticals (ALXN) Q1 2016 Results - Earnings Call Webcast https://t.co/qTrfvwtlUt $ALXNAlexion Pharmaceuticals (ALXN) Q1 2016 Results - Earnings Call Webcast https://t.co/Y8oKRHSOQA $ALXNAlexion Pharmaceuticals (ALXN) Q1 2016 Results - Earnings Call Webcast https://t.co/CqqroOCcrd $ALXNPre-Market Laggard: Alexion Pharmaceuticals $ALXN $ALXN https://t.co/F3wNjSmtLLBack in $alxn 140.10 and $celg at 50ma Let's get the test $ibb 50ma over with.Here's my watchlist: $ABBV, $ABT, $ADMS, $ALXN, $AU, $BOFI, $CAVM, $COMM, $DLB, $FB, $FE, $FSLR, $HAR, $HBI,SFTW Investor long-term stock recommendation: $ALXN Alexion Pharmaceuticals Inc. (SS: 67) https://t.co/ajLDr7suctGap Down https://t.co/fA14Z5t3N8  $ABT $ABBV $ALXN $DPZ $FSLR $GNC $RXDX $INFN $OCN $OSIS $POT $RCII $SGI $SYMC $SGYP $TPX $VAR $VRTX $WLL#Biotech Premarket
$SRPT+15.76%
$ADMS+9.14%
$MDVN+7.30%
$ALXN-4.70%
$VRTX-4.02%RT @Benzinga: Short Sellers Dump Vertex, Load Up On Baxalta $ALXN $BMRN $BXLT $VRTX https://t.co/5eVTolIlzPShort Sellers Dump Vertex, Load Up On Baxalta $ALXN $BMRN $BXLT $VRTX https://t.co/5eVTolIlzPPremarket most declined stocks: $INFN, $SYMC, $EVEP, $STMP, $XLNX, $FSLR, $ALXN, $VRTX, $VIAB, $ABMD#Mindthegap $GNC $DPZ $ALXN $FB $SRPT $MDVN $STJ $ABT $HAR $STMP $FSLR$ALXN: Alexion Pharma misses by $0.02, misses on revs; guides FY16 revs below consensus https://t.co/Lj9H4dwQIfOther neg Pre Market movers
$ALXN -4%
$VRTX -2,9%
$ABMD -2,5%Notable earnings before Thursday’s open $AB $ABBV $ACOR $ADP $AEP $AET $AIT $ALKS $ALLE $ALXN $AME #Stocks #finance  https://t.co/SLgSzcHrXrWhy ALXN Is DOWN In Premarket Trading Alexion Pharma Earnings Results https://t.co/RDvQDi01u1 $ALXNRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $…$LGCY and $ALXN are significant Pre-Market Decliners this AM on SpeculatingStocks Pre-Market, Spe... https://t.co/rHIslyq0dH #specstocksRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $…$ALXN and $VRTX are significant Pre-Market Decliners this AM on SpeculatingStocks Pre-Market, https://t.co/ayAi1CAXh9RT @bradloncar: $ALXN Q1 revenue of $701M is a miss (consensus was about $712M). Guides 2016 to be at the low end of their previous range o…$ALXN guides lower$alxn $celg and most other revs pretty punk.  Manufactured eps like $biib.  M&amp;A beyond necessary to keep multiples up moving fwd imhoRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $…#Alexion Pharmaceuticals : misses Street 1Q forecasts. Read more: https://t.co/J13EHdpyhL $ALXN#Alexion Pharmaceuticals : misses Street 1Q forecasts. Read more: https://t.co/2SmYm9C4vr $ALXN$ALXN Soliris 1Q16 net sales $665M misses consensus of $691M despite 2.4% price increase in FebruaryRT @bradloncar: $ALXN Q1 revenue of $701M is a miss (consensus was about $712M). Guides 2016 to be at the low end of their previous range o…RT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $…RT @bradloncar: $ALXN Q1 revenue of $701M is a miss (consensus was about $712M). Guides 2016 to be at the low end of their previous range o…RT @bradloncar: $ALXN Q1 revenue of $701M is a miss (consensus was about $712M). Guides 2016 to be at the low end of their previous range o…$ALXN Q1 revenue of $701M is a miss (consensus was about $712M). Guides 2016 to be at the low end of their previous range of $3.05 to $3.1B.Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $BMRN $GILD $SGENAlexion Pharmaceuticals misses by $0.02, misses on revenue $ALXN https://t.co/PscuuO7ieP$ALXN Q1 Soliris (eculizumab) net sales $665MAlexion Pharmaceuticals misses by $0.02, misses on revenue https://t.co/ZLvQK7AwEf #premarket $ALXNAlexion Pharmaceuticals misses by $0.02, misses on revenue https://t.co/PfJ3kLUfsY #premarket $ALXNAlexion Pharmaceuticals misses by $0.02, misses on revenue https://t.co/O4U3dUCJEf #premarket $ALXN$ALXN Alexion Reports First Quarter 2016 Results
From our Stock News Alerts AppEarnings-Reaction to Keep an Eye Today $ALXN, $FLS, $AMGN, $BBVA, $CCE, $SNE, $GIMO, $ALLE, $EMN, $CBG, $BOFI, $CAB https://t.co/roaB562ZmV",2016-04-28,ALXN,0
20,"@sfef84 Looks like BTIG slipped on the ice as $ALNY CC5 RNAi approach will not achieve comparable results close to $ALXN's Soliris$ALNY in their 1Q earn release admitting that CC5 is not able to achieve satisfactory results v. $ALXN Soliris. Next gen ALXN1210 is the deaNR7 Stocks https://t.co/wLxIsyIQsf $USG $EBAY $SCCO $LLTC $RDUS $ALXN $OXY $VOD $TSM $UNXL $RCL $GPK $CERS $CCL $KBE $DNR $ABC$ALXN Is Alexion Pharmaceuticals Inc (NASDAQ:ALXN) a Good Investment? .More at https://t.co/pttz5MBVar$ALXN last 138.99 Hearing Alexion Shares Downgraded to Neutral at BTIGMackenzie Financial Corp Boosts Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/c646ys6p3wMackenzie Financial Corp Boosts Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/UJBXsR5wroOn The Fly: Top five analyst upgrades $SRPT $ALXN $CIR $LLL $CL: Full Story https://t.co/k7pB5g7ec4$ALXN 134 Puts BUYING Activity expiring on 20th May, Vol 239Biotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback https://t.co/gP4H3IYbxx $ABBV $ACAD $ALXN $AMGN $DVAXBiotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback https://t.co/iWvrxmmfuK $ABBV $ACAD $ALXN $AMGN $DVAXBiotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback https://t.co/XzDIvDbS1N $ABBV $ACAD $ALXN $AMGN $DVAXBiotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback https://t.co/sr3Xe0FS3H $ABBV $ACAD $ALXN $AMGN $DVAXAlexion Pharmaceuticals, Inc. $ALXN Upgraded to “Outperform” at BMO Capital Markets https://t.co/DbJMmu3fD1Alexion Pharmaceuticals, Inc. $ALXN Upgraded to “Outperform” at BMO Capital Markets https://t.co/F6Ps2gAWHHAlexion Pharmaceuticals, Inc. $ALXN Upgraded to “Outperform” at BMO Capital Markets https://t.co/6C8V4bVowGAlexion Pharmaceuticals, Inc. $ALXN Upgraded to “Outperform” at BMO Capital Markets https://t.co/aPGJVcGB8eCowen and Company Reiterates Buy Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/IUHUeFQJQOAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Brean Capital https://t.co/doVw7uptLqAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Reaffirmed by Piper Jaffray https://t.co/Rbf1qYMC3JAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Brean Capital https://t.co/Hb82ECbLgJAlexion Pharmaceuticals, Inc. $ALXN Earns Outperform Rating from Oppenheimer https://t.co/8ofaRdFDJ4https://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSChanges to Top #Biotech Ratings. $CELG $GILD $BMRN $ALXN $AMGN
https://t.co/iveyMQSfOJInvestment Analysts' Weekly Ratings Changes for #Alexion Pharmaceuticals (). Read more: https://t.co/UbrPJprRk1 $ALXNInvestment Analysts' Weekly Ratings Changes for #Alexion Pharmaceuticals (). Read more: https://t.co/97t8bGkto8 $ALXNInvestment Analysts’ Weekly Ratings Changes for Alexion Pharmaceuticals $ALXN https://t.co/6A6YJSJusdInvestment Analysts’ Weekly Ratings Changes for Alexion Pharmaceuticals $ALXN https://t.co/MksEHGuiPUClearbridge Investments LLC Increases Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/z1tdwV4WbvRT @bradloncar: $ALXN Q1 revenue of $701M is a miss (consensus was about $712M). Guides 2016 to be at the low end of their previous range o…RT @AndyBiotech: $ALXN Soliris 1Q16 net sales $665M misses consensus of $691M despite 2.4% price increase in FebruaryRT @adamfeuerstein: Bio earnings reax:

$VRTX flat
$CELG flat
$ALXN -4%
$ACOR -1%
$BMY flatAlexion Pharmaceuticals, Inc. $ALXN Issues  Earnings Results https://t.co/6RDRJ3sHI7Alexion Pharmaceuticals Reiterated Rating by Morgan Stanley (Ranked 34th) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals Reiterated Rating by Leerink Swann (Ranked 66th) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals Downgrade by BMO Capital Markets (Ranked 12th) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2SStochastic Oversold https://t.co/vYPq8yOi6c  $CIG $RHI $BYD $MPEL $WDR $CTRP $ALXN $TWTR $CTL $NCR $APH $FBHS $DRI $SSYS $KLAC $AMBA $SPLS",2016-05-02,ALXN,1
21,"New Uptrend https://t.co/CYhutihVjR $ALXN $NTRI $PBFX $MANT $BGS $HLS $OMCL $USCR $LANC $ATRS $MDCO $FLXN $FIVN $TRUE $VEEV $EGHT $SMLPS&amp;P500 #Stocks Performance $FMC $MNK $FIS $VMC $ENDP $OI $WMB $PFE $ALXN $CVS $EXR $MYL $HCN $FLIR $CLX  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $TRIP $EXPE $MNST $CHTR $AMZN $MAR $FB $MDLZ $ULTA $LVNTA $BMRN $TSCO $PCLN $ALXN $TMUS @ https://t.co/YdSIjG11yNNasdaq100 #Stocks Performance $ENDP $ALXN $MYL $AAPL $ORLY $TRIP $AAL $COST $CA $LMCA $MAR $BIIB $CERN  more@ https://t.co/YdSIjFJqHfS&amp;P500 #Stocks Performance $FMC $MNK $FIS $ENDP $ALXN $VMC $MYL $PFE $CVS $HCN $EXR $OI $CLX $WMB $AAPL  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $TRIP $EXPE $MNST $CHTR $AMZN $MAR $FB $MDLZ $BMRN $ULTA $LVNTA $TSCO $PCLN $ALXN $TMUS @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $ENDP $ALXN $MYL $AAPL $ORLY $TRIP $BIIB $COST $CA $AAL $CERN $LMCA $DLTR  more@ https://t.co/YdSIjFJqHfRT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…Tuesday Sector Leaders: Healthcare, Utilities $ENDP $ALXN $XLV $ETR $NI #stocks https://t.co/sxFT6R4bS6RT @AndyBiotech: #ASH15 (5/N) $ALNY hemolysis reduction only ~70%, missing 80%+ mark, guess not the $ALXN Soliris killer after all;) https:…$PFE and $ALXN were money today! A lot of people think this business is about LUCK. It's NOT. It's about Hard Work! https://t.co/YiWflPb8S6#Alexion Pharmaceuticals' ""Buy"" Rating Reiterated at Brean Capital. Read more: https://t.co/gjkol4CJri $ALXN#Alexion Pharmaceuticals' ""Buy"" Rating Reiterated at Brean Capital. Read more: https://t.co/pI8I5k5xrt $ALXN$ALXN Strong On High Volume: Alexion Pharmaceuticals (ALXN) .More at https://t.co/pttz5MBVarRT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…$ALXN: Bullish analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/1QTDRm9HtR https://t.co/IELW69MzF2Connor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNR$ALXN Strong, could be heading for gap fill. In Jun 150C@RNAiAnalyst The $ALNY CC5 data was hinted at Cowen Conf in March---I guess people didn't listen. This is more of a + for $ALXN -- no compAlexion Pharmaceuticals, Inc. $ALXN Downgraded by Zacks Investment Research https://t.co/fjdmCk1EyY$ALNY down 8% after disclosing that 1 of its many product cands not replacing $ALXN's CC5 MAb?S&amp;P500 #Stocks Performance $FMC $MNK $FIS $CLX $PFE $ALXN $VMC $CMG $THC $CVS $EXR $ENDP $DAL $HCN $AZO  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $MNST $CHTR $EXPE $AMZN $LVNTA $FB $TMUS $TSCO $MDLZ $CMCSA $NTES $TRIP $BMRN $ALXN  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $ALXN $ENDP $ORLY $AAPL $CA $MYL $BIIB $CMCSA $COST $SIRI $AAL $FISV $EA  more@ https://t.co/YdSIjFJqHf$ALXN curiously up , any newsStrong On High Volume: Alexion Pharmaceuticals $ALXN $ALXN https://t.co/RVNB6RaHmIRT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…@AndyBiotech THis will likely be a moot point when $ALXN delivers data on next gen Soliris ALXN1210 soon@AndyBiotech The $ALNY CC5 data got the bulls all jacked up last yr ($140/sh!) that they would be on the hunt vs $ALXN Soliris----not closeRT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…RT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…RT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…RT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…RT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…RT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…RT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…Acabo de realizar una operación en $ALXN ID193279. Regístraste y sígueme en https://t.co/gAMajxbcql vía @TTtradertwitNuestro PRO @alikater1900 acaba de realizar una operación en $ALXN https://t.co/S9EnaIp4pt$ALXN +6.07% from new trend started https://t.co/e7VbeEiKdJ #TradingSystem #Stock$ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https://t.co/GNOWKkPpCAAlexion Pharmaceuticals’ $ALXN Buy Rating Reiterated at Piper Jaffray https://t.co/E5dXSMrNehAlexion Pharmaceuticals’ $ALXN “Buy” Rating Reiterated at Brean Capital https://t.co/KzhfIsRN1DAlexion Pharmaceuticals’ $ALXN “Buy” Rating Reiterated at Cowen and Company https://t.co/WiFr4mtO8cAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Upgraded by BMO Capital Markets https://t.co/u2jWkXrZTgAlexion Pharmaceuticals’ $ALXN “Buy” Rating Reiterated at Cowen and Company https://t.co/cp5ybgk8wnAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Upgraded by BMO Capital Markets https://t.co/y5JrFrLU0shttps://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBSFolger Hill Asset Management LP Invests $4,295,000 in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/Ue2TGkGuYV$ALXN: Bullish analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/1QTDRm9HtR https://t.co/HoWVBaRjDART @TimCarmichael3: $ALNY in their 1Q earn release admitting that CC5 is not able to achieve satisfactory results v. $ALXN Soliris. Next ge…",2016-05-03,ALXN,0
22,"$ALXN Alexion to Present at the Bank of America Merrill Lynch … https://t.co/KQGQmcto4yRT @theflynews: On The Fly: Top five analyst upgrades $SRPT $ALXN $CIR $LLL $CL: Full Story https://t.co/k7pB5g7ec4$ALXN weekly breakdown. Much lower prices ahead.ALXN 144.37 Alexion Pharm Inc $ALXN added to my watch list. Right now with ALXN I am watching the last price 1 https://t.co/HoStpNF7tH$ALXN Institutional ownership up 5.25% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0K#Long $ALXN 143 Refi;;ing plunge (147-141) in the offing prim res (147-149) 
Nr term obj: 161
Stop Loss: 132
VolatileRT @marketexclusive: Here’s Our Highlight From the Latest Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Update https://t.co/TP215PGt4q $ALXN…RT @marketexclusive: Here’s Our Highlight From the Latest Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Update https://t.co/TP215PGt4q $ALXN…RT @marketexclusive: Here’s Our Highlight From the Latest Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Update https://t.co/TP215PGt4q $ALXN…RT @marketexclusive: Here’s Our Highlight From the Latest Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Update https://t.co/TP215PGt4q $ALXN…Here’s Our Highlight From the Latest Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Update https://t.co/TP215PGt4q $ALXN $JNJ #biotechRT @WKRBNews: Alexion Pharmaceuticals’ $ALXN “Buy” Rating Reiterated at Cowen and Company https://t.co/cp5ybgk8wnAlexion Pharmaceuticals, Inc. $ALXN Lifted to Outperform at BMO Capital Markets https://t.co/0fAnJ0hGFO$ALXN Alexion to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
From our Stock News Alerts AppAlexion Pharmaceuticals, Inc. $ALXN Lifted to Outperform at BMO Capital Markets https://t.co/SKVakVnfZH$ALXN: Bullish analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/1QTDRm9HtR https://t.co/JxfNMWMCj2Alexion Pharmaceuticals, Inc. $ALXN Shares Sold by Ascend Capital LLC https://t.co/XHaTIG6g9QRT @ScalpMaster1: $PFE and $ALXN were money today! A lot of people think this business is about LUCK. It's NOT. It's about Hard Work! https…Alexion Pharmaceuticals (ALXN:NASDAQ) gains 2.73% to $144.37 on Tuesday : Among top 10 gainers on S&amp;P500. $ALXN #StockMarket #pharma #nasdaqAlexion Pharmaceuticals (ALXN:NASDAQ) gains 2.73% to $144.37 on Tuesday : Among top 10 gainers on S&amp;P500. $ALXN #StockMarket #pharma #nasdaqAlexion Pharmaceuticals, Inc. $ALXN Shares Up 3.4% https://t.co/DMmUFkBUyMAlexion Pharmaceuticals, Inc. $ALXN Shares Up 3.4% https://t.co/LZoaq5yCRgAlexion Pharmaceuticals, Inc. $ALXN Receives “Buy” Rating from Cowen and Company https://t.co/PnOOXaEiAtRT @dhovekamp42: $AZN $ALXN $BMS $CELG $GILD $GLPG $IPH $PFE $SNY $VRTX https://t.co/QKlAx6CiJlRT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…$AZN $ALXN $BMS $CELG $GILD $GLPG $IPH $PFE $SNY $VRTX https://t.co/QKlAx6CiJl$ALXN Institutional ownership up 5.25% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0KBiggest gainers today large caps:
$VRX 9.62%
$FIS 6.12%
$S 5.16%
$VMC 4.28%
$WMB 3.08%
$PFE 2.74%
$ALXN 2.73%
$CVS 2.43%
$EXR 2.31%RT @ScalpMaster1: $PFE and $ALXN were money today! A lot of people think this business is about LUCK. It's NOT. It's about Hard Work! https…RT @AndyBiotech: $ALNY -5%, $ALXN +2% --&gt; ALNY finally admits CC5 is no Soliris killer after all; also need more Ph2 work before Ph3. https…",2016-05-04,ALXN,1
23,"$ALXN: Bullish analyst action by BMO Capital on Alexion Pharmaceuticals: https://t.co/1QTDRm9HtR https://t.co/BHtJoaxHgeAlexion Pharmaceuticals, Inc. $ALXN Shares Bought by Federated Investors Inc. PA https://t.co/mFPY6moiiyNasdaq100 #Stocks Trend $NTES $YHOO $MNST $ATVI $MDLZ $CHTR $NXPI $MAR $ESRX $LVNTA $VRTX $FB $FAST $TSCO $ALXN @ https://t.co/YdSIjFJqHfhttps://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBSBiotechnology: Entering A Pocket Of Turbulence https://t.co/SyiIEsG55n $AAPL $ABBV $ABT $ACAD $AGN $ALKS $ALNY $ALPMY $ALXN $AMGN $AMZNA lot of drug stocks on the short list today. $ABMD $MDCO $GTN $RTPT $WYNN $JAZZ $ALXN $MYL $MDRXBiotechnology: Entering A Pocket Of Turbulence https://t.co/JrcEqMdJ92 $AAPL #APPLE $ABBV $ABT $ACAD $AGN $ALKS $ALNY $ALPMY $ALXN $AMGNStocks with very bearish long term charts: $ALXN $BMRN $BX $CROX $DVAX $GPRO $FSC $GS $HALO $INSM $ITCI $JUNO $MACK $MET $NBIXConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRRT @theflynews: On The Fly: Top five analyst upgrades $SRPT $ALXN $CIR $LLL $CL: Full Story https://t.co/k7pB5g7ec4I.G. Investment Management LTD. Boosts Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/g1IZJaKCJT",2016-05-05,ALXN,0
24,"50 Day Resistance https://t.co/G7ptVEGWlR $TRIP $HIMX $PDCE $TPX $VIPS $VFC $RRD $QCOM $AXTA $ALXN $LLTC $KMX $ISBC $NEON $GBDC $NEWR $WNSNasdaq100 #Stocks Trend $VRTX $ROST $DLTR $FISV $ATVI $AMZN $MDLZ $ESRX $CTSH $MNST $ALXN $TRIP $FB $INTU  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $BMRN $CERN $INCY $VRTX $MYL $BIIB $CELG $DISH $ROST $ALXN $TRIP $REGN $COST  more@ https://t.co/YdSIjFJqHfEPIRUS Bio shakes up its business; pipeline reprioritized, CEO replaced; up to 40% of wor... https://t.co/H3e0uyC4Ia $EPRS $JNJ $ALXN $RHHBYEPIRUS Bio shakes up its business; pipeline reprioritized, CEO replaced; up to 40% of wor... https://t.co/7DGk1OYH0Q $EPRS $JNJ $ALXN $RHHBYEPIRUS Bio shakes up its business; pipeline reprioritized, CEO replaced; up to 40% of wor... https://t.co/YpnSwyDf9S $EPRS $JNJ $ALXN $RHHBYEPIRUS Bio shakes up its business; pipeline reprioritized, CEO replaced; up to 40% of wor... https://t.co/FRccrp7qKm $EPRS $JNJ $ALXN $RHHBY$EPRS CEO steps down to join $ARNA. To focus on Soliris biosimilar and rare diseases $ALXNS&amp;P500 #Stocks Performance $AGN $MNK $CMG $HCP $VRTX $KR $MYL $BIIB $DRI $HRL $CERN $JWN $ALXN $CELG $MLM  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $VRTX $ROST $AMZN $DLTR $FISV $CTSH $ATVI $MDLZ $ESRX $NXPI $MNST $FB $ALXN $TRIP  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $BMRN $VRTX $MYL $BIIB $CERN $ALXN $CELG $REGN $TRIP $ROST $DISH $AMGN  more@ https://t.co/YdSIjFJqHfNuestro PRO @alikater1900 acaba de realizar una operación en $ALXN https://t.co/S9EnaIp4ptAcabo de realizar una operación en $ALXN ID440773. Regístraste y sígueme en https://t.co/gAMajxbcql vía @TTtradertwitAcabo de realizar una operación en $ALXN ID193545. Regístraste y sígueme en https://t.co/gAMajxbcql vía @TTtradertwitAlexion Pharmaceuticals Boost Price Target by Barclays Capital (Ranked 24th) to Equal Weight with 180 PT $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals's PT raised by Barclays to $180.00. equal weight rating. https://t.co/6gIFpvTthr $ALXN #ALXNRT @RatingsNetwork: Alexion Pharmaceuticals's PT raised by Barclays to $180.00. equal weight rating. https://t.co/esZ7o7b6LR $ALXN #ALXNAlexion Pharmaceuticals's PT raised by Barclays to $180.00. equal weight rating. https://t.co/esZ7o7b6LR $ALXN #ALXNNasdaq100 #Stocks Performance $CERN $REGN $TRIP $MYL $BMRN $DISH $VRTX $GILD $BIIB $ALXN $CELG $AMGN $COST  more@ https://t.co/YdSIjFJqHfRT @Taarriqq: Biotech stocks showing strength $GILD  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNKBiotech stocks showing strength $GILD  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNKStumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
$ACAD, $ABBV, $ALXN, $SGEN, $INCY
https://t.co/mHKhN92PQ5Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
$ACAD, $ABBV, $ALXN, $SGEN, $INCY
https://t.co/ADoXyYdveI$IBB bullish reversal candles on 60 min &amp; daily charts. now see if it can hold. $AMGN $BIIB $CELG $GILD $REGN $ALXN https://t.co/XEUx9LBY2QWARNING: $ALXN OPTIMISM indicator (as seen by investors in News &amp; Social Media)  is very pessimistic! https://t.co/GorHlO4SIKAlexion Pharmaceuticals, Inc. $ALXN Stake Reduced by Caisse DE Depot ET Placement DU Quebec https://t.co/3ipqfFgk1jAlexion Pharmaceuticals, Inc. $ALXN Stake Reduced by Caisse DE Depot ET Placement DU Quebec https://t.co/lFa2mfjl5xRT @WrigleyTom: $NTAP $TXN $ALXN icymi

Mutual Fund Redemptions are a
Headwind for these Large-Cap Stocks

https://t.co/xgaoLf2dE0 https://…Mutual Fund Redemptions Are A Headwind For These Large-Cap Stocks $NTAP $TXN $ALXN #wlst https://t.co/Wba8lOm1O8 https://t.co/Dr7Fs99XfH$NTAP $TXN $ALXN icymi

Mutual Fund Redemptions are a
Headwind for these Large-Cap Stocks

https://t.co/xgaoLf2dE0 https://t.co/zp4jaGhqLp$ALXN just entered #bullish zone, with a new credit grade of BBB-, #SP500 #biotech https://t.co/Y5kMTq9OiB",2016-05-09,ALXN,1
25,"$ALXN Weekly Stochs at 50ish for a bounce continuation, Monthly is OS, Daily starting to move above 20....$ALXN Monthly-Weekly-Daily Bullish Alignment.  Monthly bounce off LBB, 50 sma hold support, HH put in, perhaps working on HL nowNasdaq100 #Stocks Trend $TRIP $AMZN $TMUS $CTSH $MDLZ $ESRX $ADBE $MAR $LVNTA $VRTX $NTES $FB $CTXS $ALXN $PCAR @ https://t.co/YdSIjFJqHf$ALXN behaving nicely close above 5 and ema, 50 sma, slow ascend on daily, bullish reversal on Weekly in playImpressive turnaround day $IBB
w/some red2green

Top 10 holdings, 9/10 nHod
$AMGN $BIIB $CELG $GILD
$REGN $ALXN $VRTX $ILMN $BMRN

$MYL flatAcabo de realizar una operación en $ALXN ID440903. Regístraste y sígueme en https://t.co/gAMajxbcql vía @TTtradertwitAcabo de realizar una operación en $ALXN ID193616. Regístraste y sígueme en https://t.co/gAMajxbcql vía @TTtradertwitRT @Taarriqq: Strong again, yesterday had this post  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNK  #biotechStrong again, yesterday had this post  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNK  #biotech$ALXN Next major catalyst: Ph 3 data for REGAIN study for Soliris in myasthenia gravis on July 7 at Intl. Congress on Neuromuscular DiseasesConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNRhttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSAlexion Pharmaceuticals, Inc. $ALXN Price Target Increased to $180.00 by Analysts at Barclays https://t.co/ZEsQrpln1vWeekly Nasdaq100 #Stocks Trend $ATVI $VRTX $FISV $DLTR $ROST $AMZN $MDLZ $CTSH $ESRX $MNST $ALXN $FB $TRIP  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $ATVI $VRTX $FISV $WFM $ILMN $CTSH $EA $ALXN $GOOGL $YHOO $DLTR $LMCA  more@ https://t.co/YdSIjFJqHf",2016-05-10,ALXN,0
26,"Below Ichimoku https://t.co/XODG9FntZu $TERP $AN $TLRD $ALXN $IBB $DAN $SHOO $GMED $PLUG $ASHR $CCP $CERS $LAZ $BAH $REGN $QGEN $RAREAlexion Pharmaceuticals, Inc. $ALXN PT Raised to $180.00 at Barclays https://t.co/Ih15J8vPcbAlexion Pharmaceuticals, Inc. $ALXN PT Raised to $180.00 at Barclays https://t.co/TJROeMbMg8Alexion Pharmaceuticals, Inc. $ALXN PT Raised to $180.00 at Barclays https://t.co/x8KzunqXPkRECAP 5/11 Chatter:
$RLGY - Marcato stake
$ALXN - Cxl Conf
$GOOG - FTCAlexion Pharmaceuticals, Inc. $ALXN Shares Bought by Lord Abbett &amp; CO. LLC https://t.co/qS5oJ3WxQvRT @OpenOutcrier: $ALXN Hearing Cxl Conf chatter, unconfirmed$ALXN Hearing Cxl Conf chatter, unconfirmedhttps://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBSAcabo de realizar una operación en $ALXN ID193670. Regístraste y sígueme en https://t.co/gAMajxbcql vía @TTtradertwitAcabo de realizar una operación en $ALXN ID441074. Regístraste y sígueme en https://t.co/gAMajxbcql vía @TTtradertwitAcabo de realizar una operación en $ALXN ID193667. Regístraste y sígueme en https://t.co/gAMajxbcql vía @TTtradertwitNuestro PRO @alikater1900 acaba de realizar una operación en $ALXN https://t.co/S9EnaIp4ptCOWEN: $BPMC PoC data from GIST, HCC, SM, plus RET IND, by YE16. Believes $ALXN partnership targets fibrodysplasia ossificans progressive$GILD $CELG $BIIB $ALXN $AMGN https://t.co/I2gajuKKdoConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNR",2016-05-11,ALXN,1
27,"Stochastic Oversold https://t.co/AI95jK9eaZ $BLUE $MACK $LUV $UNP $URBN $TXMD $ALXN $MWW $ONB $AXTA $CLVS $FNGN $NEON $ENSG $DHX $LJPC $LPNTRT @mikegoodma: COWEN: $BPMC PoC data from GIST, HCC, SM, plus RET IND, by YE16. Believes $ALXN partnership targets fibrodysplasia ossifica…$ALXN may go up 10% if the bull pattern is confirmed. Chk confirmation [11%] @ https://t.co/vHPM5KTXkw. Buy level:142.2900.$ALXN green I nibbledAlexion Pharmaceuticals, Inc. $ALXN Price Target Raised to $180.00 https://t.co/reA9dOgihw$ALXN - Leerink raises PT to $210 on increasing conviction of positive pivotal trial read for soliris for MG-looking more like M&amp;A targetStockProQuotes’s Results: $ALXN opened SHORT on 5/11 at $146.40 and closed today's at $137.00 +6.42% https://t.co/g8IiczTL6h $QQQ $SPY $DJIAAlexion Pharmaceuticals hits a 1 month low https://t.co/aEEDfHQ1QP $ALXN #AlexionPharmaceuticals https://t.co/21iv2InZUoUnusually heavy option volume on today's open include $K, $CA, $ALXN, $RL, and $MON.$ALXN price target raise from Leerink not helping as #biotech continues downLeering raised target on $ALXN to $210 on increased conviction in pivotal MG results to be disclosed over the next 4-6 weeks. +++Alexion Pharmaceuticals $ALXN PT Raised to $210 at Leerink Partners https://t.co/r9GJouLUh25 blue-chip stocks to buy for breakout gains, including $BA and $ALXN https://t.co/H022mU9Sgm https://t.co/2uCap9mO3P",2016-05-12,ALXN,1
28,"S&amp;P500 #Stocks Performance $FCX $WMB $REGN $TYC $FTI $JCI $NEM $MRO $MOS $HUM $AAPL $NOV $ALXN $TJX $DAL  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $REGN $NTES $INCY $NVDA $INTU $INTC $ADBE $HSIC $EA $ATVI $CA $LBTYA $ALXN $CTSH $MSFT  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $REGN $NTES $BIDU $INCY $LBTYA $AAPL $ALXN $MYL $DLTR $NVDA $SWKS $YHOO $ROST more@ https://t.co/YdSIjFJqHfOver Ichimoku https://t.co/hftnWenZCv $AXTA $CERN $NLSN $CUBE $BIIB $ALXN $WBS $MENT $UN $SPLK $IWF $OSTK $PDCO $BMRN $CXRX $EURN $BIG$ALXN the bull pattern is confirmed &amp; a BUY signal is issued @ https://t.co/vHPM5KTXkw. Buy Level: 142.4500   Target: 156.695$ALXN:

New SEC Filing for ALXN: Form 8-K (No. 0000899866-16-000313):

https://t.co/n9nZ1CxMPJ https://t.co/ukCrxDkeD2$ALXN New SEC Document(s) for Alexion Pharmaceuticals, Inc.
From our Stock News Alerts AppRT @DrSManian: Baker 13F
Top 5 holdings 

$acad 20.4M ➡️ 24.2M sh last Q
$sgen 37M ➡️ 43M
$incy 19.4M ➡️ 23.4M
$abbv $alxn no changeRT @DrSManian: Baker 13F
Top 5 holdings 

$acad 20.4M ➡️ 24.2M sh last Q
$sgen 37M ➡️ 43M
$incy 19.4M ➡️ 23.4M
$abbv $alxn no changeBaker 13F
Top 5 holdings 

$acad 20.4M ➡️ 24.2M sh last Q
$sgen 37M ➡️ 43M
$incy 19.4M ➡️ 23.4M
$abbv $alxn no changeAlkeon Capital Management LLC Sells 257,000 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/RY7Wet21kgAlkeon Capital Management LLC Sells 257,000 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/2hQ7OV6KqSAlgo trading: OPEN signals May/16
SELL: $ALXN $WUBA $ALRT @SA_BioTech: Eleven Biotherapeutics: A Buyout Likely Coming https://t.co/cJcgxY53Cx $ALXN $ILIU $EBIONasdaq100 #Stocks Performance $REGN $NTES $BIDU $NVDA $LBTYA $AAPL $INCY $SWKS $NXPI $YHOO $ALXN $DLTR $MYL more@ https://t.co/YdSIjFJqHf$IBB blowin...wait till Bakers reveal massive $BGNE stake.... $ACAD $ANAC  $INCY $SGEN $ALXN $JNJ $ABBV $BMRN $PFE...etc...$$$Connor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRSector WinnersL $FCX $WMB $MRO $AAPL $PVH $NAVI $REGN $ALXN $MYL $DOV $TYC $MCK $NVDA $YHOO https://t.co/iC7lxcq6tA https://t.co/p9rDBpspQONasdaq100 #Stocks Trend $NTES $NVDA $INCY $EA $ATVI $CA $ALXN $ISRG $REGN $YHOO $INTU $TXN $MNST $ADBE $HSIC  @ https://t.co/YdSIjFJqHf$ALXN  funny guysSA_QuickIdeas: Eleven Biotherapeutics: A Buyout Likely Coming https://t.co/lxFlwCBNaV $ALXN $ILIU $EBIORT SeekingAlpha: Eleven Biotherapeutics: A Buyout Likely Coming https://t.co/pBck7I3KH0 $ALXN $ILIU $EBIOSeekingAlpha: Eleven Biotherapeutics: A Buyout Likely Coming https://t.co/FwMshSrSHn $ALXN $ILIU $EBIOEleven Biotherapeutics: A Buyout Likely Coming https://t.co/cJcgxY53Cx $ALXN $ILIU $EBIOEleven Biotherapeutics: A Buyout Likely Coming https://t.co/hqclo8BUZX $ALXN $ILIU $EBIO$ALXN acting so funning on this morning's 2min opening candle HOLY SHIT! lolIBM Retirement Fund Raises Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/rEBTnxruRkLeerink Swann Reiterates “Buy” Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/mYYzihjezELeerink Swann Reiterates “Buy” Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/itMzJrRRGq8,440 Shares in Alexion Pharmaceuticals, Inc. $ALXN Acquired by Kentucky Retirement Systems Insurance Trust Fund https://t.co/9yuYvoGeqsAlexion Pharmaceuticals, Inc. $ALXN Position Increased by Stifel Financial Corp https://t.co/vc37DJUFp9Alexion Pharmaceuticals, Inc. $ALXN Position Increased by Stifel Financial Corp https://t.co/axJIIhyu5M$ALXN Institutional ownership up 5.28% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0K",2016-05-16,ALXN,0
29,"RT @TradeWithSuper: Benzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/c4tS24SE4QRT @Benzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/KshODCHP0nBenzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/c4tS24SE4QHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/KshODCHP0nBelow Ichimoku https://t.co/bDRXmzceFl $SRPT $DLTR $CERN $EWY $MPEL $IMS $VLY $EQR $UMPQ $MYCC $PACB $FLIR $CBL $ALXN $NYRT $BETR $TROXAlexion Pharmaceuticals, Inc. $ALXN Stake Boosted by Chevy Chase Trust Holdings Inc. https://t.co/0nXWLoxfD5RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…Video: Nasdaq 100 Movers: $ALXN  $STX #stocks https://t.co/gCUojvCb2TI had higher hopes for $ALXN, oh well.$ALXN Current Report Filing (8-k)… https://t.co/5r9MFatjAtRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…Alexion Pharmaceuticals, Inc. $ALXN Earns “Buy” Rating from Leerink Swann https://t.co/QbyIpraTukAlexion Pharmaceuticals, Inc. $ALXN Earns “Buy” Rating from Leerink Swann https://t.co/dg4j3P2aNhAlexion Pharmaceuticals, Inc. $ALXN Earns “Buy” Rating from Leerink Swann https://t.co/owjb4IMuc4RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…Alexion Pharmaceuticals, Inc. $ALXN Position Raised by Fjarde AP Fonden Fourth Swedish National Pension Fund https://t.co/9GPuUlObGYRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…Weekly Nasdaq100 #Stocks Trend $NVDA $EA $NTES $ATVI $CA $INCY $REGN $ADBE $INTU $HSIC $INTC $LBTYA $ALXN $CTSH @ https://t.co/YdSIjFJqHfRT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…RT @BioStocks: BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE…BAKER Bros Top Holding: $INCY $SGEN $ALXN $ABBV $ACAD $BMRN 
Top sells: $GILD $DYAX $MDVN $LIFE $CPRX 
Top adds: $QURE $VTAE $AGIO $BLUERT @DrSManian: Baker 13F
Top 5 holdings 

$acad 20.4M ➡️ 24.2M sh last Q
$sgen 37M ➡️ 43M
$incy 19.4M ➡️ 23.4M
$abbv $alxn no change",2016-05-17,ALXN,1
30,"Enter Ichimoku https://t.co/22DSZR1oRl $BLDR $PNW $ANY $ALXN $CRUS $STNG $SJI $SPHD $ETSY $EPP $GOLD $DRII $EURN $EMLC $DTE $WRI $BKUNorges Bank Invests $325,573,000 in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/mY9xvbDHWcCreative Planning Has $3,014,000 Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/tVvbudUKl5The EVP &amp; Global Head of R&amp;D of Alexion Pharmaceuticals (NASDAQ: ALXN) is Selling Shares $ALXN https://t.co/xhW2mEO0BJEqis Capital Management Inc. Has $1,298,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/a70R0otSKh$ALXN New SEC Document(s) for Alexion Pharmaceuticals, Inc.
From our Stock News Alerts AppWant automatic email alerts for $AMB $IRF $BCSI $GT $ALXN? Subscribe to MarketBeat Daily https://t.co/nSJuDsYidj$ALXN:

New Insider Transaction on ALXN by EVP &amp; Global Head of R&amp;D:

https://t.co/1GXCPsHVF9 https://t.co/K1wFOnMNheAlexion Pharmaceuticals's EVP %26 Global Head of R%26D just disposed of 4,097 shares  https://t.co/rirb3fIoCH $ALXNHas A #Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD$CELG $REGN  https://t.co/RmLjOqsBNY via @benzinga #stocks$ALXN would you look at that 15 min asendent level during the doldrums...$ALXN whats up at 142.18 here 12:30  cst?Alexion Pharmaceuticals, Inc. $ALXN Shares Bought by Webster Bank N. A. https://t.co/FJnikowoEPAlexion Pharmaceuticals, Inc. $ALXN Shares Bought by Webster Bank N. A. https://t.co/2p1z3iUdcuSome #unusualactivity #options: $ALXN $ATVI $EXR $F $FL $IRWD $PLD $TIF $TRGP $WFC via https://t.co/AyoJORKy1x https://t.co/kRZKXcX7SmHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB https://t.co/Ypogpoipzq via @benzingaRT @DavidBautz: Commented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $…Pieris Pharmaceuticals: The Paradigm Shift That Antibodies Need https://t.co/RVCpEanG5L $PIRS, $ALXN, $ENUM, $GILD, $REGN, $SNYRT @DavidBautz: Commented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $…Commented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $SNY $PIRSRT SeekingAlpha: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/XnI9dWqP6U $ALXN $ENUM $GILD $REGN $SNY $PIRSSeekingAlpha: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/pGFtpN9Oqj $ALXN $ENUM $GILD $REGN $SNY $PIRSRT @SA_BioTech: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/1KRWatsdjb $ALXN $ENUM $GILD $REGN $SNY $PIRSPieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/1KRWatsdjb $ALXN $ENUM $GILD $REGN $SNY $PIRSPieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/yTGcv6TKHH $ALXN $ENUM $GILD $REGN $SNY $PIRSRT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN…RT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN…RT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN…$PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SNY $PIRS$ALXN supports @CMSGov preliminary decision to give Kanuma a unique billing code. https://t.co/0CZlSv9vCQHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB  https://t.co/SwkAGegdzO via @benzingaAlexion Pharmaceuticals, Inc. $ALXN  Shares Down 3.1% https://t.co/udiEscyL7tAlexion Pharmaceuticals, Inc. $ALXN  Shares Down 3.1% https://t.co/byUCDG05xiAlexion Pharmaceuticals decreaseses 3.19% to $139.96 on Tuesday : Among top 10 losers on S&amp;P500 $ALXN #pharma https://t.co/RkBaXT7QB9Alexion Pharmaceuticals decreaseses 3.19% to $139.96 on Tuesday : Among top 10 losers on S&amp;P500 $ALXN #pharma https://t.co/B0BKEMXyuEHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB https://t.co/Ypogpo0OHS via @benzingaRT @kapunikun: $ALXN Alexion Pharmaceuticals Kurtosis : -1.38 Skew : -0.33 Correlation Histogram #bigdata https://t.co/batufAV8Qx$ALXN Alexion Pharmaceuticals Kurtosis : -1.38 Skew : -0.33 Correlation Histogram #bigdata https://t.co/batufAV8Qx",2016-05-18,ALXN,0
31,"Below Ichimoku https://t.co/0MIpNlF5gi $TRV $ARI $CNI $ALXN $BIIB $UDR $DNOW $RGEN $PENN $PSA $CFX $KNX $SSS $IMS $CRUS $WTW $IPHI$ALXN ALXN­1210 (next­gen Soliris Per the abstract the half­life of ‘1210 was over 30 days, substantially longer than Soliris.$ALXN New SEC Document(s) for Alexion Pharmaceuticals, Inc.
From our Stock News Alerts AppAlexion Pharmaceuticals director just picked up 835 shares  https://t.co/hY9Lgafla6 $ALXNRT SeekingAlpha: Latest Indication For Soliris And U.S. Regulators Decide On ZS-9 https://t.co/tYnnX9srlR $ALXN $AZN $RLYPLatest Indication For Soliris And U.S. Regulators Decide On ZS-9 https://t.co/kUXvp86zmo $ALXN $AZN $RLYP$ALXN Statement of Changes in Beneficial Ownership (4)… https://t.co/Dk6ZLUFJFRLatest #free digest: PIII results for $ALXN Soliris in myasthenia gravis and US regulators decide on $AZN ZS-9 https://t.co/bEahxOVeqeEastern Bank Continues to Hold Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/SnlbZEWSNNEastern Bank Continues to Hold Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/XjTOxdkL3wLatest free event roundup featuring Soliris $ALXN and Astrazeneca’s ZS-9 https://t.co/Pvxap52ffwAlexion Pharmaceuticals, Inc. $ALXN EVP Martin Mackay Sells 4,097 Shares https://t.co/4lB69fLkvpAcabo de realizar una operación en $ALXN ID442185. Regístraste y sígueme en https://t.co/DIWBtiA8Ux vía @TTtradertwit$ALXN Researchers to Present Late-Breaking Data https://t.co/cdTSpxySSoTime to leave the pink glasses. Here the truth drops to an another state of reality. $IBB $ALXN $REGNHere comes the Biotech bubble. $REGN $ALXN $IBB$ALXN Researchers to Present Late-Breaking Data https://t.co/AmFKDVrG75 #biotechstocks #biotech #stockshttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSRT @BioStocks: $ALXN to present late-breaking data from a Phase 2 trial of ALXN1007 in patients with acute GI-GVHD at #EHA16 https://t.co/h…$ALXN to present late-breaking data from a Phase 2 trial of ALXN1007 in patients with acute GI-GVHD at #EHA16 https://t.co/h58Y2JbNs8$ALXN Researchers to Present Late-Breaking Data on ALXN1210 in Patients with PNH at EHA Annual Congress
From our Stock News Alerts App$ALXN Researchers to Present Late-Breaking Data on ALXN1210 in Patients with PNH at EHA Annual Congress... - https://t.co/k2q0rZxnkAWeekly Nasdaq100 #Stocks Trend $NVDA $INCY $REGN $VOD $CHTR $QCOM $NXPI $CTSH $BMRN $ALXN $LLTC $TXN $NTES $CA  @ https://t.co/YdSIjFJqHfMartin Mackay Sells 4,097 Shares of Alexion Pharmaceuticals, Inc. $ALXN Stock https://t.co/5pO9FbdmRp$ALXN received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 678Martin Mackay Sells 4,097 Shares of Alexion Pharmaceuticals, Inc. $ALXN Stock https://t.co/vul29uoqs0Martin Mackay Sells 4,097 Shares of Alexion Pharmaceuticals, Inc. $ALXN Stock https://t.co/wB4l5sm1YB",2016-05-19,ALXN,1
32,"RT @HedgeMind: Baker Bros top 10 stocks w/ SmartPick Ratings: $INCY 93 $SGEN 62 $ALXN 95 $ABBV 97 $ACAD 91 $BMRN 98 $GHDX 61 $ANAC 92 $DBVT…RT @HedgeMind: Baker Bros top 10 stocks w/ SmartPick Ratings: $INCY 93 $SGEN 62 $ALXN 95 $ABBV 97 $ACAD 91 $BMRN 98 $GHDX 61 $ANAC 92 $DBVT…Parabolic SAR Buy https://t.co/DFZK6wIEKQ $BIDU $HUM $ALXN $IJJ $IHS $VO $VBK $VMC $UTHR $IJR $IWM $VBR $CRI $IWN $IWP $NXPI $PVHRT @1ResilientSoul: #AfterHours losers📉🤔👉🏼 $BIIB $CTRP $WMGI $SSW $HES $BAH $PE $HA $PE $OAS $ALXN $LPI $BCEI $CIT $TWO $LC $ALXN $GERN $CM…RT @1ResilientSoul: #AfterHours losers📉🤔👉🏼 $BIIB $CTRP $WMGI $SSW $HES $BAH $PE $HA $PE $OAS $ALXN $LPI $BCEI $CIT $TWO $LC $ALXN $GERN $CM…RT @1ResilientSoul: #AfterHours losers📉🤔👉🏼 $BIIB $CTRP $WMGI $SSW $HES $BAH $PE $HA $PE $OAS $ALXN $LPI $BCEI $CIT $TWO $LC $ALXN $GERN $CM…RT @1ResilientSoul: #AfterHours losers📉🤔👉🏼 $BIIB $CTRP $WMGI $SSW $HES $BAH $PE $HA $PE $OAS $ALXN $LPI $BCEI $CIT $TWO $LC $ALXN $GERN $CM…#AfterHours losers📉🤔👉🏼 $BIIB $CTRP $WMGI $SSW $HES $BAH $PE $HA $PE $OAS $ALXN $LPI $BCEI $CIT $TWO $LC $ALXN $GERN $CMCSA $CMCSA $FSLR $XIVRT @HedgeMind: Baker Bros top 10 stocks w/ SmartPick Ratings: $INCY 93 $SGEN 62 $ALXN 95 $ABBV 97 $ACAD 91 $BMRN 98 $GHDX 61 $ANAC 92 $DBVT…RT @HedgeMind: Baker Bros top 10 stocks w/ SmartPick Ratings: $INCY 93 $SGEN 62 $ALXN 95 $ABBV 97 $ACAD 91 $BMRN 98 $GHDX 61 $ANAC 92 $DBVT…RT @HedgeMind: Baker Bros top 10 stocks w/ SmartPick Ratings: $INCY 93 $SGEN 62 $ALXN 95 $ABBV 97 $ACAD 91 $BMRN 98 $GHDX 61 $ANAC 92 $DBVT…HedgeMind: Baker Bros top 10 stocks w/ SmartPick Ratings: $INCY 93 $SGEN 62 $ALXN 95 $ABBV 97 $ACAD 91 $BMRN 98 $GHDX 61 $ANAC 92 $DBVT 82 …RT @HedgeMind: Baker Bros top 10 stocks w/ SmartPick Ratings: $INCY 93 $SGEN 62 $ALXN 95 $ABBV 97 $ACAD 91 $BMRN 98 $GHDX 61 $ANAC 92 $DBVT…Baker Bros top 10 stocks w/ SmartPick Ratings: $INCY 93 $SGEN 62 $ALXN 95 $ABBV 97 $ACAD 91 $BMRN 98 $GHDX 61 $ANAC 92 $DBVT 82 $ACOR 85$ALXN $GERN: significant After Hours Decliners as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7f #stocksCapital Impact Advisors LLC Cuts Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/U6wbeaN8VlAdvocacy Spotlight: SOLACE organization for LAL Deficiency https://t.co/UXj1DcnXtV $ALXN #laldeficiencyCerrado 100 largos de $ALXN a 143.85USD ganando 393USD IDOP442418 ... https://t.co/AfWjG6FdTh vía @TTtradertwitAlexion Pharmaceuticals, Inc. $ALXN EVP Sells $570,302.40 in Stock https://t.co/aXARAcL477RT @AndyBiotech: $ALNY @RNAiAnalyst The bar was raised $ALXN next-gen Soliris had 99% hemolysis inhibition w/ single  monthly SC dose
https…$ALNY @RNAiAnalyst The bar was raised $ALXN next-gen Soliris had 99% hemolysis inhibition w/ single  monthly SC dose
https://t.co/dOct7t1H3W",2016-05-23,ALXN,1
33,"Nasdaq100 #Stocks Trend $VRTX $ATVI $LLTC $CHKP $LRCX $MU $ADBE $BIIB $NXPI $ALXN $BMRN $INTC $CELG $CTXS $QCOM @ https://t.co/YdSIjFJqHfAlexion Pharmaceuticals, Inc. $ALXN Shares Bought by CrestPoint Capital Management LLC https://t.co/WSJ5VljlmDI still kind of like $ALXN.

No position.OLD National Bancorp IN Acquires 891 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/h66nC9vEUiMid to Late June – $ALXN – Soliris (eculizumab) for Myasthenia Gravis (MG)Texas Permanent School Fund Sells 2,132 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/MhHiJvFjz1performance update. @zzlangerhans #zzporte $ABBV $ALXN $AMGN $BIIB $BMY $CELG $FPRX $GILD $IBB $INO $REGN $VRX $XBI https://t.co/mKJWA9ohcTConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNRRT @Biotech_5: Afterhours #Biotechs
$SRPT+5.26%152K shares
$CCXI+2.97%17K
$SGYP+2.33%122K
$PTCT+2.08% 8K 
$ICPT-2.42% 4K
$ALXN-1.76% 42K
$G…RT @Biotech_5: Afterhours #Biotechs
$SRPT+5.26%152K shares
$CCXI+2.97%17K
$SGYP+2.33%122K
$PTCT+2.08% 8K 
$ICPT-2.42% 4K
$ALXN-1.76% 42K
$G…RT @Biotech_5: Afterhours #Biotechs
$SRPT+5.26%152K shares
$CCXI+2.97%17K
$SGYP+2.33%122K
$PTCT+2.08% 8K 
$ICPT-2.42% 4K
$ALXN-1.76% 42K
$G…RT @Biotech_5: Afterhours #Biotechs
$SRPT+5.26%152K shares
$CCXI+2.97%17K
$SGYP+2.33%122K
$PTCT+2.08% 8K 
$ICPT-2.42% 4K
$ALXN-1.76% 42K
$G…Afterhours #Biotechs
$SRPT+5.26%152K shares
$CCXI+2.97%17K
$SGYP+2.33%122K
$PTCT+2.08% 8K 
$ICPT-2.42% 4K
$ALXN-1.76% 42K
$GERN-1.41%109K",2016-05-24,ALXN,1
34,"Stochastic OB https://t.co/YrkxDXXrfn $ALXN $IWD $QLD $HZNP $MACK $VLY $UWTI $FIS $PNR $XLE $INTC $YPF $UCO $XOP $TNA $SERV $SWKS$SPY $DIA $IWM $QQQ $IBB $XBI. $ALNY no material news - trial results or company PR &amp; stock up 10% after inferior results to $ALXN...Nasdaq100 #Stocks Trend $WDC $BIIB $DISH $INCY $ALXN $AMGN $AAPL $LRCX $VIAB $CSCO $AVGO $CELG $VOD $VRTX $NTAP @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $WDC $BBBY $STX $BIIB $PCAR $ORLY $ULTA $NFLX $DISH $INCY $ALXN $AMGN $DISCA  more@ https://t.co/YdSIjFJqHfBUY $ADP 87.52, BUY $ALXN 149.61, BUY $AN 49.52, BUY $AXP 65.31. More stock tips &amp; details at: https://t.co/oklTsu6jC2$ALXN on the move with bio sector https://t.co/00I9hx0TK3$ALXN 20160617 83 trade. ~$1.2 MM notional value.$ALXN look for the stock to trade up as key data for Soliris in MG comes out in mid-June----first of many ++ triggers to come in 2H2016$ALXN 20160617 79 trade. ~$1.2 MM notional value.Sumitomo Life Insurance Co. Increases Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/JY7EELD0MWConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNRRT SeekingAlpha: Achillion's Pipeline Strengthens, With Near-Term Potential Catalysts https://t.co/IvkaP53cGa $ABBV $ALXN $BMY $GILD $JNJ …SeekingAlpha: Achillion's Pipeline Strengthens, With Near-Term Potential Catalysts https://t.co/OLhrqkrDrn $ABBV $ALXN $BMY $GILD $JNJ $AC…Achillion's Pipeline Strengthens, With Near-Term Potential Catalysts https://t.co/9q9VR19PDN $ABBV $ALXN $BMY $GILD $JNJ $ACHNAchillion's Pipeline Strengthens, With Near-Term Potential Catalysts https://t.co/quqsuMPoAh $ABBV $ALXN $BMY $GILD $JNJ $ACHN$ALXN in ABC Bullish Pattern, Targets https://t.co/zIfBkun0SzFrank Sands Sells Visa, Baidu, Alibaba $MELI $PCLN $BABA $ALXN $REGN $BIDU $V $FTI https://t.co/45jXL91DabRT SeekingAlpha: Delta Air Lines Is A Buy - Cramer's Lightning Round (5/24/16) https://t.co/fDVwuHDRNc $TASR $CSAL $ALXN $SRPT $CMRE $NAT …SeekingAlpha: Delta Air Lines Is A Buy - Cramer's Lightning Round (5/24/16) https://t.co/5TqgYHHVqU $TASR $CSAL $ALXN $SRPT $CMRE $NAT $SW…as goofy as it may seem, I kinda like $ALXN here long. chart: https://t.co/dqbjODCSgSMACD Bullish https://t.co/Yhatu5bs1a $ALXN $IWO $IJT $JLL $VOOG $UFPI $EPC $VRSK $GMF $GXC $CEB $BLKB $VLUE $BURL $PSCT $LVLT $SCHGAlexion Pharmaceuticals, Inc. $ALXN Shares Sold by Nomura Asset Management Co. Ltd. https://t.co/5g1XvD5zbv$SPY $DIA $IWM $QQQ $IBB $XBI. $ALNY inferior to $ALXN; and also says $ARWR is better in Hep B... $MDCO has lipid program. What else???",2016-05-25,ALXN,0
35,"$ALXN 20160617 69 trade. ~$1 MM notional value.$ALXN 20160617 92 trade. ~$1.4 MM notional value.RT @BioBounce: Longtime leaders of large cap biotech ($IBB), $CELG $GILD $BIIB $ALXN $VRTX &amp; $ILMN all triggered potential breakouts yester…Longtime leaders of large cap biotech ($IBB), $CELG $GILD $BIIB $ALXN $VRTX &amp; $ILMN all triggered potential breakouts yesterday.https://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBS$ALXN Company ALEXION PHARMACEUTICALS INC just submited new SEC filing https://t.co/l6new0i7Di",2016-05-26,ALXN,1
36,"Bearish Doji https://t.co/faJ7oqJ1fs $QEP $OHI $IWN $SHO $ALXN $PFE $APC $TQQQ $LLTC $DEPO $ZTS $AVP $QLD $DVN $CLR $GRPN $CLVS(3/3) 

Tweet Storm

3. R&amp;D per $1 of OpEx: $ALNY $ALKS $GILD $CELG $BMY $BIIB $ALXN

--&gt; https://t.co/MrZeDP0miW https://t.co/h9abFqOo1jRT @Lin_ling_88: Why Biotech Stocks Like Alexion May Get Burned - Forbes $ALXN  https://t.co/4XmjfleOmFWhy Biotech Stocks Like Alexion May Get Burned - Forbes $ALXN  https://t.co/4XmjfleOmF$ALXN Alexion to Present at Upcoming Investor Conferences… https://t.co/9cE3OaE0lb@BioWords @srqstockpicker @olddoggnewtrix Currently holding $PETX, $ITEK, $LOXO, $CELG, $ALXN, $CNCR, $RARE, $CCXI, $TTPH, $FOLD and othersDon't forget that $ALXN usually has a green summer. Past performance is not indicative of future gains, or duh.NDAQSystem's Results: $ALXN opened LONG on 5/27 at $147.00 and closed today's at $152.00 +3.4%... https://t.co/Rpsgpj8PXNS&amp;P500 #Stocks Trend $VRTX $MU $AEE $BIIB $URI $LM $TDC $DLTR $HAR $RHI $GLW $CERN $HPQ $XRX $TMK $ALXN $LVLT  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $VRTX $MU $BIIB $DLTR $BMRN $CERN $DISH $ALXN $AKAM $EBAY $AMGN $CELG $VIAB $FISV $ULTA @ https://t.co/YdSIjFJqHfRT @ryanmathews: $ALXN HOD https://t.co/FmDbnbHgeD$ALXN HOD https://t.co/FmDbnbHgeD$ALXN Alexion to Present at Upcoming Investor Conferences
From our Stock News Alerts App$ALXN looking higherNDAQSystem's Results: $ALXN opened LONG on 5/27 at $147.00 and closed today's at $152.00 +3.4% https://t.co/B2b5YIke3g  $QQQ $DJIA $SPY $DIAAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Oppenheimer https://t.co/TNumpSTI1xAlexion Pharmaceuticals hits a 1 month high https://t.co/aEEDfHQ1QP $ALXN #AlexionPharmaceuticals https://t.co/eFAbB3MOIMWeekly Nasdaq100 #Stocks Trend $DLTR $MU $WDC $VIAB $ULTA $NFLX $INCY $BIDU $LRCX $AMAT $BIIB $VRTX $ADSK $ALXN @ https://t.co/YdSIjG11yNAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Oppenheimer https://t.co/vWBLqwDsBXAlexion Pharmaceuticals Reiterated Rating by CIBC Oppenheimer (Ranked 50th) to Outperform with 228 PT $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals's outperform rating reiterated at Oppenheimer. $228.00 PT. https://t.co/bZoBQwwOtH $ALXN #ALXNAlexion Pharmaceuticals's outperform rating reiterated at Oppenheimer. $228.00 PT. https://t.co/ukeULZo7OX $ALXN #ALXNTop Trade Ideas for the Week of May 31, 2016: The Rest https://t.co/Lje6oMbLAZ $ABT $ALXN $LEA $MTB $PNRA $SPYRT @TomSilver39: ASCO( yes starts this Friday!) updates: $ARIA $STML $KPTI $ECYT $DNAI $KITE $JUNO $SGEN EHA (June 9-11)  : $AGIO $ALNY $GB…Alexion Pharmaceuticals, Inc. $ALXN Upgraded by Zacks Investment Research to “Hold” https://t.co/RkC7SPWo1QAlexion Pharmaceuticals, Inc. $ALXN Upgraded by Zacks Investment Research to “Hold” https://t.co/371Bppm6Ij$ALXN is in bullish cycle, it is 20% higher than 52 weeks low. https://t.co/9XqOX7rbWF #markets",2016-05-31,ALXN,1
37,"S&amp;P500 #Stocks Trend $WFM $TAP $MU $MNK $WDC $AET $CNC $REGN $JCI $ALXN $DHI $DG $MNST $MCK $TMO $TDC $VRTX $C @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $WFM $MU $WDC $DISH $ULTA $REGN $ALXN $MNST $MXIM $VRTX $MDLZ $CMCSA $VIAB $ESRX $DLTR  @ https://t.co/YdSIjG11yNNasdaq100 #Stocks Performance $ENDP $WFM $CHTR $MU $MYL $COST $WDC $STX $MAR $DISH $FOXA $ULTA $REGN $ALXN  more@ https://t.co/YdSIjFJqHf$ALXN: Alexion Pharma announces that the European Commission has granted orphan drug designation to ALXN1210 https://t.co/Eg043shYPxRT @MarketCurrents: Alexion's ALXN1210 an Orphan Drug in Europe for ultra-rare blood disorder https://t.co/lArZk92obk $ALXNAlexion's ALXN1210 an Orphan Drug in Europe for ultra-rare blood disorder https://t.co/GxNwlsCuui $ALXNAlexion's ALXN1210 an Orphan Drug in Europe for ultra-rare blood disorder https://t.co/KcLYC5VGyJ $ALXNAlexion's ALXN1210 an Orphan Drug in Europe for ultra-rare blood disorder https://t.co/lArZk92obk $ALXNRT @Allstocknews: $ALXN European Commission Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with Parox
From our St…$ALXN European Commission Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with Pa... - https://t.co/qAXnhwzOqS$ALXN receives ODD in EU for ALXN1210 in PNH$ALXN European Commission Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with Parox
From our Stock News Alerts AppS&amp;P500 #Stocks Trend $WFM $MNK $TAP $WDC $MU $REGN $ALXN $AET $MNST $CNC $DHI $TMO $TDC $WAT $DG $VRTX $CMCSA  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $WFM $WDC $MU $DISH $REGN $ALXN $ULTA $MNST $VRTX $MXIM $CMCSA $ESRX $DLTR $CERN $CTXS  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $ENDP $WFM $CHTR $MYL $COST $WDC $MU $STX $DISH $REGN $INCY $FOXA $ALXN $MAR  more@ https://t.co/YdSIjFJqHfRT @TraderMentality: Stalking $ALXN for a long entry... but not yet. Here's why:
https://t.co/5WwWmspy9OStalking $ALXN for a long entry... but not yet. Here's why:
https://t.co/5WwWmspy9OAlexion Pharmaceuticals hits a 1 month high https://t.co/aEEDfHQ1QP $ALXN #AlexionPharmaceuticals https://t.co/bbtXvIarhLNasdaq100 #Stocks Performance $ENDP $WFM $MYL $CHTR $COST $REGN $WDC $FOXA $ALXN $DISH $VRTX $ULTA $CTXS  more@ https://t.co/YdSIjFJqHf$ALXN Company ALEXION PHARMACEUTICALS INC just submited new SEC filing https://t.co/l6new0zJ1SRT @CowenResearch: Report today: Our #biotech team highlights abstracts from $AGIO $ALNY $ALXN $GBT $ONCE &amp; $QURE from European Hematology…Report today: Our #biotech team highlights abstracts from $AGIO $ALNY $ALXN $GBT $ONCE &amp; $QURE from European Hematology Association meetingWeekly Nasdaq100 #Stocks Trend $DLTR $ULTA $MU $WDC $VIAB $DISH $BIIB $VRTX $AKAM $AMGN $ALXN $NXPI $CA $TRIP  @ https://t.co/YdSIjFJqHfAlexion Pharmaceuticals, Inc. $ALXN Receives Outperform Rating from Oppenheimer https://t.co/YfdGJmfqqn$ALXN - Alexion Pharmaceuticals, Inc. #ALXN Stock Rating Upgraded by Zacks Investment… https://t.co/T8bY9TxlYy$ALXN - Alexion Pharmaceuticals, Inc. #ALXN Stock Rating Upgraded by Zacks Investment… https://t.co/Az4wm7qFHGAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Upgraded by Zacks Investment Research https://t.co/GAchPQc785Alexion Pharmaceuticals, Inc. $ALXN Stock Rating Upgraded by Zacks Investment Research https://t.co/9zF31VuIJwRT @Lin_ling_88: Why Biotech Stocks Like Alexion May Get Burned - Forbes $ALXN  https://t.co/4XmjfleOmFAlexion Pharmaceuticals, Inc. $ALXN Shares Gap Up to $150.42 https://t.co/DtQ9O9Gx3HAlexion Pharmaceuticals, Inc. $ALXN Shares Gap Up to $150.42 https://t.co/xY8pyi2DgyThese Billionaires Made a Killing on Celator. Here's What Else They've Been Buying - $cpxx $alxn $agrx Motley Fool https://t.co/mLB2WKQIcD$ALXN Institutional ownership up 5.28% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0Khttps://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBS",2016-06-01,ALXN,1
38,"Over Keltner https://t.co/G870K5b54U $SWN $XLV $FITB $HTZ $MGM $UGAZ $TMUS $ALLY $SGYP $EWH $LULU $WWAV $MCK $FRO $ALXN $URI $PSECS&amp;P500 #Stocks Trend $HUM $AET $ABBV $MDT $CNC $WYNN $ALXN $SWN $URI $TRIP $CELG $VRTX $FLS $MCK $DE $FITB  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $HUM $ENDP $KORS $LB $AET $M $ABBV $KSS $STX $MDT $CNC $JWN $WYNN $ALXN $GPS  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $DISH $BMRN $INCY $ALXN $TRIP $CELG $VRTX $TMUS $AMZN $AMGN $VIAB $WFM $CA $PAYX $CTXS  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $DISH $ENDP $BMRN $SBAC $STX $INCY $LBTYA $ALXN $TRIP $LMCA $CELG $MAR $VRTX  more@ https://t.co/YdSIjFJqHfS&amp;P500 #Stocks Trend $HUM $AET $MDT $ABBV $WYNN $CNC $SWN $ALXN $URI $CELG $TRIP $VRTX $MCK $FLS $FITB $GRMN  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $BMRN $DISH $ALXN $CELG $TRIP $VRTX $WFM $AMGN $ESRX $CTXS $FISV $MNST $ULTA $INCY  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $ENDP $BMRN $DISH $SBAC $STX $INCY $LBTYA $ALXN $HSIC $LMCA $CELG $TRIP $MAR  more@ https://t.co/YdSIjFJqHfEuropean Commission Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with PNH $ALXN https://t.co/NZeMv8Ma4z$ALXN Institutional ownership up 5.28% Q/Q, with 12,274,300 net purchase https://t.co/XBCorgOi0Kperformance update. @zzlangerhans #zzporte $ABBV $ALXN $AMGN $BIIB $CELG $FPRX $GILD $IBB $INO $MDVN $REGN $VRX $XBI https://t.co/wnL9Sfqd3pAlexion Pharmaceuticals, Inc. $ALXN Shares Gap Up to $150.42 https://t.co/WFwsDIyC12Alexion Pharmaceuticals, Inc. $ALXN Shares Gap Up to $150.42 https://t.co/Kz8zLJgkT6S&amp;P500 #Stocks Trend $AET $ABBV $WYNN $CNC $ALXN $MNK $WAT $ESRX $AMGN $RTN $MNST $HOLX $WFM $WDC $MCK $UNH  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $BMRN $DISH $ALXN $ESRX $AMGN $MNST $WFM $ULTA $WDC $VRTX $BIIB $DLTR $FISV $LRCX $REGN @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $ENDP $BMRN $STX $SBAC $WDC $MYL $INCY $MAR $DISH $LVNTA $ALXN $DISCA $LBTYA  more@ https://t.co/YdSIjFJqHfBRIEF-#Alexion Pharmaceuticals says EC grants orphan drug designation to 1210. Read more: https://t.co/7RY5AEdeGI $ALXNBRIEF-#Alexion Pharmaceuticals says EC grants orphan drug designation to 1210. Read more: https://t.co/3seF0ITVD4 $ALXNEC grants orphan drug status to #Alexion's 1210 to treat paroxysmal nocturnal hemoglobinuria. Read more: https://t.co/KTV4brFQp3 $ALXNEC grants orphan drug status to #Alexion's 1210 to treat paroxysmal nocturnal hemoglobinuria. Read more: https://t.co/9huCw7PLdT $ALXNAlexion Pharmaceuticals, Inc. $ALXN Shares Sold by Aperio Group LLC https://t.co/MTUzObSCjKRT @WrigleyTom: Some nHod, RS (1hr in)

$IBB $BIB $XBI $BMRN $SGEN
$JUNO $KITE $VRX $ENDP $VRTX
$ICPT $RDUS $PBYI $HZNP $KERX
$AGIO $BLUE $…RT @WrigleyTom: Some nHod, RS (1hr in)

$IBB $BIB $XBI $BMRN $SGEN
$JUNO $KITE $VRX $ENDP $VRTX
$ICPT $RDUS $PBYI $HZNP $KERX
$AGIO $BLUE $…Some nHod, RS (1hr in)

$IBB $BIB $XBI $BMRN $SGEN
$JUNO $KITE $VRX $ENDP $VRTX
$ICPT $RDUS $PBYI $HZNP $KERX
$AGIO $BLUE $CELG $RARE $ALXNAlexion Pharmaceuticals hits a 1 month high https://t.co/aEEDfHQ1QP $ALXN #AlexionPharmaceuticals https://t.co/Yh6jnBsYW3$ALXN trying to run already?Weekly S&amp;P500 #Stocks Trend $DLTR $MU $HPQ $DG $WDC $MNK $VIAB $WFM $CNC $VRTX $ADS $TDC $TAP $REGN $ALXN  @ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $DLTR $MU $ULTA $WDC $VIAB $DISH $WFM $VRTX $REGN $ALXN $MXIM $CMCSA $ESRX $MDLZ @ https://t.co/YdSIjFJqHfTIAA CREF Investment Management LLC Has $304,919,000 Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/isQ2z4VJg0News on $ALXN #Alexion 's ALXN1210 an #OrphanDrug in Europe for ultra-rare blood disorder https://t.co/rHkeBOTX6XAlexion Pharmaceuticals, Inc. $ALXN Lifted to “Hold” at Zacks Investment Research https://t.co/16lz5NKYX7Alexion Pharmaceuticals, Inc. $ALXN Lifted to “Hold” at Zacks Investment Research https://t.co/1ZRa5tAiPiAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Reaffirmed by Oppenheimer https://t.co/v81R1ub1ICWeekly Investment Analysts’ Ratings Changes for Alexion Pharmaceuticals $ALXN https://t.co/Bvp5lpKeijWeekly Investment Analysts’ Ratings Changes for Alexion Pharmaceuticals $ALXN https://t.co/mUQsfsPeMvWeekly Investment Analysts’ Ratings Changes for Alexion Pharmaceuticals $ALXN https://t.co/eZjbErcCmwOver Bollinger https://t.co/7PI1UaZ8KU $ATRS $NKTR $ATNM $COMM $SEMG $MOH $RPTP $ALXN $SCI $EGHT $GDDY $EPZM $ACCO $CYNO $JAZZ $MIK $CUDA$ALXN  announces that the European Commission has granted orphan drug designation to ALXN1210",2016-06-02,ALXN,0
39,"RT @theflynews: On The Fly: After Hours Movers $UNFI $XTLY $FDX $AEZS $SRPT $Z $ZG $NWS $NWSA $CASY $SIGM $COVS $DRYS $ALXN $... https://t.…@TimCarmichael3 read my tweets before commenting. i shorted and covered at 138. locked my profit in $alxnRT @theflynews: On The Fly: After Hours Movers $UNFI $XTLY $FDX $AEZS $SRPT $Z $ZG $NWS $NWSA $CASY $SIGM $COVS $DRYS $ALXN $... https://t.…2 winners after hours long $srpt and short $alxnRT @theflynews: On The Fly: After Hours Movers $UNFI $XTLY $FDX $AEZS $SRPT $Z $ZG $NWS $NWSA $CASY $SIGM $COVS $DRYS $ALXN $... https://t.…$ALXN presents a great risk/reward TRADE right here @ $139 post the conf call. Peel back the data on MG &amp; you will see why. Also 1210 is dueRT @theflynews: On The Fly: After Hours Movers $UNFI $XTLY $FDX $AEZS $SRPT $Z $ZG $NWS $NWSA $CASY $SIGM $COVS $DRYS $ALXN $... https://t.…On The Fly: After Hours Movers $UNFI $XTLY $FDX $AEZS $SRPT $Z $ZG $NWS $NWSA $CASY $SIGM $COVS $DRYS $ALXN $... https://t.co/A0GKUIlKSpRT @ProfitTradeRoom: Market After Hours 📈📉
$GRMN +12.4%
$QUNR +12%
$UNFI +10.4%
$Z +4.5%
$DNAI +3.9%
$ALXN -10.3%
$IBN -16.6%
$ENVA -10%
$E…Explore #fundamental numbers and pros and cons for $ALXN https://t.co/TneFdj2OSu$ALXN #Alexion shares plummet in #Afterhours trading after drug study fails to reach main goal https://t.co/AW8VTJOaggWhy These Stocks Are Trading Down After Hours https://t.co/9qFZJt3EOl $ALXN $CASY $DISCA $DRYS $DSW $ENVA $MSTX $SIGM $TRUAfter Hours Biggest Losers: $ALXN $IBN $ENVA $ESIAfter-Hours Losers, as of 5.25p.m.: $ALXN -10.3% $IBN -16.6% $ENVA -10.0% $ESI -8.2% $SIGM -5.9%Market After Hours 📈📉
$GRMN +12.4%
$QUNR +12%
$UNFI +10.4%
$Z +4.5%
$DNAI +3.9%
$ALXN -10.3%
$IBN -16.6%
$ENVA -10%
$ESI -8.2%
$SIGM -5.9%$CSCO $ALXN are the Most Active in After Hours as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjr8WvP #stocks$ALXN $LSBG $SIGM are significant After Hours Decliners as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7fgood earn  after close $unfi  bas casy  fsx raises div to 40 a quarter  $wgbs deal with japan  $alxn bad reults hit hard drys ship also$ALXN Alexion Pharma Shares Halted News Pending #stockmarket #news #stockWhy ALXN Is DOWN In After Hours Trading Alexion Pharmaceuticals, Inc. https://t.co/VdeyjEcO63 $ALXNWondering about risks of $ALXN? The 21-day volatility is 9.62% https://t.co/feQ379ObFfBillion Dollar Unicorns: Moderna Therapeutics A Promising, Unproven Bet $AZN $MRK $ALXN https://t.co/M73yw1R0SV$ALXN Get alerts on momentum stocks before the run happens! Here’s How…Google “pennystock101” and thank me later.We calculated 63-day Expected Return of $ALXN for you: 8.54% https://t.co/kH5TlD4T2dRT @megtirrell: Citi lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trialRT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @megtirrell: Citi lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trial@sassyoptions $IBB down a tad Ahs the back of $ALXN.After Hours Gainers / Losers
 https://t.co/fYRGNYIdqN $GRMN, $QUNR, $UNFI, $Z, $DNAI, $ALXN, $IBN, $ENVA, $ESI, $SIGMNot sure what to do with $ALXN? Explore our #fundamental pros and cons.  https://t.co/1pL72NIQxO@tripil7z $ALXN lookout belowRT @megtirrell: Citi lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trialBenzinga: 4 Stocks Moving In Monday's After-Hours Session $ALXN $ENVA $ESI $UNFI https://t.co/ZFg5WApgq0megtirrell: Citi lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trial@paulwoll what's the next support I should watch for on $alxn. currently holding short positionBenzinga: 4 Stocks Moving In Monday's After-Hours Session $ALXN $ENVA $ESI $UNFI https://t.co/nIoVAFX6rpRT @megtirrell: Citi lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trial$alxn shorted right after it opened in 140's. Any ideas about next support areaRT @MarketCurrents: Alexion's Soliris flunks late-stage study in ultra-rare type of myasthenia gravis; shares off 9% after hours https://t.…RT @megtirrell: Citi lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trialRT @megtirrell: Citi lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trialCiti lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trial4 Stocks Moving In Monday's After-Hours Session $ALXN $ENVA $ESI $UNFI https://t.co/IfbjNLLAF5@GeeSmithMD $ALXN next gen 1210 for Soliris data will do same to $OMER 721 what it did to $ALNY CC5 --- always playing catch-up ball@Sport234a Time will tell on Kanuma but Strensiq may have 1B or better potential. $ALXN over the next 9-12 months will have lots of flowRT @OptionsHawk: $ALXN opens down $11, buyer of 375 July 8th (W) $152.5/$133 put spreads 25 minutes before the close$ALXN short 100 shares $140.60RT @OptionsHawk: $ALXN opens down $11, buyer of 375 July 8th (W) $152.5/$133 put spreads 25 minutes before the close$ALXN 135 comin right up lol$ALXN - Barclays saying down 15-20$ on this endpoint miss.The *largest decliners in after hours* for you to watch tomorrow: $ALXN $LSBG $PTEN $VBLT and $SLMBP.@GeeSmithMD When pro- $ALXN sell-side analysts best defense is only that ALXN has more safety data than $OMER -Know OMERs in a good position@Sport234a $ALXN has 2 new $1 bil+ products in Strensiq &amp; Kanuma that are rolling out with lots in the pipeline. Revs up 20% --- looks good$ALXN $LSBG $PTEN are significant After Hours Decliners as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7fAlexion Pharmaceuticals $ALXN Lags In Post-Market Trading $ALXN https://t.co/8m0FahIntwPopular: $ALXN, $THO, $CASY, $MDVN, $TRIP, $CF, $TSN, $SIGM, $IILG, $STML, $MCRB, $XLRN, $TLLPBAR - $ALXN miss raises questions on growth outlook, expect shares dn $15-20 (had assigned 500m peak)RT @ stockguy22 ""have a good night everyone ! 

only big mover I see #afterhours is
$ALXN down 8.91% to $141.18 
check in later if more""$ALXN:

New SEC Filing for ALXN: Form 8-K (No. 0000899866-16-000322):

https://t.co/ci9p7HmztS https://t.co/NH959P2RBx$ALXN missed a trial, weighing on $IBB a bit AH$ALXN &lt; 142 is bad on weekly  &lt; 139 is bad on Monthly.  Conference call in 11 minutes.RT @stockguy22: have a good night everyone ! 

only big mover I see #afterhours is
$ALXN down 8.91% to $141.18 
check in later if moremegtirrell: $ALXN opens down 7.4% https://t.co/L4c2qAbRa4have a good night everyone ! 

only big mover I see #afterhours is
$ALXN down 8.91% to $141.18 
check in later if moreRT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…Alexion Pharmaceuticals down 8% after Phase III study of its drug Soliris fails to meet primary endpoint
https://t.co/v6wokbmucB $ALXN$ALXN New SEC Document(s) for Alexion Pharmaceuticals, Inc.
From our Stock News Alerts AppAlexion's Soliris flunks late-stage study in ultra-rare type of myasthenia gravis; shares off 9% after hours https://t.co/zKmSt1WaKi $ALXNAlexion's Soliris flunks late-stage study in ultra-rare type of myasthenia gravis; shares off 9% after hours https://t.co/PwQsQCoon6 $ALXNAlexion's Soliris flunks late-stage study in ultra-rare type of myasthenia gravis; shares off 9% after hours https://t.co/aiINv5dkcw $ALXNAlexion's Soliris flunks late-stage study in ultra-rare type of myasthenia gravis; shares off 9% after hours https://t.co/IHdEpAPpcK $ALXN$ALXN reopens with a punch to the jaw, -8%$ALXN reopens with a punch to the jaw, -8%5-minutes late though. 3:30 @RampCapitalLLC is the proper time to front run drug study P/Rs. $ALXN https://t.co/mQDmoxjBth$ALXN WE TRACK ALXN OFFICERS WHEN THEY BUY AND SELL. LAST ONE 2016-05-16
Mackay EVP  Sale $139.19-$570,284$ALXN   #ALXN  #OURFREESTOCKPICKSRT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…$ALXN Phase three failure for Solaris not good$ALXN 142 200EMA weekly (if doesn't hold by end of week) - Could see 128 (Less than 128 would be more another red flag zone)RT @OptionsHawk: $ALXN opens down $11, buyer of 375 July 8th (W) $152.5/$133 put spreads 25 minutes before the closeMoving afterhours on news:
$UNFI +9.19% $DNAI +3.38% $XTLY +2.86%
$ALXN -9.03% $CASY -2.15%
#stocks$ALXN back open: sliced$alxn i need more$$$$$$$$$$$$$$$$ down to cova$ALXN Soliris fails in ph3 Regain study. Call at 5pm.$ALXN - Back open... https://t.co/PmkPxgC8gh$ALXN 144.32 is weekly 20 SMA. (Middle of BBs)$ALXN 144.32 is weekly 20 SMA.$ALXN opens down 7.4% https://t.co/o3rj4MmZLnThis is just the beginning of the $ALXN downtrend as $OMER '721 will begin to eat Soliris' lunch in 2017/2018.@OptionsHawk @HumbleBioTrader SEC should be making some phone calls. Buyer better have a good explanation. $ALXN$ALXN- Topline Results from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis (gMG)RT @OptionsHawk: $ALXN opens down $11, buyer of 375 July 8th (W) $152.5/$133 put spreads 25 minutes before the closeRT @OptionsHawk: $ALXN opens down $11, buyer of 375 July 8th (W) $152.5/$133 put spreads 25 minutes before the closeRT @OptionsHawk: $ALXN opens down $11, buyer of 375 July 8th (W) $152.5/$133 put spreads 25 minutes before the close$ALXN opens down $11, buyer of 375 July 8th (W) $152.5/$133 put spreads 25 minutes before the close$ALXN trading down in ah $IBB$ALXN tanks $12 or 7.66% at opening.$ALXN opens at $143, down $11Alexion Pharmaceuticals falls afterhours.
$ALXN -7.92% at 142.72 #biotech #stocks$IBB feeling a little pain after hours (possibly on $ALXN bad news).  ?RT @Street_Insider: Alexion Pharma $ALXN halted, news pendingCall at 15:00 EST  - $ALXN $IBB https://t.co/mWbDKyqEUMRT @Street_Insider: Alexion Pharma $ALXN Phase 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance https://t.co/3O29hOjDO1RT @zbiotech: $ALXN missed in MG studywheere shud i cova my $alxn ?$ALXN unhalts in 4-5 minutes I think.RT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…Would $ALXN run into drug pricing issues if they had breakthrough results in 1 indication+so-so results in another for same drug?$alxn -3% +RT @zbiotech: $ALXN missed in MG study$ALXN Can someone explain me the relation btw C5 and myasthenia gravis? I am surprised they tried it that way, like using it for Graves..RT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @CashRocket: Looks like $ALXN size buyers of Jun 160 calls last Friday about to be pulverized on this #fail 🚑

 https://t.co/3VyhX6nAhpRT @megtirrell: $ALXN to resume trading 4:30pmET per StreetAccount. Analyst telling me stock may open down $10-$15/shr https://t.co/R2K4BER…RT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @megtirrell: $ALXN to resume trading 4:30pmET per StreetAccount. Analyst telling me stock may open down $10-$15/shr https://t.co/R2K4BER…BINGO! Bulls Eye! $ALXN #Biotech https://t.co/p4mzGmbMHMLooks like $ALXN size buyers of Jun 160 calls last Friday about to be pulverized on this #fail 🚑

 https://t.co/3VyhX6nAhpCan $ALNY's RNAi approach succeed where $ALXN's MAb just failed?
https://t.co/M5AcSeBKMMMight be ugly when the halt is lifted. $ALXN worth noting that officers and directors have been selling around the $140 levels rencently.$ALXN LOL 
https://t.co/cZt1MaJMvvmegtirrell: $ALXN to resume trading 4:30pmET per StreetAccount. Analyst telling me stock may open down $10-$15/shr https://t.co/9blDfkyUgImegtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halte… https://t.co/UttInMwYe8RT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @megtirrell: $ALXN to resume trading 4:30pmET per StreetAccount. Analyst telling me stock may open down $10-$15/shr https://t.co/R2K4BER…RT @megtirrell: $ALXN to resume trading 4:30pmET per StreetAccount. Analyst telling me stock may open down $10-$15/shr https://t.co/R2K4BER…$ALXN to resume trading 4:30pmET per StreetAccount. Analyst telling me stock may open down $10-$15/shr https://t.co/R2K4BERI7MRT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…$ALXN - Thank gooness for market order shorting in after-hours!adamfeuerstein: RT megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis … https://t.co/0sUXzcAt55adamfeuerstein: RT zbiotech: $ALXN missed in MG studyRT @Street_Insider: Alexion Pharma $ALXN Phase 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance https://t.co/3O29hOjDO1$ALXN: Alexion Pharma Shares to Resume Trade at 4:30 p.m. EDTRT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @AndyBiotech: $ALXN Ph3 myasthenia gravis misses primary endpt

https://t.co/ZWZVOziniHRT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @AndyBiotech: $ALXN Ph3 myasthenia gravis misses primary endpt

https://t.co/ZWZVOziniH$ALXN halted news pending.RT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…$ALXN Will resume 16:30:00. News and Resumption Times. (Halted: 16:00:17)RT @The_Real_Fly: $ALXN halted, news pending$ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https://t.co/g5Po10cX00$ALXN looks like they missed phase 3 study on Eculizumab.$ALXN  the primary efficacy endpoint did not reach statistical significance (p=0.0698)16:01 $ALXN Alexion Announces Topline Results from Phase 3 REGAIN Study of Eculizumab (Soliris ®) in Patients with… https://t.co/9bT9QK3n6SAlexion Pharma $ALXN Phase 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance https://t.co/QrkOTVzqog via → @AlertTradeAlexion Pharma $ALXN halted, news pending via → @AlertTrade$ALXN Halt - News Released. Halt time: 16:00:17.RT @The_Real_Fly: $ALXN halted, news pending$ALXN Phase 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance https://t.co/qoDfGp5cTLRT @zbiotech: $ALXN missed in MG study$ALXN our predictive algorithms are starting to bear fruit.  Teams have been in place all afternoon. https://t.co/AlVPvfwa2q$ALXN halted, news pending$ALXN halted, news pendingRT @WrigleyTom: $ALXN

Primary Endpoint of REGAIN Study
Missed Statistical Significance

https://t.co/Frp0g4CdvIRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significance$ALXN

Primary Endpoint of REGAIN Study
Missed Statistical Significance

https://t.co/Frp0g4CdvIRT @bored2tears: Alexion announces disappointing results from Eculizumab study. https://t.co/CZjKhybzy9 $ALXN halted afterhours #biotech #s…RT @Street_Insider: Alexion Pharma $ALXN Phase 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance https://t.co/3O29hOjDO1RT @zbiotech: $ALXN missed in MG studyRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significanceAlexion Pharma $ALXN Phase 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance https://t.co/3O29hOjDO1$ALXN Ph3 myasthenia gravis misses primary endpt

https://t.co/ZWZVOziniH$ALXN halted. Pending news.RT @BiotechSage: Phase 3 REGAIN #FAIL https://t.co/YFqx5T7b89 $ALXNAlexion announces disappointing results from Eculizumab study. https://t.co/CZjKhybzy9 $ALXN halted afterhours #biotech #stocksRT @zbiotech: $ALXN missed in MG studyRT @BiotechSage: Phase 3 REGAIN #FAIL https://t.co/YFqx5T7b89 $ALXN$ALXN #fail fasten your seatbelts$ALXN Halted,n Says Primary Endpoint of REGAIN Study Missed Statistical Significancewe missed the primary endpoint, however.... $ALXN$ALXN Alexion Announces Topline Results from Phase 3 REGAIN Study of Eculizumab (Soliris(R)) in Patients with
From our Stock News Alerts App$ALXN halted. Ph3 data perhaps?RT @AndyBiotech: $ALXN halted, presumably Ph3 myasthenia gravis dataRT @zbiotech: $ALXN missed in MG study$ALXN wins award for shortest time from halt to announcing they missed, with 8 secondsRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significanceRT @WrigleyTom: $ALXN
Halted, news pending$ALXN Alexion Announces Topline Results from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients wi... - https://t.co/LQhtFCzB5IRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significancePhase 3 REGAIN #FAIL https://t.co/YFqx5T7b89 $ALXNRT @zbiotech: $ALXN halted, newsAlexion Pharma $ALXN halted, news pendingRT @zbiotech: $ALXN missed in MG study$alxn my short is nice$ALXN #FailRT @zbiotech: $ALXN missed in MG study$ALXN REGAIN phase 3 missedRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significanceRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significanceRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significanceRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significanceRT @zbiotech: $ALXN missed in MG studyRT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significanceRT @WrigleyTom: $ALXN
Halted, news pending$ALXN halt, news$ALXN missed in MG studyRT @WrigleyTom: $ALXN
Halted, news pending$ALXN REGAIN Phase 3 did not reach statistical significanceRT @AndyBiotech: $ALXN halted, presumably Ph3 myasthenia gravis dataRT @AndyBiotech: $ALXN halted, presumably Ph3 myasthenia gravis data$ALXN halted, presumably Ph3 myasthenia gravis dataRT @WrigleyTom: $ALXN
Halted, news pending$ALXN Halt - News Pending. Halt time: 16:00:17.RT @zbiotech: $ALXN halted, news$ALXN haltedRT @zbiotech: $ALXN halted, news$ALXN
Halted, news pendingRT @zbiotech: $ALXN halted, newsRT @zbiotech: $ALXN halted, newsRT @zbiotech: $ALXN halted, news$ALXN halted, newsIf you did buy these #biotech, not bad taking some profit off the table. $CELG $REGN $GILD $ALXN https://t.co/maN1PtuKjkAll of the following are excellent put ratio spread candidates, tweet us if u want specifics. $BIIB $ALXN $REGN $CMG $TSLA $AMZN $AGN $NTESA lot of technical similarities in $IBB $ALXN $CELG $BIIB $BMRN.  Smaller bios look like short covering which could foretell macro moveBillion Dollar Unicorns: #ModernaTherapeutics A Promising, Unproven Bet $AZN $MRK $ALXN https://t.co/JcUx5XaXPA$ALXN ""Recent Biotech Buyouts of Publicly Traded Companies"" on ADFN InvestorsHub message boards: https://t.co/VhZ9YkUBkahttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Lowered by Vetr Inc. https://t.co/Wpl94u0Lo3Oppenheimer Reaffirms “Outperform” Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/oncyQd3QLFTWTR Under Armour, Inc. Company Info
https://t.co/H3LbTUHv7U

$TWTR $V $IFGL $ALXN  #stock #stockNWBO Palo Alto Networks Inc. Open
https://t.co/QiIsPyl4NG

$NWBO $NUGT $ALXN $FXI  #stockmarket #pennystocksIPI Ivanhoe Mines Ltd. Quotes
https://t.co/qdqwwxZcuh

$IPI $ALXN $VTI $DVAX  #invest #nasdaqAlexion Pharmaceuticals, Inc. $ALXN Shares Sold by BlackRock Fund Advisors https://t.co/S0fDMq44nAAlexion Pharmaceuticals, Inc. $ALXN Shares Sold by BlackRock Fund Advisors https://t.co/urK0ISKuoQALXN Alexion Pharmaceuticals, Inc. Summary
https://t.co/uGkcoebytF

$ALXN $ECA $CRY $XLY  #stockmarket #tradeideasSentry Investment Management LLC Holds Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/WvuVb9sX45RT @AndysCycles: $IBB biotech index components. $ENDP $VRTX $MYL $BIIB $ALXN $AMGN $ILMN $REGN $CELG $BMRN $INCY $JAZZ $GILD $MDVN https://…$IBB biotech index components. $ENDP $VRTX $MYL $BIIB $ALXN $AMGN $ILMN $REGN $CELG $BMRN $INCY $JAZZ $GILD $MDVN https://t.co/EdsQv7Pvjx",2016-06-06,ALXN,0
40,"RT @davemabe: Here's my watchlist for the day: $ALXN, $BIIB, $CTLT, $ENDP, $MIK, $RL, $RLYP, $SRPT, $UNFI, $VRX, $Z powered by @TradeIdeas1…RT @LTbioinvestor: $XBI $IBB weak day in #biotechs but could have been even worse given 3 giants smackdown ... 
$ALXN $BIIB $VRXDaily Most Covered Stock: 8 reports on $ALXN https://t.co/Q2kHA1QF2SInvestors Buy Alexion Pharmaceuticals, Inc. $ALXN on Weakness After Analyst Downgrade https://t.co/vGGNFltwPaInvestors Buy Alexion Pharmaceuticals, Inc. $ALXN on Weakness After Analyst Downgrade https://t.co/3O1hPX83ryInvestors Buy Alexion Pharmaceuticals, Inc. $ALXN on Weakness After Analyst Downgrade https://t.co/XYkAQjSot6Investors Buy Alexion Pharmaceuticals, Inc. $ALXN on Weakness After Analyst Downgrade https://t.co/PHzeeT7RN8RT @tgtxdough: @megtirrell $ALXN after today $ALXN may be interested in boosting the pipeline. Nice cash flow also for deal https://t.co/OB…$ALXN: Analyst action by Morgan Stanley on Alexion Pharmaceuticals: https://t.co/kQc0BTe5an https://t.co/7B0tzDhsRV$ALXN - Investors Buy Alexion Pharmaceuticals, Inc. #ALXN on Weakness After Analyst Downgrade https://t.co/F2AUQfYoq2Today's losers: $BIIB $ALXN $MIK $IONS $LC $PBYIBelow Ichimoku https://t.co/LYE28NW1kE $BIIB $ALXN $DIS $GLD $IAU $URRE $WEN $KANG $OPK $MACK $EAT $PBI $ONTY $GSM $PENN $COWN $CHKPRT @Biotech_5: Today's #Biotech Losers
$VRX-14.5%
$BIIB-12.7%
$TRXC-12.5%
$ALXN-10.8%
$CYCC-10.5%
$NWBO-9.8%
$MRTX-9.3%
$OMED-8.1%
$RGLS-8%…Scan results - Fell Below 50 DMA today: $OLLI $MIK $KANG $BIIB $ALXN $WERN $DISCA $EAT $IVZ $IMAX ... https://t.co/uz6R7G85PQAlexion Closed Down 10%; Piper Says Buy On Weakness $ALXN https://t.co/tjOY1ERlBw via @benzinga$ALXN, $ALXN Alexion Closed Down 10%; Piper Says 'Buy On Weakness' - https://t.co/UgHeZRdA2y → via @AlertTrade https://t.co/bl0KAcvHcMRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…$ALXN - SELL Signal at 138.29 on Jun 07, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investing$ALXN, $ALXN Alexion Closed Down 10%; Piper Says 'Buy On Weakness' - https://t.co/FZVRDwRuBDRT @TheStreet: Biogen &amp; Alexion take hits after promising new products failed clinical trials: https://t.co/5xF9p7lt1E $BIIB $ALXN
https://…Biogen &amp; Alexion take hits after promising new products failed clinical trials: https://t.co/5xF9p7lt1E $BIIB $ALXN
https://t.co/0YRkpOWqfnWorst $SPY performers today: $BIIB $ALXN $TRIP $DISCA $FCX $CMG $DISCK $STZ  https://t.co/iC7lxcHHSa https://t.co/DLTlWZwCUnRT @insidermonkey: Stocks Not Having A Good Day: $CTLT, $ALXN, $DRYS, More
$ENDP, $MIK
https://t.co/siEAd9uKW1RT @LTbioinvestor: $XBI $IBB weak day in #biotechs but could have been even worse given 3 giants smackdown ... 
$ALXN $BIIB $VRXRT @Biotech_5: Today's #Biotech Losers
$VRX-14.5%
$BIIB-12.7%
$TRXC-12.5%
$ALXN-10.8%
$CYCC-10.5%
$NWBO-9.8%
$MRTX-9.3%
$OMED-8.1%
$RGLS-8%…RT @Biotech_5: Today's #Biotech Losers
$VRX-14.5%
$BIIB-12.7%
$TRXC-12.5%
$ALXN-10.8%
$CYCC-10.5%
$NWBO-9.8%
$MRTX-9.3%
$OMED-8.1%
$RGLS-8%…RT @Biotech_5: Today's #Biotech Losers
$VRX-14.5%
$BIIB-12.7%
$TRXC-12.5%
$ALXN-10.8%
$CYCC-10.5%
$NWBO-9.8%
$MRTX-9.3%
$OMED-8.1%
$RGLS-8%…RT @LTbioinvestor: $XBI $IBB weak day in #biotechs but could have been even worse given 3 giants smackdown ... 
$ALXN $BIIB $VRXRT @Biotech_5: Today's #Biotech Losers
$VRX-14.5%
$BIIB-12.7%
$TRXC-12.5%
$ALXN-10.8%
$CYCC-10.5%
$NWBO-9.8%
$MRTX-9.3%
$OMED-8.1%
$RGLS-8%…Losers https://t.co/ChzbY3xQiD $AAMC $ALXN $BIIB $CTLT $CYCC $FCEL $HOFT $IONS $LC $LEU $MIK $MRTX $OMED $OMER $OPTT $RGLS $URRE $VBLT $VRXRT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. Valeant slashes guidance again &amp; more news.. https://t.co/rbH0b53Am4 #pharma $VRX…RT @Biotech_5: Today's #Biotech Losers
$VRX-14.5%
$BIIB-12.7%
$TRXC-12.5%
$ALXN-10.8%
$CYCC-10.5%
$NWBO-9.8%
$MRTX-9.3%
$OMED-8.1%
$RGLS-8%…SELL $ALXN 137.64, BUY $BA 131.93, SELL $BIDU 170.86, SHORT $BIIB 252.86. More stock tips &amp; details at: https://t.co/H3lx4ECnG4Today's #Biotech Losers
$VRX-14.5%
$BIIB-12.7%
$TRXC-12.5%
$ALXN-10.8%
$CYCC-10.5%
$NWBO-9.8%
$MRTX-9.3%
$OMED-8.1%
$RGLS-8%
$IONS-8
$OMER-82⃣0⃣ Biggest Market Losers $DRYS $OPTT $VBLT $VRX $BIIB $URRE $TRXC $ESI $FCEL $ALXN $MRTX $CTLT $MIK $RGLS $BAS $LC https://t.co/sdLj8qPE6YRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…Top Decliners (&gt;$30)
$BIIB $ALXN $KMERF $BUNL $FMCB $LABU $PBYI $SENEB $BIB $DWTI $BMRN $CACC
https://t.co/0S0F4IUGSSTop Decliners (&gt;$5)
$ISHCP $ISHCO $VRX $VBLT $BIIB $FCEL $CYCC $ALXN $PNTR $MRTX $AAMC $CTLT
https://t.co/0S0F4ID5uiTuesday Sector Laggards: Healthcare, Utilities $BIIB $ALXN $XLV $PEG $ED #stocks https://t.co/PpNYwvEoIS$BIIB -12.75%
$ALXN -10.65%
$AUMN +28.53%

Additional information on #stocks at https://t.co/MbrZzsgTfi$ALXN knew to stay away from this today! -10.72% .For #great #trades,get the #free #android #app: https://t.co/mDjS7SZlMlRT @LTbioinvestor: $XBI $IBB weak day in #biotechs but could have been even worse given 3 giants smackdown ... 
$ALXN $BIIB $VRX$XBI $IBB weak day in #biotechs but could have been even worse given 3 giants smackdown ... 
$ALXN $BIIB $VRXHate failures like $ALXN / $BIIB but exactly that will generate more chances to sell/license platform/candidate for SMID cap bios $ARWRJune 7 Breakout Reversal Market Update and Big Stock Scan $SPX $BIIB $ALXN $IP https://t.co/rHY0KgCfRB $$Amazing Day in #AwesomeCalls Another 10 Trading Idea Laid out ALL Pre-Market Nailed $RL $ALXN $VLTC $HMNY $CALI $URRE $SRPT $AXON $MRO $ACIART @ConsumerFeed: Alexion Pharmaceuticals's buy rating reiterated at BMO Capital Markets. https://t.co/sxOIi726mb $ALXN #ALXNRT @TipRanksFeed: 3-star analyst Geoff Porges from Leerink Swann reiterated a BUY on $ALXN.  https://t.co/96W42bhw3F #NASDAQ #stocks #ALXNRT @firsttomarkets: Alexion Pharmaceuticals Reiterated Rating by Piper Jaffray (Ranked 59th) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2S@megtirrell $ALXN after today $ALXN may be interested in boosting the pipeline. Nice cash flow also for deal https://t.co/OBMrKRa2I8RT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…Video: Tuesday's ETF Movers: $XOP  $IBB $NFX $EOG $BIIB $ALXN #stocks https://t.co/QqylIunjQsAlexion Pharmaceuticals, Inc. $ALXN Price Target Lowered to $165.00 at Barclays https://t.co/V1kyMTa7lBAlexion Pharmaceuticals, Inc. $ALXN Price Target Lowered to $165.00 at Barclays https://t.co/3hSTwXFwV2Benzinga: Barclays Cuts Alexion Pharmaceuticals Target From $180 To $165 $ALXN  https://t.co/YlxdHC77tiAlexion Pharmaceuticals's PT cut by Barclays to $165.00. https://t.co/r3kX4F6q7T $ALXN #ALXNBenzinga: Barclays Cuts Alexion Pharmaceuticals Target From $180 To $165 $ALXN  https://t.co/2YvVjXPibLUnicorn Bay rating for $ALXN is 2.17 out of 5. https://t.co/y0AwClEnelBarclays Cuts Alexion Pharmaceuticals Target From $180 To $165 $ALXN  https://t.co/bNySIKdVkEStocks Not Having A Good Day: $CTLT, $ALXN, $DRYS, More
$ENDP, $MIK
https://t.co/siEAd9uKW1Stocks Not Having A Good Day: $CTLT, $ALXN, $DRYS, More
$ENDP, $MIK
https://t.co/sASn7KsxvLAlexion Pharmaceuticals Lower Price Target by Barclays Capital (Ranked 25th) to  with 165 PT $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals’ $ALXN Buy Rating Reaffirmed at Piper Jaffray https://t.co/K21f2Sevx7Alexion Pharmaceuticals’ $ALXN Buy Rating Reaffirmed at Piper Jaffray https://t.co/cCZHVEwNVoAlexion Pharmaceuticals, Inc. $ALXN Given “Buy” Rating at Bank of America https://t.co/JMAsKUP0u3Btw, Estimated #Earnings Per Share for $ALXN is $1.32 it's 0.85% of the current price https://t.co/EUmfP56dp8Alexion Pharmaceuticals, Inc. $ALXN Receives “Hold” Rating from Credit Suisse https://t.co/23d8ryOCDFTop Decliners (&gt;$30)
$BIIB $ALXN $KMERF $BUNL $CLAW $CASY $GYRO $DUG $ELFIF $BIB $BMRN $LBND
https://t.co/0S0F4IUGSSTop Decliners (&gt;$5)
$ISHCP $ISHCO $VRX $VBLT $BIIB $CYCC $ALXN $FMCCH $OMED $BPESY $PNTR $AAMC
https://t.co/0S0F4IUGSSAlexion Pharmaceuticals: Time to Buy? Yes, Oppenheimer Says https://t.co/0Ay5oSFpsl via @barronsonline $ALXNRT @theflynews: Failure in Biogen clinical trial drives Piper to call for strategic change $BIIB $RHHBY $ALXN: Full Story https://t.co/wUNJ…RT @theflynews: Failure in Biogen clinical trial drives Piper to call for strategic change $BIIB $RHHBY $ALXN: Full Story https://t.co/wUNJ…S&amp;P 500 nears record high; Tesla drives ahead: https://t.co/IiV8TaxAdf $TSLA $Z $UNFI $HA $ALXN $THOFailure in Biogen clinical trial drives Piper to call for strategic change $BIIB $RHHBY $ALXN: Full Story https://t.co/wUNJiI69USMid-Day Losers: $DRYS -42% $VRX -14% $OPTT -14% $VBLT -12% $CYCC -12% $BIIB -12% $ALXN -11% $OCC -11% $GIGA -11% $ESI -11%@autumnalcity87 ehr... $IBB is down because of $BIIB and $ALXN, zero to do with $VRX...$ALXN - Citigroup Inc. Reaffirms ""Hold"" Rating for Alexion Pharmaceuticals, Inc. #ALXN https://t.co/JEvqJY4xiN$ALXN - Citigroup Inc. Reaffirms ""Hold"" Rating for Alexion Pharmaceuticals, Inc. #ALXN https://t.co/wgGFnXnzIMCut 1/4 of $ALXN calls for profit ITM.Why ALXN Is DOWN Tuesday https://t.co/aE19Rf5LW2 $ALXNRecent analyst upgrades worth watching this week - $ALXN $COR $SRPT $HZNP $RGLS $V $MNK read here - https://t.co/9tEe1dyHocAlexion Pharmaceuticals, Inc. $ALXN Stock Rating Reaffirmed by Oppenheimer https://t.co/Id9y7DIHprAlexion Pharmaceuticals, Inc. $ALXN Receives “Hold” Rating from Credit Suisse https://t.co/QcYdC0QXBC@autumnalcity87 @JFinDallas $IBB down on $BIIB and $ALXN, not even sure if the ETF holds $VRX at all. /pedanticAlexion Pharmaceuticals Reiterated Rating by Piper Jaffray (Ranked 59th) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals Reiterated Rating by Credit Suisse (Ranked 27th) to Hold $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals Reiterated Rating by Bank of America (Ranked 45th) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals Reiterated Rating by Citigroup (Ranked 28th) to Hold $ALXN #ALXN https://t.co/Q2kHA1QF2SAlexion Pharmaceuticals Reiterated Rating by Leerink Swann (Ranked 70th) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2SRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…@StockTwits Trending via @Stocks_Live $HMNY $PACD $TSLA $WYNN $RGLS $KNDI $BIIB $RL $RH $JNJ $RGSE $ALXN https://t.co/bArKcXb9SOGood entry points for $ALXN and $BIIB ?  This article thinks so

Alexion Pharmaceuticals: Time to Buy? https://t.co/0J52C1Q3zz$ALXN shares tumble after drug misses trial goal https://t.co/bol493t0THStocks Not Having A Good Day: Catalent, #Alexion Pharmaceuticals, DryShips, More. Read more: https://t.co/C1oODQQSMX $ALXNStocks Not Having A Good Day: Catalent, #Alexion Pharmaceuticals, DryShips, More. Read more: https://t.co/MO4LKt3wDK $ALXNRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…3-star analyst Geoff Porges from Leerink Swann reiterated a BUY on $ALXN.  https://t.co/96W42bhw3F #NASDAQ #stocks #ALXNU.S. Losers: $VRX -12.62%, $BIIB -12.39%, $ALXN -10.94%, $MIK -9.07%, $VGK -8.9% https://t.co/jdoP0QgKi5 #StockWarsNoteworthy Tuesday Option Activity: $CALD  $ALXN  $CVX #stockoptions https://t.co/nOACy6RufB$ALXN am a buyer vat 120 I think it gets there over the next few months.$ALXN $VRX $BIIB . That is individual stories inside $IBB . Nothing wrong with sector. Already many green stocks like $ACAD or $ALDR$VRX https://t.co/KYNGRKZWtC its going to Zero. Keep an eye $IBB, $ALXN, $BIIB, $REGN major components tripping the $IBB today.RT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…Top Decliners (&gt;$30)
$BIIB $ALXN $BUNL $SYNA $SENEB $EP.PR.C $GBTC $RL $BIB $PBYI $RARE $MAYS
https://t.co/0S0F4IUGSSTop Decliners (&gt;$5)
$VBLT $VRX $ISHCO $BIIB $ALXN $ISHCP $BUNL $MIK $HOFT $OMED $PNTR $CTLT
https://t.co/0S0F4IUGSSAlexion Pharmaceuticals’ $ALXN “Buy” Rating Reiterated at BMO Capital Markets https://t.co/mxnrI7Y13BAlexion Pharmaceuticals’ $ALXN “Buy” Rating Reiterated at BMO Capital Markets https://t.co/iMquM9wHEVVolume Alert - ALXN 138.10 Alexion Pharm Inc $ALXN Hit a high today of 140.75 Closing the day 10:30 at 138.10  https://t.co/psmZhnw4uRAlexion Pharmaceuticals Reiterated Rating by BMO Capital Markets (Ranked 13th) to Buy $ALXN #ALXN https://t.co/Q2kHA1QF2SLooks like $ALXN wants to play some more! ;) #bearswin #DayTradingAlexion Pharmaceuticals's buy rating reiterated at BMO Capital Markets. https://t.co/sxOIi726mb $ALXN #ALXNHealthcare - Top 5 Gainers / Losers as of 11:00 am .
https://t.co/YQkMzTO1W2 $LDRH, $SRPT, $CERC, $GBSN, $BDSI, $VRX, $BIIB, $VBLT, $ALXNHealthcare - Top 5 Gainers / Losers as of 11:00 am $LDRH $SRPT $CERC $GBSN $BDSI $VRX $BIIB $VBLT $ALXN $GEN https://t.co/3KG1YX8F4s$DRYS $VRX $BIIB $ALXN ass rape in progress!!!!!!!!!!!!!!!!!!!!  and $CALI getting fisted non-stop since 9:35am.Alexion Pharmaceuticals, Inc., $ALXN, is down 10.9% - https://t.co/sJv4mQlP9YBig Loser Alert: Trading today’s -9.9% move in ALEXION PHARMACEUTICALS $ALXN https://t.co/vvicBvzvu2 https://t.co/sExd9VPYw0$gs $biib $alxn https://t.co/753gsqfL4rRT @theflynews: Goldman cuts Biogen price target cut to $267 following failed multiple sclerosis trial: https://t.co/WckBpQfxO1 $BOIB $ALXNRT @theflynews: Goldman cuts Biogen price target cut to $267 following failed multiple sclerosis trial: https://t.co/WckBpQfxO1 $BOIB $ALXNRT @theflynews: Goldman cuts Biogen price target cut to $267 following failed multiple sclerosis trial: https://t.co/WckBpQfxO1 $BOIB $ALXNGoldman cuts Biogen price target cut to $267 following failed multiple sclerosis trial: https://t.co/WckBpQfxO1 $BOIB $ALXN$IBB relatively okay on a bad news from $BIIB $ALXN day.StockTwits Trending Alert: Trading recent interest in ALEXION PHARMACEUTICALS $ALXN https://t.co/JcOd39OiXA https://t.co/6UlbkURb2sRT @davemabe: Here's my watchlist for the day: $ALXN, $BIIB, $CTLT, $ENDP, $MIK, $RL, $RLYP, $SRPT, $UNFI, $VRX, $Z powered by @TradeIdeas1…Alexion's (NASDAQ:ALXN) Soliris for rare neuromuscular disease fails in Phase 3 trial https://t.co/0SaAUlG6sX $ALXN #pharmaceutical #stocks$ALXN should put some of that cash to work and/or take on some debt because market doesn't seem to like REGAIN missJune 7 Biotech Update $ALXN $BIIB $CELG $SRPT $vrx https://t.co/ixWmUgTAUfRT @slammingpicks: StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to B… http…RT @G6Trading: Some of the stocks that we will be watching this morning : $BIIB $NAV $UNFI $SYRG $WLL $COP $TRIP $LCI $ALXN $MIK $RL  #g6tr…RT @OptionAlert: Unusually heavy option volume on today's open include $ALXN, $UNP, $MRK, $BIIB, and $STZ.RT @ stockguy22 ""% Movers 
UP $LDRH $SRPT $UNFI $WLRHW $CTIC $NAV $CJES $EMES $PWE

DOWN $DRYS $BIIB $ALXN $VBLT $… https://t.co/PB01v5sXUw""$ALXN calls https://t.co/9AXg8ogls3RT @stockguy22: % Movers 
UP $LDRH $SRPT $UNFI $WLRHW $CTIC $NAV $CJES $EMES $PWE

DOWN $DRYS $BIIB $ALXN $VBLT $BATRR $VRX $ESI etc https:…% Movers 
UP $LDRH $SRPT $UNFI $WLRHW $CTIC $NAV $CJES $EMES $PWE

DOWN $DRYS $BIIB $ALXN $VBLT $BATRR $VRX $ESI etc https://t.co/53FX8d32Q1Unusually heavy option volume on today's open include $ALXN, $UNP, $MRK, $BIIB, and $STZ.@JFinDallas can't forget top US pick at BoAML $ALXN down a sweet $18!Nasdaq Biotech Index looks pretty beaten up today, with $BIIB, $ALXN, $ENDP leading the decliners$ALXN 1000 NOV $120 P seller $6.90, interestingRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…Trade-Ideas: Alexion Pharmaceuticals $ALXN Is Today's Unusual Social Activity Stock $ALXN https://t.co/Onz8dlDExvRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…RT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…Just when hc traders started to feel ""better"" $alxn $biib $vrxNot sure what to do with $ALXN? Explore our #fundamental pros and cons.  https://t.co/Ckq9cMgfEULeerink analyst Geoffrey Porges decreased his price target of Alexion Parma $ALXN to $200 from $210.Goldman analyst Terence Flynn decreased his price target of Alexion Parma $ALXN to $160 from $167.Baird analyst Michael Ulz decreased his price target of Alexion Parma $ALXN to $145 from $165.Barclays analyst Geoff Meacham decreased his price target of Alexion Parma $ALXN to $165 from $180.$IBB down 2.2% 

After $BIIB &amp; $ALXN down ~10%;

$BIIB ~ 8% holding, $ALXN 4%Credit Suisse analyst Alethia Young decreased her target of Alexion Parma $ALXN to $186 from $195.BMO analyst Ian Somaiya decreased his price target of Alexion Parma $ALXN to $160 from $168.RT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…Here's my watchlist for the day: $ALXN, $BIIB, $CTLT, $ENDP, $MIK, $RL, $RLYP, $SRPT, $UNFI, $VRX, $Z powered by @TradeIdeas1 @TradeIdeasStockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to B… https://t.co/e9UxrpsOGi$BIIB, $ALXN, $SRPT all &gt; 30 day volatility, and $VRX is plunging on a massive guidance cut. Biopharma!Some of the stocks that we will be watching this morning : $BIIB $NAV $UNFI $SYRG $WLL $COP $TRIP $LCI $ALXN $MIK $RL  #g6trading #gaptraderRT @WrigleyTom: Some %
+
$EAC 207
$CALI 174
$LDRH 63
$SRPT 33
$GEVO 24
$VNCE 15
$Z $MGT 10

-
$DRYS 35
$VRX 19
$HMNY $VBLT $ESI 14
$RL 12
$…RT @WrigleyTom: Some %
+
$EAC 207
$CALI 174
$LDRH 63
$SRPT 33
$GEVO 24
$VNCE 15
$Z $MGT 10

-
$DRYS 35
$VRX 19
$HMNY $VBLT $ESI 14
$RL 12
$…Some %
+
$EAC 207
$CALI 174
$LDRH 63
$SRPT 33
$GEVO 24
$VNCE 15
$Z $MGT 10

-
$DRYS 35
$VRX 19
$HMNY $VBLT $ESI 14
$RL 12
$BIIB $ALXN $MIK 9Pre Market top Losers: $DRYS $ESI $VRX $VBLT $HMNY $RL $PPP $ALXN $BIIB $MIK https://t.co/KcFFcat9X0gap and go stocks: $UNFI $Z $AXLL $GRMN $COT $VRX $RL $ALXN $BIIB $MIK trade in direction of stock #intraday #daytrading #stocks #followmeThe *largest decliners in the premarket* for you to watch at the open: $VBLT $BIIB $ALXN $MIK and $ENDP.$BIIB $ALXN $VRX all smacked this AM we'll see if that kills some of the mania we've seen past week or so.RT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…RT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…12 Stocks Moving In Tuesday's Pre-Market Session $ALXN $BIIB $CTIC #premarket https://t.co/OdcouBh07Q via @benzingaStockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to B… https://t.co/NhIM9iFuArRT @CBOE: DOWNSIDE pre-mkt: $VRX, $VBLT, $RL, $BIIB, $ALXN, $MIK, $CTLT, $CYCC, $ENDP, $JBL powered by https://t.co/scoWUQ48H7 https://t.co…RT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…RT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…$ALXN not bad either as ss, void until 137sh. $GEVO penny trying to breakout in pm #stocks #investing #tradeideasRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…RT @RobInTheBlack: #Mindthegap $UNFI $Z $TRIP $EAC $LDRH $AXLL $CTLT $ENDP $RL $MIK $TRU $NUGT $ALXN $BIIB $VRXRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/ujXGZ9KzcSRT @RobInTheBlack: #Mindthegap $UNFI $Z $TRIP $EAC $LDRH $AXLL $CTLT $ENDP $RL $MIK $TRU $NUGT $ALXN $BIIB $VRX$ALXN down sharply in pre-market trading on data https://t.co/Fr1Tm45LpTRT @TradeWithSuper: Benzinga: 12 Stocks Moving In Tuesday's #PreMarket Session $ALXN $BIIB $LDRH $SRPT $UNFI $RGLS $ESI $DRYS $VRX $VB… htt…RT @LKrauskopf: Looking like ugly day for healthcare stocks: $VRX down 17% premarket after weak outlook, $BIIB $ALXN each off +8% after dis…$ALXN Get alerts on momentum stocks before the run happens! Here’s How…Google “pennystock101” and thank me later.RT @Top5Traders: Benzinga: 12 Stocks Moving In Tuesday's #PreMarket Session $ALXN $BIIB $LDRH $SRPT $UNFI $RGLS $ESI $DRYS $VRX $VB… https:…RT @TradeWithSuper: Benzinga: 12 Stocks Moving In Tuesday's #PreMarket Session $ALXN $BIIB $LDRH $SRPT $UNFI $RGLS $ESI $DRYS $VRX $VB… htt…RT @HughJRobbins: $LDRH buyout. $EAC may be the crazy one today. $ALXN pot reversal, clobbered #stocks #investing #tradeideas#Mindthegap $UNFI $Z $TRIP $EAC $LDRH $AXLL $CTLT $ENDP $RL $MIK $TRU $NUGT $ALXN $BIIB $VRXAlexion Announces Phase 3 Trial Failure; Shares Down 9% In After-Hours Trade $ALXN https://t.co/XCWqRmNwKwRT @CBOE: DOWNSIDE pre-mkt: $VRX, $VBLT, $RL, $BIIB, $ALXN, $MIK, $CTLT, $CYCC, $ENDP, $JBL powered by https://t.co/scoWUQ48H7 https://t.co…Looking like ugly day for healthcare stocks: $VRX down 17% premarket after weak outlook, $BIIB $ALXN each off +8% after disappointing dataWhy These Stocks Are Gapping Down https://t.co/jONAXTOH9h  $ALXN $BIIB $CASY $DISCA $DRYS $DSW $ENVA $ESI $MSTX $MIK $SIGM $TRU $VRX$ALXN: Analyst action by Morgan Stanley on Alexion Pharmaceuticals: https://t.co/kQc0BTe5an https://t.co/Rlo72lOjh6#Premarket ― DOWNSIDE pre-mkt: $VRX, $VBLT, $RL, $BIIB, $ALXN, $MIK, $CTLT, $CYCC, $ENDP, $JBL powered by… https://t.co/uCYE6WXxi2Premarket Biotech Digest: $SRPT Soars, $VBLT Rallies on Data, $ALXN Tumbles https://t.co/h1aUuXlwQlRT @Benzinga: 12 Stocks Moving In Tuesday's #PreMarket Session $ALXN $BIIB $LDRH $SRPT $UNFI $RGLS $ESI $DRYS $VRX $VBLT $HMNY https://t.co…$ALXN removed from US 1 List at BofA/MerrillDOWNSIDE pre-mkt: $VRX, $VBLT, $RL, $BIIB, $ALXN, $MIK, $CTLT, $CYCC, $ENDP, $JBL powered by https://t.co/scoWUQ48H7 https://t.co/qt6yb4fDhKStocks in play martes 07 de junio 2016:
$AAPL $FB $NUGT $BABA $VRX $VBLT $RIO $UNFI $LDRH $Z $ALXN $BIIB $OLLI... https://t.co/plllYA9ihzStocks in play martes 07 de junio 2016:
$AAPL $FB $NUGT $BABA $VRX $VBLT $RIO $UNFI $LDRH $Z $ALXN $BIIB $OLLI $FCX $CTLT $EAC $RL$LDRH buyout. $EAC may be the crazy one today. $ALXN pot reversal, clobbered #stocks #investing #tradeideasRT @23aloha: If biotech can have a not horrible day after $BIIB, $ALXN, &amp; $VRX news - plus another Berens run at $RLYP - that would really…RT @OptionsHawk: $IBB set for a tough day w/ $ALXN and $BIIB each down around 10%Premarket most declined stocks: $VBLT, $BIIB, $ALXN, $MIK, $ENDP, $HZNP, $RLYP, $BIB, $USLV, $TVIXRT @TomSilver39: Suntrust Top Three Picks in Biotech: $ADAP(P I/II NY-ESO TCR data~ ESMO), $ALXN(ALXN-1210 in PNH), $ITCI (Mid-2016: ITI-00…RT @23aloha: If biotech can have a not horrible day after $BIIB, $ALXN, &amp; $VRX news - plus another Berens run at $RLYP - that would really…Do you know that #WallStreet price for $ALXN is $194.61 https://t.co/dQxv29AsudBenzinga: 12 Stocks Moving In Tuesday's #PreMarket Session $ALXN $BIIB $LDRH $SRPT $UNFI $RGLS $ESI $DRYS $VRX $VB… https://t.co/q0sfybd2iPRT @LTbioinvestor: yday 4 big crash: $MRTX $OCUL $DNAI $ADMP today 3 big plays getting sold PM - $BIIB $ALXN $VRX ...
IF #biotechs can go a…RT @TomSilver39: Suntrust Top Three Picks in Biotech: $ADAP(P I/II NY-ESO TCR data~ ESMO), $ALXN(ALXN-1210 in PNH), $ITCI (Mid-2016: ITI-00…Pharmalot.. Pharmalittle.. Good Morning.. Valeant slashes guidance again &amp; more news.. https://t.co/rbH0b53Am4 #pharma $VRX $PFE $ALXN$ALXN in pre-market: bouncing @ credible technical support https://t.co/kOhLv4r3SNRT @LTbioinvestor: yday 4 big crash: $MRTX $OCUL $DNAI $ADMP today 3 big plays getting sold PM - $BIIB $ALXN $VRX ...
IF #biotechs can go a…Benzinga: 12 Stocks Moving In Tuesday's #PreMarket Session $ALXN $BIIB $LDRH $SRPT $UNFI $RGLS $ESI $DRYS $VRX $VB… https://t.co/pUNGLmLEFPWatch Idea - Gappers: $SRPT $UNFI $VRX $TRIP $BIIB $RL $MIK $ALXN $MNK  #stocks #trading #options  -rNotable Morning Gappers 

Up: $EAC $LDRH $SRPT $GIGA $UNFI $ZG $Z $AXLL 

Down: $VRX $VBLT $DRYS $HMNY $ALXN $BIIB $MIK $ENDP $ESI $RL $TRU$VBLT $BIIB $ALXN are significant Pre-Market Decliners this AM on SpeculatingStocks Pre-Market, https://t.co/ayAi1CAXh9RT @Benzinga: 12 Stocks Moving In Tuesday's #PreMarket Session $ALXN $BIIB $LDRH $SRPT $UNFI $RGLS $ESI $DRYS $VRX $VBLT $HMNY https://t.co…$BIIB $ALXN $VRX clowns to the left of me, jokers to the right@zbiotech Cowen ---which has the been the long-term bull for years on $ALXN --- had no rev in its model. Where did you get 500 mil ?RT @LTbioinvestor: yday 4 big crash: $MRTX $OCUL $DNAI $ADMP today 3 big plays getting sold PM - $BIIB $ALXN $VRX ...
IF #biotechs can go a…#biotech $ALXN $BIIB $VRX Can the sector hold up in deluge of big negative events?RT @LTbioinvestor: yday 4 big crash: $MRTX $OCUL $DNAI $ADMP today 3 big plays getting sold PM - $BIIB $ALXN $VRX ...
IF #biotechs can go a…RT @matthewherper: Leerink's Porges says $ALXN's Soliris still has 60% odds of approval in myasthenia gravis despite yesterday's trial fail…Why ALXN Is DOWN In Premarket Trading Alexion Pharmaceuticals, Inc. https://t.co/aE19Rf5LW2 $ALXN$ALXN hearing DowngradedRT @23aloha: If biotech can have a not horrible day after $BIIB, $ALXN, &amp; $VRX news - plus another Berens run at $RLYP - that would really…RT @LTbioinvestor: yday 4 big crash: $MRTX $OCUL $DNAI $ADMP today 3 big plays getting sold PM - $BIIB $ALXN $VRX ...
IF #biotechs can go a…RT @LTbioinvestor: yday 4 big crash: $MRTX $OCUL $DNAI $ADMP today 3 big plays getting sold PM - $BIIB $ALXN $VRX ...
IF #biotechs can go a…$ALXN maintains Overweight rating at Morgan Stanley- PT cut $189 from $203RT @LTbioinvestor: yday 4 big crash: $MRTX $OCUL $DNAI $ADMP today 3 big plays getting sold PM - $BIIB $ALXN $VRX ...
IF #biotechs can go a…Vetr Inc. Lowers Alexion Pharmaceuticals, Inc. $ALXN to Buy https://t.co/3fE39fi2txyday 4 big crash: $MRTX $OCUL $DNAI $ADMP today 3 big plays getting sold PM - $BIIB $ALXN $VRX ...
IF #biotechs can go ahead of this : good$VBLT $ALXN $BIIB are significant Pre-Market Decliners this AM on SpeculatingStocks Pre-Market, S... https://t.co/4r8tddMTZI #specstocks12 Stocks Moving In Tuesday's #PreMarket Session $ALXN $BIIB $LDRH $SRPT $UNFI $RGLS $ESI $DRYS $VRX $VBLT $HMNY https://t.co/D38E1srmCEIf biotech can have a not horrible day after $BIIB, $ALXN, &amp; $VRX news - plus another Berens run at $RLYP - that would really be something.OpenOutcrier: $ALXN (-9.2% pre) Alexion Pharma P 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significan… https://t.co/cdS6SM9f7vRT @OptionsHawk: $IBB set for a tough day w/ $ALXN and $BIIB each down around 10%Lots of different sectors with bad news -   $drys, $rl, $biib, $vrx, $alxn, $esi, $enva$alxn recency bias helped me avoid the retreat to 140 .. Same with $biib .. I imposed stronger rules saving me $Notable PreM Movers 06/07: (Up) $LDRH $SRPT $UNFI $Z $AXLL $WMB $BITA (Down) $VRX $BIIB $ALXN $CTLT $SCCO $HZNP $MNK$ALXN Extreme Negative investor sentiment Jun 7, 8:19 AM ET, see chart at https://t.co/HPQzSpigDU #sentiment #trading #stocksRT @matthewherper: Leerink's Porges says $ALXN's Soliris still has 60% odds of approval in myasthenia gravis despite yesterday's trial fail…CITI $ALXN goes down by $500m at peak. It changes our DCF derived TP from $165 to $154/sh.Leerink's Porges says $ALXN's Soliris still has 60% odds of approval in myasthenia gravis despite yesterday's trial failure.RT @Drchik23: $ibb #2 holding is $biib &amp; #7 is $alxn
Both down ~10% pre market https://t.co/O5ZcB23VuoNot much good news today $biib $vrx $rl $alxn.  Go market!!RT @OptionsHawk: $IBB set for a tough day w/ $ALXN and $BIIB each down around 10%RT @TripleDTrader: Talking the Biotech Wreck LIVE right now - https://t.co/nUSojmvD8i $BIIB $ALXN $VRX#Alexion drug study fails to reach main goal; shares halted. Read more: https://t.co/KuLqMFy29R $ALXN#Alexion drug study fails to reach main goal; shares halted. Read more: https://t.co/hunquQbFbR $ALXNRT @Drchik23: $ibb #2 holding is $biib &amp; #7 is $alxn
Both down ~10% pre market https://t.co/O5ZcB23VuoRT @Drchik23: $ibb #2 holding is $biib &amp; #7 is $alxn
Both down ~10% pre market https://t.co/O5ZcB23VuoRT @OpenOutcrier: $ALXN (-9.2% pre) Alexion Pharma P 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance - SI 

https://t.c…Alexion's (NASDAQ:ALXN) Soliris for rare neuromuscular disease fails in Phase 3 trial https://t.co/0SaAUlG6sX $ALXN #pharmaceutical #stocksTalking the Biotech Wreck LIVE right now - https://t.co/nUSojmvD8i $BIIB $ALXN $VRXRT @OpenOutcrier: $ALXN (-9.2% pre) Alexion Pharma P 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance - SI 

https://t.c…$ALXN (-9.2% pre) Alexion Pharma P 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance - SI 

https://t.co/gWWmSy9CD6$ibb #2 holding is $biib &amp; #7 is $alxn
Both down ~10% pre market https://t.co/O5ZcB23VuoAlexion's (NASDAQ:ALXN) Soliris for rare neuromuscular disease fails in Phase 3 trial https://t.co/3iIFuReZAP $ALXN #pharmaceutical #stocksRT @OptionsHawk: $IBB set for a tough day w/ $ALXN and $BIIB each down around 10%RT @OptionsHawk: $IBB set for a tough day w/ $ALXN and $BIIB each down around 10%Alexion's (NASDAQ:ALXN) Soliris for rare neuromuscular disease fails in Phase 3 trial https://t.co/zW8EbVg0op $ALXN #pharmaceutical #stocks$IBB been nice knowing you $ALXN $BIIB $VRXRT @OptionsHawk: $IBB set for a tough day w/ $ALXN and $BIIB each down around 10%Big Biotech components of $IBB:  $ALXN -10.5% $BIIB -8.5%RT @OptionsHawk: $IBB set for a tough day w/ $ALXN and $BIIB each down around 10%RT @OptionsHawk: $IBB set for a tough day w/ $ALXN and $BIIB each down around 10%$IBB set for a tough day w/ $ALXN and $BIIB each down around 10%Alexion's (NASDAQ:ALXN) Soliris for rare neuromuscular disease fails in Phase 3 trial https://t.co/ra5UIsvMrL $ALXN #pharmaceutical #stocksAlexion's (NASDAQ:ALXN) Soliris for rare neuromuscular disease fails in Phase 3 trial https://t.co/0SaAUlG6sX $ALXN #pharmaceutical #stocksAlexion Pharmaceuticals Lower Price Target by Morgan Stanley (Ranked 33rd) to Overweight with 189 PT $ALXN #ALXN https://t.co/Q2kHA1QF2SBlackRock Institutional Trust Company N.A. Has $779,892,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/4ZN1sWN34bTopline Results from Phase 3 REGAIN Study of Eculizumab (Soliris) in Patients with Refractory gMG $ALXN https://t.co/fQEvTJvscDAlexion Pharma $ALXN: MG P3 Miss Increases Importance of ALXN-1210; PT to $160 - BMO https://t.co/Rsw4xmMYefRT @fwpharma: Alexion's Soliris fails to hit main goal of late-stage study for myasthenia gravis https://t.co/4ojQfXfYGJ $ALXN #pharmaRT @fwpharma: Alexion's Soliris fails to hit main goal of late-stage study for myasthenia gravis https://t.co/4ojQfXfYGJ $ALXN #pharmaAlexion's Soliris fails to hit main goal of late-stage study for myasthenia gravis https://t.co/4ojQfXfYGJ $ALXN #pharmaJPMorgan Chase &amp; Co. Acquires 266,270 Shares of Alexion Pharmaceuticals, Inc. $ALXN https://t.co/q3n3WbamEqAlexion Announces Phase 3 Trial Failure; Shares Down 9% In After-Hours Trade $ALXN https://t.co/KP4JB1U8zQConnor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/DgrNThhkJM  $DIS $ALXN $NOAH $GILD $QUNRRT @megtirrell: $ALXN says Soliris misses primary goal in refractory generalized myasthenia gravis study; shares halted, call 5pmET https:/…RT @OptionsHawk: $ALXN REGAIN Phase 3 did not reach statistical significanceRT @OptionsHawk: $ALXN opens down $11, buyer of 375 July 8th (W) $152.5/$133 put spreads 25 minutes before the closeRT @TomSilver39: Suntrust Top Three Picks in Biotech: $ADAP(P I/II NY-ESO TCR data~ ESMO), $ALXN(ALXN-1210 in PNH), $ITCI (Mid-2016: ITI-00…Billion Dollar Unicorns: Moderna Therapeutics A Promising, Unproven Bet $AZN $MRK $ALXN https://t.co/JcUx5XaXPART @megtirrell: Citi lowers $ALXN target price from $165 to $154 after Soliris misses endpoint in ph3 myasthenia gravis trial4 Stocks Moving In Monday's After-Hours Session $ALXN $ENVA $ESI  https://t.co/i4xuHPsxCvSuntrust Top Three Picks in Biotech: $ADAP(P I/II NY-ESO TCR data~ ESMO), $ALXN(ALXN-1210 in PNH), $ITCI (Mid-2016: ITI-007 top-line data)Btw, Estimated #Earnings Per Share for $ALXN is $1.32 it's 0.86% of the current price https://t.co/EUmfP56dp8We calculated 63-day Expected Return of $ALXN for you: 8.54% https://t.co/kH5TlD4T2d$ALXN AH on the 60. Wow! Damn... I had puts, but took them off. 😨 May consider calls tomorrow. https://t.co/hf9gmBLg32@GeeSmithMD Are you remotely familiar with $ALXN's Soliris ? Do you know much about next gen Soliris whish is ALXN1210 ? First problem ?Not sure what to do with $ALXN? Explore our #fundamental pros and cons.  https://t.co/Ckq9cMgfEUNotable Movers in After Hours Trading: (Up) $SRPT $MS $FDP $GRMN $UNFI $Z $AXLL (Down) $NTES $ALXN $CTRP $CAH Bottom Losses:
$NTES -21.4%
$CACC -18.7%
$IBN -16.6%
$PSIX -16.2%
$EBF -10.8%
$ENVA -10.8%
$ALXN -10.6%
$CTRP -8.9%After-hours buzz: Sarepta $SRPT Alexion $ALXN Whole Foods  $WFM &amp; more https://t.co/py8K4B7mbQAlexion Announces Phase 3 Trial Failure; Shares Down 9% In After-Hours Trade $ALXN https://t.co/XCWqRmNwKwWondering about risks of $ALXN? The 21-day volatility is 9.62% https://t.co/feQ379wAgFSpread TTB https://t.co/U2LyGOEPuh $ALXN $APU $ATU $BTZ $CBRL $CGW $CHCT $CSOD $ELRC $ENZL $GLOB $IGI $IJK $IYZ $LCI $LDL $LXKRT @theflynews: Piper still sees accelerated approval for Soliris despite trial miss $ALXN: Full Story https://t.co/EWOBDac6MF#StockNews ― Piper still sees accelerated approval for Soliris despite trial miss $ALXN: Full… https://t.co/Lh2vl2FMJR → via @AlertTradeRT @theflynews: Piper still sees accelerated approval for Soliris despite trial miss $ALXN: Full Story https://t.co/EWOBDac6MFRT @theflynews: Piper still sees accelerated approval for Soliris despite trial miss $ALXN: Full Story https://t.co/EWOBDac6MFRT @theflynews: Piper still sees accelerated approval for Soliris despite trial miss $ALXN: Full Story https://t.co/EWOBDac6MFPiper still sees accelerated approval for Soliris despite trial miss $ALXN: Full Story https://t.co/EWOBDac6MFAfter Hours Gainers / Losers $GRMN $QUNR $UNFI $Z $DNAI $ALXN $IBN $ENVA $ESI $SIGM #IPO #unified like $NPK $TNH  https://t.co/FXPZSVBH9Mfirst 5 figure day ever for me opening balance of acc this morning was 27k thanks to $CYCC $HMNY $ALXN $VBLT $SRPT https://t.co/aXlXciJ8sDDo you know that #WallStreet price for $ALXN is $194.61 https://t.co/ZnxDR6OP9N",2016-06-07,ALXN,1
41,"NR7 Stocks https://t.co/8yEoKfpijJ $ALXN $KORS $VEEV $YPF $CIEN $PAAS $SNH $FDC $HL $NWSA $PPP $HYG $KEY $UNM $IWD $GRFS $CARRT @FiercePharma: Alexion's Soliris didn't ace its myasthenia gravis trial, but it might still win big sales https://t.co/zIjjpsy1FN $ALXN…RT @BioWorld: With Synageva, $ALXN got more synergies: opportunity for third rare disease asset, ""egg white"" platform, PPV, #Allicense2016…RT @BioWorld: $ALXN acquired Synegeva for high premium on science, ""transformational"" effect on second ""devastating"" disease. #Allicense201…With Synageva, $ALXN got more synergies: opportunity for third rare disease asset, ""egg white"" platform, PPV, #Allicense2016 #BIO2016$ALXN acquired Synegeva for high premium on science, ""transformational"" effect on second ""devastating"" disease. #Allicense2016 #BIO2016$ALXN Eculizumab in Refractory gMG REGAIN Phase 3 Results Presentation is now available #earnings https://t.co/wDWkEWnzY7$ALXN Bank of America Merrill Lynch 2016 Health Care Conference Presentation is now available #earnings https://t.co/xMIvOMvJ6QRT @FiercePharma: Alexion's Soliris didn't ace its myasthenia gravis trial, but it might still win big sales https://t.co/zIjjpsy1FN $ALXN…Alexion's Soliris didn't ace its myasthenia gravis trial, but it might still win big sales https://t.co/zIjjpsy1FN $ALXN #pharma #marketing#AlexionPharmaceuticals $ALXN S&amp;P lowered their rating from Buy to Hold #financialadvice #moneymanagement #stocks #investing #WallStreethttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBSVolume Alert - ALXN 138.76 Alexion Pharm Inc $ALXN Hit a high today of 139.79 Closing the day 10:30 at 138.76  https://t.co/9ETmXoL7dS7 users on Vetr are bullish on Alexion Pharmaceuticals, Inc., indicating a STRONG BUY Rating (5 stars) for $ALXN https://t.co/9E59wxz4mN$ALXN: Analyst action by Morgan Stanley on Alexion Pharmaceuticals: https://t.co/kQc0BTe5an https://t.co/OZ4qDBtEGuPrudential Financial Inc. Has $48,131,000 Stake in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/Mimoj4zsM7Trending #Biotech topics include $MDVN, $ALXN, #Cfda #stocks #invest See more https://t.co/EpbbdqDEG1$ALXN - SELL Signal at 138.13 on Jun 07, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investing#biotech #ASCO2016 Goldman Jeffries $BIIB $ALXN and it's only Wednesday $ANTH $ACAD $ALKS $INCY $MDCO $NVAX$BIIB $ALXN $FFIV options have the largest change in price. Free options screener. https://t.co/xifIUdCHXqAlexion Pharmaceuticals loses 10.88% to $138.13 on Tuesday:Among top 10 losers on S&amp;P500 https://t.co/EcJGUmJE9p $ALXN #nasdaq #stockmarketStocks to watch for today: $AMG $ALXN $MO $BHI $CMS $ED $DISCA $DISCK $ILMN $IVZ $LOW $TAP $NWS $NKE $NI $ORCL $PEG $SIG $TROW $TRIP $VIA.BBiotech Forum Daily Digest: Buyout Ahead For Acadia? Two High Profile Trial Disappointments... https://t.co/knotLGQS40 $ACAD $ALXN $BIIBBiotech Forum Daily Digest: Buyout Ahead For Acadia? Two High Profile Trial Disappointments... https://t.co/zvtgIgcKHI $ACAD $ALXN $BIIBBiotech Forum Daily Digest: Buyout Ahead For Acadia? Two High Profile Trial Disappointments... https://t.co/cBqo6Pwvbm $ACAD $ALXN $BIIBI am bullish on $ALXN with a target price of $165.76 in 6 mos. on Vetr! https://t.co/5lI6hLXyKmRT @specstockspulse: Get your say in on $ALXN at SpeculatingStocks, the discovery engine. https://t.co/cZYMJI2GFb #stocksGet your say in on $ALXN at SpeculatingStocks, the discovery engine. https://t.co/cZYMJI2GFb #stocks@jimcramer any idea what's going on with $alxn? re lawsuits?Regain Pain For Alexion's Soliris https://t.co/3TvsYHWWdr $ALXNRegain Pain For Alexion's Soliris https://t.co/mZ5eU1Eg02 $ALXNOk, so momentum has been falling and price crossed below 50MA. What do you think from here for $ALXN?… https://t.co/TCLS0mZKG9#Pharma $ALXN (Alexion Pharma) dwn -10.9% on 4.3x vol, 1W prf of -9.54% TD:07-Jun-2016 $VHT https://t.co/Me8imXM1vK https://t.co/CNDHR3BBDuRT @dass5981: Alexion Pharmaceuticals loses 10.88% to $138.13 on Tuesday:Among top 10 losers on S&amp;P500 https://t.co/XDBZbuxUAD $ALXN #nasda…Alexion Pharmaceuticals loses 10.88% to $138.13 on Tuesday:Among top 10 losers on S&amp;P500 https://t.co/XDBZbuxUAD $ALXN #nasdaq #stockmarketAlexion Pharmaceuticals loses 10.88% to $138.13 on Tuesday:Among top 10 losers on S&amp;P500 https://t.co/NgpAjMA0nu $ALXN #nasdaq #stockmarketRT @BikeRieder: Hate failures like $ALXN / $BIIB but exactly that will generate more chances to sell/license platform/candidate for SMID ca…Alexion Pharmaceuticals loses 10.88% to $138.13 on Tuesday:Among top 10 losers on S&amp;P500 https://t.co/bGX5mcPfvB $ALXN #nasdaq #stockmarketAlexion Pharmaceuticals loses 10.88% to $138.13 on Tuesday:Among top 10 losers on S&amp;P500 https://t.co/EcJGUmJE9p $ALXN #nasdaq #stockmarketRT @theflynews: Goldman cuts Biogen price target cut to $267 following failed multiple sclerosis trial: https://t.co/WckBpQfxO1 $BOIB $ALXNBenzinga: Alexion Closed Down 10%; Piper Says 'Buy On Weakness' $ALXN https://t.co/6OELtTBNyzBenzinga: Alexion Closed Down 10%; Piper Says 'Buy On Weakness' $ALXN https://t.co/8grx4Wf0NyAlexion Closed Down 10%; Piper Says 'Buy On Weakness' $ALXN https://t.co/ueTCn7ZQ7M#Alexion skids as muscle drug trial fails to meet primary goal . Read more: https://t.co/Zl7T7IeVjL $ALXN#Alexion skids as muscle drug trial fails to meet primary goal . Read more: https://t.co/y5EkfRGHZT $ALXNColumbia Partners L L C Investment Management Has $5,806,000 Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/9vvQIny1ey$ALXN: Analyst action by Morgan Stanley on Alexion Pharmaceuticals: https://t.co/kQc0BTe5an https://t.co/wpsuooaXzN#Alexion Levi &amp; Korsinsky, LLP Announces the Commencement of an Investigation Into Possible... Read more: https://t.co/ultrksZI1r $ALXN#Alexion Levi &amp; Korsinsky, LLP Announces the Commencement of an Investigation Into Possible... Read more: https://t.co/zfBtOWGl0G $ALXN#Alexion SHAREHOLDER ALERT: Levi &amp; Korsinsky, LLP Announces the Commencement of an Investig... Read more: https://t.co/ibGikC2pva $ALXN#Alexion SHAREHOLDER ALERT: Levi &amp; Korsinsky, LLP Announces the Commencement of an Investig... Read more: https://t.co/LJB6jpATaz $ALXNAlexion Pharmaceuticals, Inc. $ALXN Given “Buy” Rating at BMO Capital Markets https://t.co/k3xhXnxUpYAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Credit Suisse https://t.co/OsltW5IqxhAlexion Pharmaceuticals, Inc. $ALXN Given “Buy” Rating at BMO Capital Markets https://t.co/jmveUwYT4QAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Credit Suisse https://t.co/kQWgscMQ3RAlexion Pharmaceuticals, Inc. $ALXN Given New $165.00 Price Target at Barclays https://t.co/7zYGnsHUA4Alexion Pharmaceuticals, Inc. $ALXN Given Hold Rating at Citigroup Inc. https://t.co/fzdNWfrksqBank of America Reiterates “Buy” Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/JxJiC7NIuWAlexion Pharmaceuticals, Inc. $ALXN Given “Buy” Rating at Oppenheimer https://t.co/sdC2v3S9Q5Alexion Pharmaceuticals’ $ALXN Buy Rating Reaffirmed at Leerink Swann https://t.co/BOj9uortkaAlexion Pharmaceuticals, Inc. $ALXN Given “Buy” Rating at Oppenheimer https://t.co/0BOd1DHIhgBank of America Reiterates “Buy” Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/WsjR1D2YEhAlexion Pharmaceuticals’ $ALXN Buy Rating Reaffirmed at Leerink Swann https://t.co/hE0tqk6ujGAlexion Pharmaceuticals, Inc. $ALXN Given Hold Rating at Citigroup Inc. https://t.co/5Kfk05ITVOAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Piper Jaffray https://t.co/0N2jXwvvVrAlexion Pharmaceuticals’ $ALXN Buy Rating Reaffirmed at Leerink Swann https://t.co/ZbLU9HExiaAlexion Pharmaceuticals, Inc. $ALXN Given Hold Rating at Citigroup Inc. https://t.co/eEjC7Cte93Alexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Piper Jaffray https://t.co/cigvVhAFPx$ALXN 138,13$ -10,9% enttäuschende Studiendaten - #BBBiotech Top-6-Wert kräftig unter Druck #BBiotech #Buy /SC https://t.co/GVj9rr6MF5RT @theflynews: Failure in Biogen clinical trial drives Piper to call for strategic change $BIIB $RHHBY $ALXN: Full Story https://t.co/wUNJ…$ALXN - SELL Signal at 138.13 on Jun 07, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investingWe have detected 4you, extraordinary volume change on $ALXN https://t.co/vfU8zMv4R7 #stocksInvestors Buy Alexion Pharmaceuticals, Inc. $ALXN on Weakness After Analyst Downgrade https://t.co/DA4lEeCvwTToday's #SP500 biggest winners: $FFIV (+13%), $NBR (+6%), $EOG (+5%). The biggest losers: $BIIB (-13%), $ALXN (-11%), $TRIP (-4%)$ALXN: Analyst action by Morgan Stanley on Alexion Pharmaceuticals: https://t.co/kQc0BTe5an https://t.co/JyDcEri8nrAlexion Pharmaceuticals, Inc. $ALXN Rating Increased to Strong-Buy at Vetr Inc. https://t.co/iWqilqiZSLRT @theflynews: Failure in Biogen clinical trial drives Piper to call for strategic change $BIIB $RHHBY $ALXN: Full Story https://t.co/wUNJ…Alexion Pharmaceuticals upgraded by Vetr Inc. to strong-buy. $171.50 PT. https://t.co/Y8hbIkzvmS $ALXN #ALXNRT @theflynews: Failure in Biogen clinical trial drives Piper to call for strategic change $BIIB $RHHBY $ALXN: Full Story https://t.co/wUNJ…Alexion Pharmaceuticals Reiterated Rating by CIBC Oppenheimer (Ranked 50th) to Buy $ALXN #ALXN https://t.co/Q2kHA28grsAlexion Pharmaceuticals Reiterated Rating by Brean Capital (Ranked 73rd) to Buy $ALXN #ALXN https://t.co/Q2kHA28grsBiggest losers today large caps:
$BIIB -12.76%
$ALXN -10.88%
$JD -5.62%
$BMRN -4.49%
$TRIP -3.96%
$INCY -3.57%
$DISCA -3.57%
$FCX -3.52%RT @LTbioinvestor: $XBI $IBB weak day in #biotechs but could have been even worse given 3 giants smackdown ... 
$ALXN $BIIB $VRXon watch tomorrow $VRX $SRPT $ZG $Z $MIK $ENDP $ALXN $BIIB $TOL $TEAM $IONS $RLYP $KANGRT @scalpthatstock: Clinical Trial Failures Hit Shares of Biogen and Alexion
   
  https://t.co/wmkXoKxynJ
   
  $BIIB $ALXN https://t.co/I…RT @LTbioinvestor: $XBI $IBB weak day in #biotechs but could have been even worse given 3 giants smackdown ... 
$ALXN $BIIB $VRXJune 7, 2016 RS Movers – GTLackey's RPM https://t.co/hWAwxlxtYC $URA $IHF $XTN $IAI $ACAT $MOS $PCLN $NOV $SLB $SWKS $BEAV $TXT $BIIB $ALXNWatch these gap downs for intra-day bounce plays
https://t.co/AQhrxDM6Oa
$VRX $FCX $BIIB $MIK $CTLT $ALXN $MONClinical Trial Failures Hit Shares of Biogen and Alexion
   
  https://t.co/wmkXoKxynJ
   
  $BIIB $ALXN https://t.co/IY14AmtTu2Stock Market Mentor: 3 Stocks I Saw on TV
   
  https://t.co/8zGl055Ks2
   
  $AMZN $GOOGL $ALXN https://t.co/93zKv03xjv$ALXN is one of biggest losers #stocks today. read more: - Alexion Pharmaceuticals, Inc. (symbol: ALXN) was one... https://t.co/Al3f5uz5uqRT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. Valeant slashes guidance again &amp; more news.. https://t.co/rbH0b53Am4 #pharma $VRX…$ALXN is one of biggest losers #stocks today. read more:  https://t.co/bzkhCLNzmbNext $ALXN this was a beauty, I wanted more range on it, BUT I told Subs watch for the pull to $137 at open GO LONG! https://t.co/R7ZSVUIFq8",2016-06-08,ALXN,0
42,"Stochastic OS https://t.co/eRLoLsMZmZ $BIIB $ALXN $ARCC $BEN $RDN $SEAS $XON $FOLD $LYG $JMEI $AST $RBS $ECPG $CYTR $OMED $PUK $NPTNRT @StockTwits: Look at biotech today. 3 stocks are dropping hard:

$BIIB -9%
$ALXN -9%
$VRX - 17%

What happened to Biogen:… https://t.co/…Will be out of town til mid next week.   Eyeing weekly chart on $BIIB $ALXN looking for breakdown.bubble is bursting $BIIB $IBB $REGN $ALXNS&amp;P500 #Stocks Performance $SJM $AAL $ENDP $UAL $AAP $LUV $TRIP $SYK $ALXN $BCR $DAL $TSN $XL $BSX $ATVI  more@ https://t.co/RPeaHBZz9yhttps://t.co/5ebuP3bH7e Free trial of JBS stock trading teaching service! $LGND $UTHR $ALXN $EBSAll out $ALXN for profit.Took more $ALXN off for gains. Still holding 1/4 of original position.#WiadomościETF #ETF $ALXN $SPY $IBB $VRX https://t.co/VomjTb8LoA#Alexion #Pharmaceuticals, #Solaris Fails to Fight Myasthenia Gravis $ALXN ➜ https://t.co/eBowMz3Zqk https://t.co/aaSTYZST1OOPPY EHA E-Posters To Be Released Tomorrow: Complement in Focus
$ALXN $ACHN $AKTX $ALNY$ALXN - SELL Signal at 138.13 on Jun 07, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investing@tgtxdough I wonder how much $ALXN's FCF forecasts have come down after Phase 3 MG miss?$ALXN Goldman Sachs 37th Annual Global Healthcare Conference Audio is now available #earnings https://t.co/9mMtwzpHq3Alexion Pharmaceuticals’ $ALXN “Buy” Rating Reiterated at Bank of America https://t.co/9bHC4pVVk5Alexion Pharmaceuticals, Inc. $ALXN Upgraded to “Strong-Buy” at Vetr Inc. https://t.co/S3uplmqW12Alexion Pharmaceuticals’ $ALXN “Buy” Rating Reiterated at Bank of America https://t.co/rfN4Xtoh1eAlexion Pharmaceuticals, Inc. $ALXN Upgraded to “Strong-Buy” at Vetr Inc. https://t.co/L4EZELRkTTBMO Capital Markets Reiterates Buy Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/r72vf4skqfLeerink Swann Reiterates “Buy” Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/0nzMTFi3G7Alexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Morgan Stanley https://t.co/zNoTLmm5iKAlexion Pharmaceuticals, Inc. $ALXN PT Lowered to $165.00 https://t.co/jk16wrAkeNAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Brean Capital https://t.co/VgvaUeOI2JBMO Capital Markets Reiterates Buy Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/uHUV797VWxAlexion Pharmaceuticals, Inc. $ALXN Earns Buy Rating from Piper Jaffray https://t.co/mn0tSAgSObAlexion Pharmaceuticals, Inc. $ALXN PT Lowered to $165.00 https://t.co/4wZxtgUvLZAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Brean Capital https://t.co/ZrnWz9SGH0Credit Suisse Reaffirms Hold Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/yRI9il1JctAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Morgan Stanley https://t.co/CNR6gZsikdAlexion Pharmaceuticals, Inc. $ALXN Upgraded to “Strong-Buy” at Vetr Inc. https://t.co/DGPRoQIVlmAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Oppenheimer https://t.co/Prha2DCDCALeerink Swann Reiterates “Buy” Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/P4oLrcnV6pCredit Suisse Reaffirms Hold Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/E0ENVcYdfjAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Brean Capital https://t.co/bzNJEzayiVCredit Suisse Reaffirms Hold Rating for Alexion Pharmaceuticals, Inc. $ALXN https://t.co/ixZL6onPHXAlexion Pharmaceuticals, Inc. $ALXN Rating Reiterated by Morgan Stanley https://t.co/UmPfvp1PKHAlexion Pharmaceuticals, Inc. $ALXN Upgraded to “Strong-Buy” at Vetr Inc. https://t.co/pmabZVA3hcRegain Pain For $ALXN #Alexion 's Soliris https://t.co/y3Sg89H5GWWe calculated 21-day Expected Return of $ALXN for you: -2.18% https://t.co/kH5TlDmuqNDo you know that #Book Value for $ALXN is $35.96 https://t.co/yRAeHkOIJHAlexion Pharmaceuticals, Inc. $ALXN Receives “Buy” Rating from Cowen and Company https://t.co/QGHmDP16OS$ALXN Alexion Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript #earnings https://t.co/0JhqqGJppART @BioWorld: $ALXN acquired Synegeva for high premium on science, ""transformational"" effect on second ""devastating"" disease. #Allicense201…Alexion Pharmaceuticals Reiterated Rating by Cowen &amp; Co (Ranked 53rd) to Buy $ALXN #ALXN https://t.co/Q2kHA28grsTraders Buy Alexion Pharmaceuticals, Inc. $ALXN on Weakness Following Analyst Downgrade https://t.co/5QvW0jZglFAlexion Pharmaceuticals's buy rating reiterated at Cowen and Company. https://t.co/UAFzGcF3Dp $ALXN #ALXNTraders Buy Alexion Pharmaceuticals, Inc. $ALXN on Weakness Following Analyst Downgrade https://t.co/8fAxQOOyzVAlexion Pharmaceuticals, Inc. $ALXN  Shares Down 10.5%  Following Analyst Downgrade https://t.co/4a0a21BMcx$ALXN: Analyst action by Morgan Stanley on Alexion Pharmaceuticals: https://t.co/kQc0BTe5an https://t.co/cTX2AO8tK0Connor Bruggeman SchoolTrader made $300,000 and he is only 17! https://t.co/Zemtk5KBsT  $DIS $ALXN $NOAH $GILD $QUNR$BIIB $ALXN $FFIV options have the largest change in price. Free options screener. https://t.co/xifIUdCHXqRT @iviewmarkets: Worst $SPY performers today: $BIIB $ALXN $TRIP $DISCA $FCX $CMG $DISCK $STZ  https://t.co/iC7lxcHHSa https://t.co/DLTlWZw…Alexion Pharmaceuticals, Inc. $ALXN Sees Large Volume Increase https://t.co/iexQUmmNFKAlexion Pharmaceuticals, Inc. $ALXN Sees Large Volume Increase https://t.co/5pqaJfKHHA",2016-06-09,ALXN,0
43,"Below Keltner https://t.co/oKkGrzDjn0 $BAC $VEA $MTG $GRPN $AMX $MRNS $TSN $VEU $SCHF $EWW $PBF $IEFA $SFM $ALJ $VNTV $SNY $ALXNhttps://t.co/5ebuP3bH7e EXCLUSIVE OFFER for stock trading teaching service!!!!!$LGND $UTHR $ALXN $EBS@RNAiAnalyst MG data was skewed by 3 patient drops with 2 doing v well. $ALXN will press on &amp; see what happens in this debilitating disease$ALXN - Alexion Pharmaceuticals' #ALXN Neutral Rating Reiterated at Robert W. Baird https://t.co/WTs21Ae1BEAlexion Pharmaceuticals's neutral rating reiterated at Robert W. Baird. $145.00 PT. https://t.co/efW0zeIHUv $ALXN #ALXNBAML ALN-CC5 is not clinically viable as a monotherapy for PNH and the competitive threat from ALN-CC5 on $ALXN is all but gone.Alexion Pharmaceuticals, Inc. $ALXN Raised to “Strong-Buy” at Vetr Inc. https://t.co/d8Jgv4HJwVBiotech Forum Daily Digest: Biotech Gives Back Gains. Eagle Soars On Patent Ruling! Positiv... https://t.co/SbCUYj8AHj $AGEN $AGN $ALXN@smallcapbiotech The $ALNY news that CC5 is not competitive with $ALXN Soiris1210 is not new news since the co said this last Q conf callNN Investment Partners Holdings N.V. Takes Position in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/0fJ6jwfbts$ALXN:

Alexion Pharma (ALXN): Alnylam Misstep with ALN-CC5 Does Not …:

https://t.co/1k8LkQH4oUAlexion Pharmaceuticals, Inc. $ALXN Earns “Buy” Rating from Cowen and Company https://t.co/TL2vifvxG2Alexion Pharmaceuticals, Inc. $ALXN Earns “Buy” Rating from Cowen and Company https://t.co/hceY7y9XmMRecent Analysts’ Ratings Updates for Alexion Pharmaceuticals $ALXN https://t.co/57IaNfLoeqAlexion Pharmaceuticals, Inc. $ALXN Receives “Overweight” Rating from Morgan Stanley https://t.co/rpTqlWLg3f_EDR Education Realty Trust Inc. Yield
https://t.co/NOsBRePO92

$_EDR $ALXN $MNKD $X  #finance #stockGILD Gilead Sciences, Inc. Yield
https://t.co/SjMyCxU6Rp

$GILD $GRCU $ALXN $AAPL  #nasdaq #stocksALXN Alexion Pharmaceuticals, Inc. Last Price
https://t.co/dDysS7rBFW

$ALXN $NKE $DGAZ $INTC  #finance #tradeideas",2016-06-13,ALXN,0
44,"The EVP &amp; GC of Alexion Pharmaceuticals (NASDAQ: ALXN) is Selling Shares $ALXN https://t.co/saofOYzwpr$ALXN New SEC Document(s) for Alexion Pharmaceuticals, Inc.
From our Stock News Alerts App$ALXN:

New Insider Filing on

EVP &amp; General Counsel

JOHN B MORIARTY:

https://t.co/EB1H5Yppt4 https://t.co/dOTW5nZf05$ALXN William Blair 36th Annual Growth Stock Conference Presentation is now available #earnings https://t.co/OA73Bx4pfdhttps://t.co/ipALk92X8U  Learn Jason Bonds Trading Secrets Now! *Free Trial*!!! $ALXN $VBLT $ZRT @TomSilver39: GS:"" M&amp;A: $ALXN, $CELG, $GILD and $VRTX =late stage smid-caps are most likely targets...""GS:"" M&amp;A: $ALXN, $CELG, $GILD and $VRTX =late stage smid-caps are most likely targets...""Alexion Pharmaceuticals hits a 1 month low https://t.co/aEEDfHQ1QP $ALXN #AlexionPharmaceuticals https://t.co/KPYc1fFDcz$AGEN $AGN $ALXN $BIIB $EGRX $FLML $GALE $MRK $MYL $PFE $PRGO $SPH https://t.co/EHhnPaDEYjRT @tgtxdough: $ALXN Phase II trial for Kanuma in infants with Rapidly Progressive Lysosomal Acid Lipase Deficiency moved ahead  from Feb 2…$ALXN Phase II trial for Kanuma in infants with Rapidly Progressive Lysosomal Acid Lipase Deficiency moved ahead  from Feb 2019 to May 2018.Alexion Pharmaceuticals, Inc. $ALXN Given “Neutral” Rating at Robert W. Baird https://t.co/Bb3lWZEgRPAlexion Pharmaceuticals, Inc. $ALXN Upgraded at Vetr Inc. https://t.co/aPAclmugH7$IBB monthly $GILD $CELG $BIIB $REGN $CELG $ALXN $AGN https://t.co/HwAS0vZjv3$ALXN: Analyst action by Morgan Stanley on Alexion Pharmaceuticals: https://t.co/kQc0BTe5an https://t.co/urm0uSiiypRT @JFDI: Charts Of Interest - $IBB $ALXN $ILMN $JAZZ $REGN  $BIIB https://t.co/tEw4yl1SrtCharts Of Interest - $IBB $ALXN $ILMN $JAZZ $REGN  $BIIB https://t.co/tEw4yl1Srt",2016-06-14,ALXN,0
45,"Wondering about #sentiment indicator for $ALXN? The Short Ratio is 4.1% https://t.co/Kq9dHopACbDo you know that #Book Value for $ALXN is $35.96 https://t.co/yRAeHkOIJHWondering about risks of $ALXN? The 21-day volatility is 13.75% https://t.co/feQ379ObFf$ALXN William Blair 36th Annual Growth Stock Conference Audio is now available #earnings https://t.co/nrXSpuL2cqAlexion Pharmaceuticals, Inc. $ALXN EVP Sells $124,590.96 in Stock https://t.co/z2mpcIIHjCAlexion Pharmaceuticals, Inc. $ALXN EVP Sells $124,590.96 in Stock https://t.co/a2MqoIkIE9Alexion Pharmaceuticals, Inc. $ALXN EVP Sells $124,590.96 in Stock https://t.co/jGK1mzIAGDTriple Bottom BD https://t.co/dpEnLSD5JR $AIMT $ALJ $ALXN $APA $BFCF $CNTF $CPSI $CTB $CUTR $DANG $DHX $DTYS $ESL $GES $GIFI $GME $GUSH",2016-06-15,ALXN,0
